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ANTHONY PRESLEY LEONARD. Phosphodiesterase Inhibition and Adenosine 
A2B Receptor Signaling in Mitochondrial Function: Pharmacology and Toxicology of 3-
isobutyl 1-methylxanthine (IBMX) in the 661w Retina-Derived Cell Line. (Under the 
direction of Bärbel Rohrer and Craig Beeson) 
3-isobutyl 1-methylxanthine (IBMX) is a commonly used inhibitor of cyclic 
nucleotide phosphodiesterases (PDE) and G protein coupled adenosine receptors. 
Administration of IBMX to retina photoreceptor-derived 661w cell line results in 
decreased mitochondrial respiration followed by cell death, mimicking phenomena 
observed in inherited retina neurodegeneration in humans and animals and thus 
suggesting their use as a cell-based model of retina degeneration. In this dissertation, 
the temporal relationship between pathways altered by IBMX and how these pathways 
affect mitochondrial physiology are evaluated. These studies utilize a novel high content 
microscopic method for simultaneously measuring mitochondrial morphology and 
membrane potential in living cultured cells to identify an increase in networked 
morphology (pro-fusion) and mitochondrial membrane potential within 1-4 h of IBMX 
administration that is sustained and accompanied by decreased uncoupled respiration at 
24 h. cGMP PDE inhibition was observed to recapitulate both the immediate and 
sustained physiological alterations as selective inhibitors of PDE3 and PDE5 increased 
mitochondrial membrane potential and interconnected morphology at 1 h which was 
followed by a decrease in mitochondrial respiration at 24 h similar to that elicited by 
IBMX. Administration of selective inverse agonist of adenosine A2B receptor 
xviii 
 
recapitulated the latent (24 h), but not early (1 h) IBMX-induced alterations in 
mitochondrial physiology. Administration of a selective agonist and antagonist prior to 
IBMX abrogated latent but not early IBMX-induced alterations. A similar pattern of 
reductions in latent but not early alterations were achieved by activating adenylate 
cyclase or protein kinase C. Inhibition of protein kinase A resulted in increased 
mitochondrial membrane potential at 1 h and 24 h. The concomitant increase of 
mitochondrial membrane potential with decreased respiration suggested decreased 
permeability of the mitochondrial inner membrane to inward proton flux, perhaps due to 
lack of ADP availability or decreased mitochondrial Complex V activity. Inhibiting 
mitochondrial permeability transition pore (mPTP) regulator GSK-3β prior to IBMX 
administration prevented increases in both membrane potential and networked 
morphology, suggesting GSK-3β activation follows IBMX. Taken together, this work 
demonstrates that IBMX first increases cGMP via inhibition of PDEs at 1 h to modulate a 
rise in mitochondrial membrane potential and networked morphology, followed by 
inverse agonism at the adenosine A2B receptor at 24 h. Downstream pathways invoked 
at 24 h include decreased adenylate cyclase and PKA signaling, as well as PKC. GSK-
3β activation following loss in PKA and PKC activity may integrate these PDE- and 





These studies use a cell-based model of retina mitochondrial dysfunction, in 
which concentration-dependent decreases in mitochondrial respiratory capacity (which 
corresponds to maximal ability to produce ATP [2]) occur following 24 h administration of 
IBMX (3-isobutyl 1-methylxanthine) to 661w photoreceptor cells, followed by cell death 
at 48 h [3, 4]. Although this model recapitulated mitochondrial dysfunction prior to cell 
death featured in rodent models of inherited retinal degeneration, the upstream 
mechanism or mechanisms by which IBMX leads to these cell-death associated 
decreases in mitochondrial respiration were unknown.  
The present work uses a high content imaging assay for mitochondrial 
morphology and function (Section 3—Chapter 1) to demonstrate that losses in 
mitochondrial respiratory capacity at 24 h and cell death at 48 h are preceded by 
mitochondrial membrane hyperpolarization and an increase in networked morphology as 
early as 1-4 h following IBMX treatment (Section 4—Chapter 2). Next, the modes of 
action of IBMX on two pharmacologically relevant target classes are evaluated: cyclic 
nucleotide phosphodiesterases (PDE, discussed in Section 5—Chapter 3) and the G 
protein-coupled receptor adenosine A2B receptor (Adora2b, discussed in Section 6—
Chapter 4). 
Taken together, these results lead to the hypothesis that IBMX alters 
mitochondrial physiology via two distinct modes of action – inhibition of 
phosphodiesterases and inverse agonism of the adenosine receptor A2B (Adora2b) – 
and that these distinct pathways show the potential for crosstalk as well as for 
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convergence on common downstream mediator GSK-3β to effect changes in 




2. Review of Literature 
2.1 Mitochondrial Function and Retina Neurodegeneration 
In humans, the typical course of the inherited retina neurodegenerative disease 
retinitis pigmentosa (RP) is characterized by a progressive loss of rod photoreceptors, 
leading to symptoms of decreased peripheral vision and night vision over months to 
decades. After loss of peripheral vision, many patients will also lose central vision [5]. 
RP comprises 50% of all inherited retina degenerations, which as a whole affect 200,000 
Americans. Highly heterogeneous in its genetic etiology, RP may appear by itself or as 
part of a syndrome or other complex disease (e.g. Usher, Bardet-Biedl). The Retina 
Information Network (RetNet) to date has identified 252 genes and loci associated with 
diseases and syndromes that feature inherited retina degeneration, 57 of which are 
associated with isolated RP (accessed May 1, 2014: https://sph.uth.edu/retnet). 3100 
mutations have been identified in these genes associated with isolated RP, and RP 
arising from just Usher or Bardet-Biedl syndromes alone are associated with 1200 
mutations in 29 genes. This genetic diversity leads to not only difficulty in identifying the 
genotype associated with RP, but highlights the difficulty of developing a single therapy 
to treat a genetically heterogeneous disease. As an example, even with modern deep 
sequencing methodologies, successful identification of a mutation is achieved in only 
80% of patients, whereas with more common genotyping strategies identification may be 
as poor as 30% [6]. 
Therapeutic strategies for RP may be broadly classified into two categories: 
those which aim to protect still living photoreceptors from degeneration (e.g. gene 
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therapy to correct loss of function mutations, neuroprotective drugs, and biologicals), 
and those that aim to recover loss of retina function (e.g. stem cell transplantation, 
regeneration, optogenetic modification of surviving retina neurons) [7]. Although the 
retina is particularly amenable to gene therapy approaches due to its immunoprivileged 
status and ease of access via its anatomical location [8], the genetic heterogeneity of RP 
suggests that either a single gene replacement therapy or a series of gene replacement 
therapies will likely face significant research, development, and/or regulatory hurdles in 
seeking approval. Thus, the identification of common phenotypic features amongst 
heterogeneous genotypes of RP is of paramount importance as such work may identify 
common targets to perturb that may mitigate or eliminate disease progression. 
Furthermore, support of these common phenotypic features may synergize with 
regenerative strategies or support cellular function in gene therapy strategies.  
One common phenotype of RP is bioenergetic failure as evidenced by decreases 
in mitochondrial function that is succeeded by cellular death. Indeed, mutations in 
nuclear or mitochondrial genes encoding for mitochondrial proteins often feature retina 
degenerative phenotypes in humans, such as Kearns-Sayres syndrome, Leber’s 
hereditary optic neuropathy, and Leigh syndrome [9]. Several groups have characterized 
that mitochondrial dysfunction is common to several mouse models of RP resulting from 
mutations in non-mitochondrial genes, including PDE6brd1/rd1, Rho-/-, PDE6batrd1/ atrd1, and 
Prph2rds/rds [10]. The best characterized animal model of RP, the rd1 mouse 
(PDE6brd1/rd1), is characterized by a rapid death of rod photoreceptor cells beginning at 
postnatal day (PND) 15 [5, 11-14]. However, as early as at PND 11 in the rd1 mouse, 
intramitochondrial Ca2+ (Ca2+m) levels significantly rise as evidenced by increased Rhod2 
fluorescence intensity [15].  
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Based on these studies, it was hypothesized that support of mitochondrial 
function, and thus maintaining bioenergetic capacity, may serve as a therapeutic option 
for photoreceptor neurodegeneration. To evaluate this hypothesis, the Rohrer lab 
developed a cell-based model of retina degeneration that mimics the mitochondrial 
dysfunction preceding cell death. Briefly, in this model, following administration of 3-
isobutyl-1-methylxanthine (IBMX) to the 661w photoreceptor cell line, loss in 
mitochondrial respiratory capacity occurs at 24 h followed by cell death at 48 h [4]. This 
sequence recapitulates the sequence observed in RP.  
2.2 3-isobutyl 1-methyl xanthine (IBMX) 
IBMX is a commonly used non-selective small molecule inhibitor of cyclic 
nucleotide phosphodiesterase (PDE) enzymes and adenosine receptors (ADOR) [16, 
17]. Our lab previously published that administration of 1 mM IBMX leads to an increase 
in reactive oxygen species (ROS) as evidenced by increased fluorescence intensity of 
redox-sensitive dye dihydrodichlorofluorescein (DCF) as early as 15 min, calpain 
activation as early as 1 h and caspase activation as early as 6 h [3]. Any one of these 
changes in and of themselves may lead to mitochondrial dysfunction by damage of 
electron transport chain (ETC) proteins. However, the upstream regulation of these 
effectors of cell death is poorly understood as are other relevant pathways that may 
mediate cellular mitochondrial dysfunction. Thus, it is the goal of this work to 
characterize the role of IBMX-induced alterations in PDE activity and adenosine 





2.3 The 661w Photoreceptor Cell Line 
The 661w cell line was first generated by the generation of a transgenic mouse 
line expressing the viral oncoprotein SV40 T antigen driven by the human IRBP 
(interphotoreceptor binding protein) promoter. These mice developed spontaneous, 
bilateral tumors in the brain and retina [18]. Cells from these tumors were found to 
survive in culture and later characterized to express a number of photoreceptor proteins 
[19]. When transfected with RPE65 hydrolase, 661w cells were determined to cycle 
exogenously administered 11-cis retinol to all-trans retinal, indicating functional activity 
of the phototransduction cascade [20]. However, 661w cells lack some key members of 
the phototransduction cascade, including subunits of the cyclic nucleotide gated-cation 
channel (CNG) [21, 22]. Investigations confirmed that 661w cells do not conduct a 
plasma membrane current in response to stimulation of this channel by exogenously 
administered IBMX, cGMP, or activation of guanylate cyclase with nitric oxide donors 
(Supplementary Figure 11). Further studies using Ca2+-sensitive dye Fluo-4 AM 
demonstrated no increase in intracellular Ca2+ following IBMX administration 
(unpublished results). Therefore, early-onset changes in 661w cell physiology as a result 
of IBMX administration are not likely due to increased Ca2+ current through CNG but are 
instead due to alteration of other intracellular pathways, including elevation of 
intracellular concentrations of cAMP and/or cGMP.   
Of importance to note is that in the absence of CNG channel-mediated influx of 
Ca2+ into the cytoplasm, 661w cells may be able to achieve even greater intracellular 
cGMP accumulation. Ca2+ influx normally inactivates guanylate cyclase (GC), a negative 
feedback mechanism which offsets the increase induced by inhibition of cGMP-specific 
PDE’s [23]. Evidence of this feedback mechanism in photoreceptors has been 
demonstrated; administration of PDE inhibitors to purified rod outer segments resulted in 
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only 20-30% increases in intracellular cGMP in the absence of Ca2+ buffer EGTA but 
when EGTA was included, 400% increases were observed, suggesting compensatory 
GC inactivation was overcome by removing Ca2+ stimulus [24]. 
2.4 Cyclic Nucleotide Phosphodiesterases (PDE) and Retina 
Neurodegeneration 
Cyclic nucleotide phosphodiesterase (PDE) enzymes are present in virtually all 
tissues and catalyze the conversion of one or both biological cyclic nucleotides cyclic 
adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) into 
their non-cyclic forms (AMP, GMP) [25]. In humans, there are 11 PDE isoforms which 
are each comprised by one or more subunits encoded by one gene for each. Although 
the PDEs have been primarily popularized as a drug target by the advent of PDE5 
inhibitors to treat erectile dysfunction, other PDEs play important physiological roles [26, 
27]. In the retina, two distinct trimeric isoforms (one in rods, one in cones) of PDE6 aid in 
the transduction of light to a neuronal (electrical) signal by loss of inhibition via their 
gamma, or inhibitory subunits, following binding of the G protein alpha subunit 
transducin. Thus, when stimulated by light, the G protein coupled receptor cone opsin 
(or rhodopsin in rods) leads to PDE6 activation, catalyzing the turnover of cGMP, which 
subsequently leads to the closure of cGMP-cated cation channels to stop the influx of 
Ca2+ into the cell. This cessation of Ca2+ hyperpolarizes the photoreceptor, which is 
interpreted by multiple downstream neurons as light. 
In the rd1 mouse (also known as C3H or rd), a non-sense mutation in the β, or 
catalytic, subunit of PDE6, PDE6Brd/rd, leads to rapid photoreceptor death characterized 
both by increased intracellular Ca2+ and cGMP [11-14, 28, 29]. Interestingly, however, 
either pharmacological or genetic inhibition of the CNG channel in the rd1 mouse have 
each been demonstrated to achieve only partial recovery against photoreceptor cell 
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death [30, 31]. Further evidence suggests that protein kinase G (PKG, another cGMP-
activated protein) activation in the absence of CNG-mediated Ca2+ influx is toxic to 
photoreceptors in that pharmacologic inhibition of PKG partially rescued rd1 retina 
explants against photoreceptor cell death and activation of PKG in wild type retina 
explants induced cell death [32]. These findings are important as in the IBMX/661w 
model of photoreceptor degeneration there is no Ca2+ influx owing to the absence of 
CNG channels (Supplementary Figure 11), and highlights the possibility that 
cGMP/PKG may mediate the cytotoxicity observed. 
Sparked by multiple reports that PDE5 inhibitor sildenafil has toxicity issues in 
some humans (patients report seeing blue), Nivison-Smith et al. studied sildenafil 
exposure in rd1 mice. Firstly, they demonstrate that electroretinogram (ERG) responses 
in wild type mice experience a dose-responsive decrease following sildenafil exposure 
which typically recovered within two days. They showed that mouse carriers 
(heterozygous) for the rd1 mutation in PDE6B (PDE6Brd1/wt) in comparison to wild type 
controls displayed a prolonged (2 week) decrease in ERG responses following exposure 
to PDE5 inhibitor sildenafil. Additionally, retinas showed an increase in cytochrome C 
expression [33]. These data lend credence to the hypothesis that inhibition of cGMP-
specific phosphodiesterase enzymes (PDE5 and PDE6) and the subsequent increase in 
intracellular [cGMP] leads to mitochondrial dysfunction. 
3’-5’ cyclic guanosine monophosphate (cGMP) is a common intracellular 
messenger best known for its vasodilatory effects in response to endothelial cell-derived 
nitric-oxide in turn activating cGMP synthesis in vascular smooth muscle via activation of 
guanylate cyclase [34]. However, cGMP has tissue- and subcellular-specific roles as 
well. Its role in photoreceptor cell phototransduction and viability in retina degeneration 
has been discussed earlier. cGMP has been shown to modulate signaling events as 
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diverse as neuronal long-term potentiation (important for learning) [35] and renal 
mitochondrial biogenesis [36]. Therefore, measuring the concentration of cGMP alone is 
not predictive of cellular response, as both the tissue and subcellular context are of 
paramount importance. The role of subcellular compartmentalization of these cyclic 
nucleotides, their generators adenylate/guanylate cyclase, and their resolvers the PDEs 
has been underscored in a recent review [37]. For instance, PDE5 has been shown to 
localize to the plasma membrane, ER, and cytoplasm. In these three compartments, 
respectively, PDE5 has been shown to have an effect in cardiac myocyte contractility, 
platelet aggregation, and cardiac contractility. PDE3A and PDE3B demonstrate even 
more complex and varied subcellular localization patterns that result in the regulation of 
processes as varied as cardiac/myocyte contractility, plasma membrane potential, 
vesicular transport, and insulin-mediated lipolysis. Quite interestingly, PDE4A and 
PDE4B have even been reported to bind to mitochondrial A kinase anchoring protein 
AKAP149 in T lymphocytes [38], mutations in which result in a more fissioned 
mitochondrial morphological phenotype in HeLa cells [39]. Further evidence for a linkage 
between cAMP elevation and increased mitochondrial network elongation has been 
demonstrated by Merrill et. al. in that PC12 cells exogenously administered a cell-
permeable analog of cAMP or forskolin increased mitochondrial length [40].  
2.5 Adenosine Receptor Function  
Adenosine signaling is an important regulator of myriad physiological functions, 
from wakefulness and metabolic regulation in the central nervous system (CNS) and 
heart, and from photoreceptor coupling (increasing sensitivity to dim light at the cost of 
resolution) in the retina to mitochondrial susceptibility to damage following 
ischemia/reperfusion injury in central nervous system, heart, and kidney [41-44].  
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Signaling through extracellular release of adenosine or conversion of 
extracellular ATP to adenosine are two methods by which plasma membrane adenosine 
receptors may be activated [45]. Adenosine and its biological or pharmacological 
derivatives bind to a number of extracellular G protein-coupled receptors (GPCRs) and 
ligand-gated ion channels split into three broad classes. The first major class of 
adenosine-binding receptors are deemed the P2X receptors, and are oligomeric ion 
channels activated by various phosphorylated purines and pyrimidines (e.g. adenosine 
di- and tri-phosphate [ADP, ATP], and uridine diphosphate [UDP] and UDP-glucose). 
P2Y receptors are the second major class of purine phosphate-binding receptors, and 
are GPCRs displaying low affinity for unmodified adenosine. The P1, or simply termed 
adenosine receptor class, is represented currently by four GPCRs, the A1, A2A, A2B, and 
A3 adenosine receptors. Each receptor has varying specificity as to which G protein 
subunit(s) it couples to, and are involved in diverse intracellular signaling mechanisms 
within the cell (Table 6-1). As the xanthine derivative 3-isobutyl 1-methylxanthine (IBMX) 
has been previously described to inhibit the P1 or adenosine receptor subclass, and this 
subclass has been linked to the regulation of mitochondrial physiology, the studies in this 
dissertation will focus on understanding the role of P1 adenosine receptor signaling. 
Regulation of A2B signaling kinetics, like most GPCRs, is multifactorial; an 
important regulatory step in desensitization is manifest in post-translational modification 
of the A2B receptor by beta adrenergic receptor kinase 1 (BARK1/GRK2) [46], and by 
subsequent or independent regulation of its internalization/subcellular localization by 
arrestins or other known mechanisms of GPCR regulation [47].  
Indeed, retinal adenosine regulates retinal vascular function like it does in the 
heart and central nervous system, as well as regulating intraocular pressure [48]. 
Namely, agonism of adenosine receptors results in vasodilation and decreased 
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intraocular pressure. Although not a direct link between adenosine and retinal vasomotor 
responses, Brandli and Stone provide an argument for a soluble mediator (perhaps 
adenosine) by demonstrating that 10 min of ischemia induced in the hindlimb of rats 
resulted in significant (14%) increases in the a wave and b wave of the electroretinogram 
despite no changes in system vascular response (blood pressure, heart rate, oxygen 
saturation) [49].  
In the teleost retina, cone photoreceptor cells undergo elongation and shortening 
in a circadian pattern as a means of regulating sensitivity. Burnside et. al. showed that 
this process of myoid elongation is regulated by an A2-like adenosine receptor [50]. 
Activities of both the high-affinity A2A and a low-affinity (likely A2B) receptor were 
demonstrated in bovine rod outer segments, but the A2B subtype predominated in retinal 
pigment epithelium [51, 52]. 
2.6 RGC-5 Is a Subclone of the 661w Cell Line 
Very interestingly, a series of recent reports have demonstrated that the cell line 
RGC-5, originally characterized as a rat retina ganglion cell line [53], actually arose out 
of contamination in the originator’s lab with the murine 661w cell line [54, 55], leading to 
retraction of the former publication characterizing the cell line. Therefore, many of the 
publications using this cell line (which number 246 by keyword search “RGC-5” in 
MEDLINE at time of writing) may indeed be indicative of 661w (photoreceptor) 
physiology, and not that of retina ganglion cells. Of particular interest is a 2007 
publication using the RGC-5 cell line that demonstrated an increase in fissioned 
mitochondrial morphology, mitochondrial localization of Drp1 and decreased cellular 
ATP content following culture at 30 mmHg pressure (to simulate increased intraocular 
pressure seen in glaucoma) [56]. In a subsequent study, the same lab demonstrated 
Opa1 (fusion protein) and cytochrome c release from mitochondria cytoplasm and 
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activation of caspase 3 and apoptotic cell death following elevation of hydrostatic 
pressure [57]. Together, these studies demonstrate the feasibility of measuring 
mitochondrial morphology in 661w and highlights the possibility that increased 
hydrostatic pressure alone (in the absence of ischemia) may alter mitochondrial 
bioenergetics.  
2.7 Regulation of Mitochondrial Morphology 
Mitochondrial morphology is an actively regulated and dynamic feature altered by 
a number of molecular processes which can be generally segregated into two 
categories: those that promote fission and those that promote fusion. Small dynamin-like 
GTPase protein dynamin-related protein 1 (Drp1) assembles into a molecular motor that 
forms constricting rings around the mitochondrial outer membrane, utilizing energy 
derived from GTP hydrolysis to aid in membrane scission, or simplification of 
mitochondrial networks into smaller, simpler shapes (e.g. rod-like, puncta). Regulation of 
Drp1 occurs via several upstream modulators, including isoforms of cAMP-dependent 
protein kinase (PKA) and phosphatase PP2A [40, 58-63], translocation of Bax [63], and 
ubiquitylation by E3 ubiquitin ligase parkin [64]. The physiological importance of Drp1 is 
underscored as mutation in mice leads to embryonic lethality, and a single case report in 
a human neonate describes classical mitochondrial defects (lactic acidemia, abnormal 
brain development, and optic atrophy) prior to lethality at 37 days [65, 66]. On the other 
hand, the molecular motors that regulate mitochondrial membrane fusion serve at two 
distinct subcellular locations, the mitochondrial outer membrane and the mitochondrial 
inner membrane. Outer membrane regulators include mitofusin 1 (Mfn1) and mitofusin 2 
(Mfn2) while inner membrane fusion (and therefore cristae structure) is regulated by the 
protein optic atrophy 1 (Opa1) [67-69].  
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Frequently, mitochondrial morphology has been characterized by manual 
scoring. In an effort to reduce the selection bias and observer bias made necessary by 
the laborious process of manual inspection, a method was developed to classify and 
measure mitochondrial morphology, and is described in Section 3, Chapter 1—
Quantitative Analysis of Mitochondrial Morphology and Membrane Potential in 





3. Chapter 1—Quantitative Analysis of Mitochondrial 
Morphology and Membrane Potential in Living Cells Using 
High Content Imaging, Machine Learning, and Morphological 
Binning 
3.1 Highlights 
• Automated analysis of mitochondrial morphology & membrane potential in live cells 
• Mitochondrial shapes fit in four “bins”: punctate, rod, networked and large & round 
• Machine learning-derived algorithm categorizes mitochondria into morphological bins 
• Automated assessment of mitochondria-specific membrane potential (ΔΨm) using 
TMRM 
• Large and round category represents mitochondrial swelling 
3.2 Abstract 
Understanding the processes of mitochondrial dynamics (fission, fusion, 
biogenesis, and mitophagy) has been hampered by the lack of automated, deterministic 
methods to measure mitochondrial morphology from microscopic images. A method to 
quantify mitochondrial morphology and function is presented here using a commercially 
available automated high content wide field fluorescent microscopy platform and R 
programming language-based semi-automated data analysis to achieve high throughput 
morphological categorization (puncta, rod, network, and large & round) and 
quantification of mitochondrial membrane potential. In conjunction with cellular 
respirometry to measure mitochondrial respiratory capacity, this method detected that 
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increasing concentrations of mitochondrial toxicants (t-butyl hydroperoxide [TBHP], 
rotenone, antimycin A, oligomycin, ouabain, and carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone [FCCP]), decreased mitochondrial networked area in 
cultured 661w cells by 20-60% at concentrations that inhibited respiratory capacity 30-
80%. Mitochondrial swelling was indicated by 40-130% increases in large & round areas 
in response to TBHP, oligomycin, or ouabain. The automated identification of 
mitochondrial location enables accurate quantification of mitochondrial membrane 
potential by measuring tetramethylrhodamine methyl ester (TMRM) fluorescence 
intensity specifically within mitochondria. Administration of 1 μM FCCP or 10 μM 
oligomycin resulted in depolarization and hyperpolarization of mitochondria, respectively, 
as evidenced by changes in intramitochondrial TMRM fluorescence intensities to 10% 
and 300% of vehicle control values. In summary, this method demonstrates sensitivity to 
rapidly and accurately quantify mitochondrial morphology and membrane potential in 
hundreds of thousands of cells on a per-cell basis, with sufficient throughput for 
pharmacological or toxicological evaluation. 
3.3 Introduction 
Mitochondrial morphology is an actively regulated and dynamic feature altered 
via mitochondrial dynamics (MD) – the combination of mitochondrial fission, fusion, 
biogenesis, and mitochondrial autophagy (mitophagy). These changes have been 
associated with regulation of oxidative metabolism, calcium homeostasis, and apoptotic 
or necrotic cell death [69, 70].  
The evaluation of mitochondrial morphology using microscopy was originally 
limited to electron microscopy and manual classification. The development of multi-
photon microscopy and fluorescent dyes, coupled with high-definition videography, 
greatly improved the observation of MD. However, the scale of mitochondrial content 
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within cells makes manual classification and quantification prohibitive; the ~100 
individual mitochondria observed within each cell translates to > 104 mitochondria per 
high power (40 x) microscopic field. Furthermore, quantification of mitochondrial 
morphology across a series of experiments quickly scales the volume of data and 
complexity of the analysis. Due to these limitations, many researchers report 
mitochondrial morphology via display of representative fields per treatment group and 
without robust quantification. Consequently, throughput is insufficient and the resultantly 
small subsets of mitochondria evaluated may be affected by sampling bias.  
Previous studies using microscopy and computational image analysis, commonly 
referred to as High-Content Microscopy or Image Cytometry, demonstrate the strength 
of this approach with regards to limiting observer and selection bias in morphological 
evaluations while increasing throughput [1, 71-75]. While several groups have made 
efforts to apply high-content fluorescence microscopy to the task of mitochondrial 
morphological evaluation [71-75], only the approach of Koopman et. al. has 
demonstrated the throughput necessary for pharmacological/toxicological evaluation 
[75]. However, by looking at morphometric measures across the diverse range of 
mitochondrial morphological subtypes in aggregate, that approach loses power to detect 
subtler changes in interconnectedness, and is not well suited to quantify the abundance 
of rare subtypes. 
The method presented here for analyzing individual mitochondrial morphologies 
is capable of large-scale mitochondrial measurement; that is to say millions to billions of 
mitochondria across thousands of cells can be classified within a single experiment 
according to mitochondrial interconnectedness and complexity. This was achieved 
through automated live-cell wide-field fluorescence imaging coupled with image-based 
computational high content analysis and the use of a classifier developed using machine 
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learning to segregate mitochondria into four categories [76]. The method is further 
extended to observe changes in mitochondrial membrane potential (ΔΨm).The 
development of a deterministic fully automated algorithm allows for evaluation of entire 
cellular populations within multiple replicate microscopic fields across repeated 
experiments, resultantly improves throughput, reduces observer and sampling bias, and 
advances the field of mitochondrial biology.  
3.4  Materials and Methods 
3.4.1 Cell culture 
661w photoreceptor cells were generously provided by Dr. M. Al-Ubaidi 
(University of Oklahoma) [18] and maintained under standard conditions using DMEM-
HG media (Sigma-Aldrich #D-7777) supplemented with 10% fetal calf serum (FCS, 
Atlanta Biologicals #S11550) and 1 mM L-alanyl-L-glutamine (GlutaMAX™, Life 
Technologies #35050-061). Cells of passages 15-25 were cultured to 80% confluency 
before trypsinization and seeded at a cell density of 8,000 cells per well in 96 well plates 
(Nunc Edge Plate, Thermo Scientific #167314) supplemented with 5% FCS and edge 
reservoirs filled with 1x phosphate buffered saline, (PBS, Life Technologies #14080-
055). After allowing cells to reach 80% confluency (24 h), cells were washed in PBS, and 
media was changed to DMEM with 5.5 mM glucose without phenol red (Sigma-Aldrich 
#D-5030) supplemented with 1% FCS to induce cell cycle arrest. Cells were used for 
experiments 24 h after this switch to normal glucose and 1% FCS-containing media, with 
treatments for either 24 h (morphological analysis) or 1 h (membrane potential analysis). 
All compounds used for treatment were from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified, and were prepared at 1000x concentration in DMSO before 
administration to cells (final [DMSO] = 0.1%).   
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3.4.2 Live Cell Staining 
Cells were stained with Hoechst 33342 (Anaspec #83218), and MitoTracker 
Deep Red FM (MTDR, Life Technologies #M22426). After determining the lowest dose 
of dye necessary to acquire high signal to noise ratio (>3) images while maintaining 
exposure times under 1 sec, cells were stained for 30 min at 37° C with the above dyes 
in phenol-red free DMEM supplemented with 1% FCS (Hoechst at 10 μM and MTDR at 
50 nM), after which the media was replaced for imaging. It is important to note that while 
membrane potential drives loading of MTDR into mitochondria, once covalently bound to 
mitochondrial proteins its distribution is relatively insensitive to subsequent changes in 
polarization or acidification (such as that encountered by mitochondria undergoing 
autophagy in the lysosome). Mitochondrial retention despite depolarization (see 
Supplementary Fig. 1b) is afforded by a chloromethyl moiety that covalently binds 
protein sulfhydryls; whereas its insensitivity to acidic changes in pH is based on the fact 
that MTDR’s fluorophore is a delocalized cationic enamine with a pKa comparable to 
that of an amide (~14).  
3.4.3 Image Acquisition and Analysis: Overview 
Briefly, 661w photoreceptor cells cultured on 96-well plates were stained with 
Hoechst 33342 and MTDR, and imaged using wide-field fluorescence microscopy (see 
Figure 3-1a and Section 3.4.4, Automated Microscopy—Step 1: Image Acquisition). 
A z stack of seven images was collected of MTDR-stained mitochondria and 2D 
deconvolution applied to the stack to output a single in-focus field with out-of-focus 
information removed (a process that simulates confocal microscopy). Mitochondria were 
identified from deconvolved and preprocessed images using the “object” segmentation 
algorithm in GE INCell Developer Toolbox 1.9.1, a variation of the “top hat” approach to 
segmentation (Figure 3-1b-c). Developer Toolbox is available within the GE INCell 
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Investigator 1.6.1 software package (GE Healthcare Bio-Sciences, Pittsburgh, PA. As 
mitochondria display a variety of shapes which indicate interconnectedness and health, 
four categories were established: puncta, rod, networked, large & round. Rods are an 
intermediate phenotype between puncta and networks. The large & round group likely 
represents a combination of pathologically swollen mitochondria as well as normal 
mitochondria undergoing fission or fusion (see 3.6, Discussion). To automate 
classification of mitochondria into these bins, 1386 mitochondria were manually 
classified, and a subset of 897 with 35 morphometric measures calculated on each then 
used to train a classifier using conditional inference recursive partitioning [76]. The 
remaining 489 (test data, not used to train classifier) were used to test its performance. 
The R code as well as training and test data sets are included in Section 9: Appendix 





Figure 3-1. Overview of morphological binning-based analysis of mitochondrial morphology.  
Automated wide-field fluorescence microscopy (a) was followed by preprocessing (2D deconvolution, 
intensity normalization) (b), segmentation (identification of mitochondria) (c), and classification of 
mitochondria into 4 morphological subtypes (puncta, rods, networks, and large & round) (d, colors defined in 
f) using a machine learning-based classifier. Morphological measures for each subtype (area, count, length, 
etc.) were calculated and then aggregated on a per-cell basis (target linking). Per-mitochondrion quality 
control was achieved by exclusion of small, dim objects (junk category defined in Supplementary Figure 2). 
Data were annotated with experimental meta-data (treatment, concentration, plate, etc.) to achieve 
unsupervised and supervised exclusion of low-quality cells and microscopic fields (out of focus, poorly 
stained) to facilitate statistical analysis using new scripts developed in the R platform (e). Examples of 
mitochondrial subtypes – puncta are small and round, rods are elongated, and networks are further 
elongated. Large and round are distinctly larger than puncta but still round (f). 
3.4.4 Automated Microscopy—Step 1: Image Acquisition 
Wide-field fluorescent imaging of live cells was coupled with off-line 
deconvolution of MTDR-stained mitochondria to increase acquisition speed but maintain 
adequate lateral spatial resolution (Rayleigh: 717 nm; Nyquist: 555 nm) (Figure 3-1a). 
Stained cells were imaged using filters corresponding to each dye and polychroic mirror 
(“X”, QUAD1) on the GE INCell 2000 Analyzer automated wide field fluorescence 
microscope. The objective used was a 40x Nikon ELWD NA 0.6 matched with the large-
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format 2048x2048 pixel 12-bit Coolsnap K4 camera (z/sampling height 1.55 µm, 
xy/lateral pixel dimensions of 0.185 µm). Resolving small objects near resolution limits 
like mitochondria requires high signal to noise ratio imaging. To achieve this, seven 
images were acquired in a z-stack, each image 1.55 µm apart on the Cy5 filter set 
(MTDR-stained mitochondria) to enable 2D deconvolution (See Section 3.4.5.1, Step 2: 
Image Pre-processing) A single z section was obtained for Hoechst-stained nuclei on 
the DAPI filter set. Two series of images (fields or locations) of each set of wavelengths 
were acquired in each well of two duplicate wells per condition. Thus, each treatment 
condition was represented by 4 to 8 fields per plate, leading to 12 to 72 fields overall 
acquired for each condition. Each plate is treated as an individual experiment, n=3-9 per 
condition. 
3.4.5 Computational Analysis 
3.4.5.1 Step 2: Image Pre-processing 
Image stacks were opened in the GE INCell Developer Toolbox 1.9.1 program. 
Using the advanced track and block feature for plate mapping, the software was 
configured to visualize all z sections and wavelengths acquired at each time point 
(Supplementary Figure 3 and Supplementary Figure 4), and the image histogram 
expanded from 12 bit to a 16 bit range (65,536 gray levels) to accommodate for 
deconvolution (written to process 16 bit images) and to accommodate for images 
previously registered using the RNiftyReg algorithm (also written to process 16-bit 
images; see Section 3.4.6, Detection of Mitochondrial Membrane Potential (ΔΨm) 
and Section 9.4: parallelImageReg.R). Next, the nearest-neighbor deblur (2D 
deconvolution) algorithm available in Developer Toolbox was applied to the seven z 
sections acquired of MTDR to simultaneously remove out of focus pixels and increase 
signal to noise of the in focus section, followed by flat field correction of the resulting 
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image. Next, image histogram data was normalized using the Information Equalization 
transformation to achieve normalized intensity values from one field to another (Figure 
3-1b). Normalized intensity values were critical to allow for exclusion of aberrantly 
detected mitochondria and for inter-experiment comparisons (see text at 3.4.5.2, Step 3: 
Segmentation and 3.4.5.3, Step 4: Denoise-Free Aberrant Object Exclusion). See 
Figure 3-1b and Figure 3-2a-b for examples of preprocessed images. 
3.4.5.2 Step 3: Segmentation 
To locate mitochondria, the processed images were subjected to Developer 
Toolbox’s object-based segmentation based on local intensity variations (3 pixel kernel, 
75% sensitivity). Bright objects (indicating high membrane potential) were detected 
along with dimmer objects (lower membrane potential) as local changes in intensity (not 
a global threshold) were used for detection. Nuclei were detected with Developer 
Toolbox’s nuclear segmentation algorithm (100% sensitivity, 1.90 sensitivity range, and 
100 μm2 minimum target area) in the Hoechst channel. The cellular cytoplasm was 
estimated by extending the mitochondrial area in a process known as opening (dilating 
objects outward until they touch/overlap followed by eroding the aggregated area). 
Opening results in an efficient estimation of the cytoplasmic area based on location of 
subcellular objects (mitochondria in this case) without the need for a specific cytosolic or 
membrane stain [77]. To separate cells from one another, clump breaking was then 
performed on the cytoplasm mask, using the nuclei image as a seed (1 cytoplasm = 1 
nucleus). Example segmentation is shown in Figure 3-1c. 
3.4.5.3 Step 4: Denoise-Free Aberrant Object Exclusion 
Following detection of mitochondria during segmentation, the results (Figure 
3-1c, a 1-bit image, or mask) were further processed to remove aberrantly detected 
22 
 
objects and improve the masks’ representation of the experimental data. Post-
processing quality control focused on excluding objects detected in background noise. 
Denoising algorithms can contribute artifacts to microscopic data, including 
undersegmentation [78]. Undersegmentation in this analysis is a particularly important 
problem as it can cause aggregation of multiple individual mitochondria, resulting in an 
inappropriate categorization of simpler phenotypes (puncta, rods) as more complex 
(networks). To ensure that mitochondria were maximally separated, a watershed clump 
breaking algorithm, which uses the presence of local intensity minima within an object, 
was applied to the mask to separate aggregates of adjacent individual objects. Finally, 
small objects (<0.35 μm2) were excluded as any object represented by less than 3x3 
pixels would violate the Nyquist limit of resolution (sampling frequency) [79]. To 
simultaneously avoid incorrect categorization of mitochondrial phenotypes and avoid 
aberrant object detection (mitochondrion-level quality control), measures were calculated 
on individual objects to exclude objects that were too dim or too small (see “Junk” 
category in 3.4.5.6, Step 7: Individual Mitochondrial Subtype Classification and 
Supplementary Figure 2). These efforts reduced background detection of aberrant 
objects without increasing clumping/undersegmentation (data not shown). Following 
post-processing, the final mask was stored in cache and used for subsequent measures 
of cells and mitochondria in the same image. 
3.4.5.4 Step 5: Target Linking 
To compare mitochondrial morphological and intensity-based parameters across 
mitochondrial subtypes within individual cells and from cell to cell, from well to well and 
between experiments/treatment groups, a hierarchical target linking strategy was 
employed to assign smaller objects (mitochondria of each subtype, nuclei) to larger 
objects (cells). This was achieved using two levels of hierarchy by first assigning every 
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nucleus or mitochondrial subtype to a specific cytoplasm object (defining the 
combination of one nucleus and surrounding cytoplasm as a Cell) and then assigning 
individual mitochondrial subtype-cytoplasm linkages to each Cell. For a graphical 
representation of this concept, please see Supplementary Figure 5.  
3.4.5.5 Step 6: Morphometric Measures Calculation 
Measures of object morphology and intensity were calculated for every 
mitochondrion, and grouped on a per-morphological subtype basis for every cell. That is, 
one row of data describes the total or average value for mitochondria within an individual 
cell (e.g. Networked Total Area is the area (in μm2) of the mask representing 
mitochondria classified as networked and assigned to an individual cell; Average 
Networked Fiber Length is the average fiber length of individual networked mitochondria 
within cells – in μm). These measures also included counts of mitochondria, area of 
mitochondria; and for complex shapes (networks), average length and fiber length. Fiber 
length is a variant of length that is derived by skeletonizing the mitochondrial network 
into its individual branches [73], followed by summation of the length of all branches. 
Length is simply the longest distance between two pixels in an object, and thus part of 
the complexity is lost in this measure alone. To enable correlation of the individual 
mitochondrial measures within a cell, results from all target linkages are assigned to 
cells by enabling the option “Display Measures in Primary Target Set” for each linkage in 
each target link’s options in Developer Toolbox (see Section 3.4.5.4, Step 5: Target 
Linking and Supplementary Figure 5).  
3.4.5.6 Step 7: Individual Mitochondrial Subtype Classification  
The next step of the analysis is to classify mitochondria by morphological 
subtype to evaluate interconnectedness. In order to classify, an algorithm (decision tree) 
24 
 
was established using machine learning (see Section 3.4.5.7 Step 7.1: Using 
Conditional Inference-based Machine Learning to Derive Mitochondrial 
Morphological Subtype Classification Scheme). Four mitochondrial subtypes were 
defined, based on morphology and intensity measures (Section 3.4.5.6, Step 7: 
Individual Mitochondrial Subtype Classification) and previously published literature: 
puncta, rods, networks, and large & round [74, 80]. The morphological parameters 
displayed in Supplementary Figure 2 define the decision tree. Each subtype was 
defined as a separate “target set” (independent object type), converting the decision tree 
into a series of complementary logic statements within Developer Toolbox’s option for 
inclusion criteria in each target set. Exclusion of a fifth class, “junk”, was useful in 
improving the classification scheme; this was made necessary by the use of denoise-
free preprocessing which increases the segmentation algorithm’s likelihood of finding 
objects comprised of small fluctuations in background intensity (see 3.4.5.3, Step 4: 
Denoise-Free Aberrant Object Exclusion).  
3.4.5.7 Step 7.1: Using Conditional Inference-based Machine Learning to 
Derive Mitochondrial Morphological Subtype Classification Scheme 
To generate the classifier used in Section 3.4.5.6, Step 7: Individual 
Mitochondrial Subtype Classification, initial efforts used empirical methods to establish 
cutoff values for calculated morphometric measures (area, length, etc.) to bin 
mitochondria into the four categories using a decision tree of 5-7 nodes. However, low 
accuracy of this manually established tree and lack of generalizability amongst 
experiments encouraged use of computational methods to determine a more reliable 
decision tree classification scheme. Machine learning is a statistical and computational 
technique that may be used to derive a classification scheme from classified training 
data [76, 81, 82]. In this case, images were processed using the steps outlined in 
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Sections 3.4.5.1, 3.4.5.2, and 3.4.5.5, reporting instead all calculable measures on every 
individual mitochondrion (rather than aggregating on a per cell basis). Manual 
classification was performed on 1386 mitochondria within a variety of microscopic fields 
representing both cells treated with toxic compounds and compounds treated with 
vehicle. The ctree method from a published computational toolbox for conditional 
inference recursive partitioning (CRAN: party) was used in R version 3.0.1 (64 bit) to 
establish a classification scheme [76]. The algorithm grouped mitochondrial subtypes 
using 26 binary nodes that followed logic (networks had the longest length, puncta are 
small and have a form factor near 1, etc.). See Supplementary Figure 2 to view the 
entire decision tree, Figure 3-1d, Figure 3-2c-d for examples of the classifier’s 
performance overlaid on microscopic images and Figure 3-1f for mitochondrial shapes 
exemplary of the puncta, rod, network, and large & round subtypes. 
3.4.5.8 Step 8: Supervised Analysis, Data Annotation 
The result of the above analysis is a matrix, with each row representing an 
individual cell and each column a measure conducted on that particular cell. These data 
matrices were annotated to enable rapid interrogation of relevant measures and 
statistical calculations on a multilevel basis (groups of experiments, per-plate, per-
treatment group, per-field, and per-cell). This is conceptually outlined in Figure 3-1e. 
Data between experimental replicates were aggregated into spreadsheets within 
Microsoft Excel 2010 (Microsoft, Seattle, WA), and replicate experiments tracked by 
inclusion of metadata columns that described each plate. Text-based metadata 
extraction formulae were also incorporated to group cells and fields by treatment group 
(minimum of 4 replicates per condition per plate). Data were aggregated into column 
format (each row now representing the average or total value of a particular measure per 
field per experiment) for import into GraphPad Prism 6.02 (GraphPad Software, La Jolla, 
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CA) using a PivotTable. Subsequent studies of membrane potential (Section 3.4.6 - 
Detection of Mitochondrial Membrane Potential (ΔΨm)) used a new function 
developed in R for fully automated data annotation (see annotateData.R in Section 9.3, 
Appendix B—Computer Programs).  
3.4.6 Detection of Mitochondrial Membrane Potential (ΔΨm) 
In a second series of experiments, 62.5 nM TMRM (tetramethylrhodamine methyl 
ester perchlorate, #T5428 Sigma-Aldrich, St. Louis, MO) was loaded into 661w cells 
simultaneously with 50 nM MTDR and 10 μM Hoechst 33342 for 30 min. Cells were 
washed with PBS, media changed to 90 μL DMEM with no phenol red (imaging buffer), 
then incubated an additional 3 h prior to treatment to allow MTDR’s free chloromethyl 
group to react with free protein sulfhydryls (a covalent linkage). Treatments were 
prepared at 10x final concentrations in imaging buffer, and 10 μL of each dosed to each 
well of the imaging plate simultaneously using the VIAFLO 96 (Integra Biosciences, 
Hudson, NH) multichannel liquid handling system (0.1 % [DMSO] final). The GE INCell 
2000 Analyzer was configured to acquire the nuclear image in channel 1 (DAPI filter 
set), the MTDR z series in channels 2-8 (Cy5 filter set), and the TMRM image in channel 
9 (Cy3 filter set). Chromatic aberration in the optical setup led to lateral (XY) 
misalignment of Cy3 images relative to DAPI and Cy5 images. To correct this aberration, 
the misaligned TMRM images were registered after acquisition but prior to other 
preprocessing steps (Section 3.4.5.1, Step 2: Image Pre-processing) using the 
RNiftyReg package in R 3.0.1 64-bit, using the middle (in-focus) section of the MTDR 
series as “target”, and the TMRM image as “source” [83]. Pearson’s correlation R values 
were calculated using Coloc2 in FIJI (FIJI version 1.47d, http://fiji.sc). See 
parallelImageReg.R in Section 9, Appendix B—Computer Programs for the code 
used. Once registered, the images were analyzed as before in Developer Toolbox 
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(Section 3.4.5), including additional measures of average TMRM object intensity for 
nuclear, cytoplasmic, and individual mitochondrial subtypes. Following analysis, data 
was annotated using newly developed functions in R for interfacing with Developer 
Toolbox data output (annotateData.R in Section 9.3, Appendix B—Computer 
Programs) and subsetted by treatment group for analysis (Figure 3-1e). To correct for 
background signal, for each cell the average TMRM fluorescence intensity was 
determined within each mitochondrial subtype per cell followed by subtraction of the 
average TMRM fluorescence intensity within the nucleus for that cell (a region devoid of 
mitochondria) to correct for background TMRM fluorescence. Images displayed in 
Figure 3-6a-c were obtained by the multiply function in Image Calculator using FIJI, 
enabling the 32-bit (float) option and applying the “Fire” look-up table to the result to 
enhance the contrast of the polarization signal. The input images for multiplication were 
the mask derived from segmentation in Developer Toolbox (1-bit) and the registered and 
flat-field corrected TMRM image. The minimum and maximum settings in the Brightness 
and Contrast were adjusted to be equal amongst all images. Supplementary Figure 1 
was generated using similar techniques (equal contrast settings for each row) whilst 
leaving the look up table as grayscale and not applying the segmented mask via 
multiplication (i.e. a raw image). Figure 3-6d was generated by the ‘density function in 
R’s “stats” package, which is an implementation of kernel density estimation [84]. 
Density estimation bandwidth was set to defaults for each plot. The Kolmogorov-Smirnov 
test (ks.test function, CRAN: stats package) was used to make pairwise comparisons 
between treatment group populations (vehicle v. FCCP, vehicle v. oligomycin, FCCP v. 
oligomycin) (see dPsi.R in Section 9.1, Appendix B—Computer Programs for code 
used for generation of Figure 3-6d). 
3.4.7 Seahorse XF96 Respirometry 
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661w photoreceptor cells were seeded (6,000 cells/well) into XF96 polystyrene 
plates (Seahorse Biosciences, Billerica, MA) and incubated for 48 h in DMEM-HG 
(Sigma-Aldrich) supplemented with 5% FCS. Lower seeding densities were used since 
XF96 plate well bottom area is significantly smaller (~60%) compared to standard 96 
well plates. Following this growth period, media was changed for DMEM supplemented 
with 5.5 mM glucose and 1% FCS and vehicle or toxicant treatments administered for 24 
h. Just prior to time of assay, media was switched to bicarbonate-ion free RS (reduced 
serum) buffer at pH 7.4 prepared with 130 mM NaCl, 5.33 mM KCl, 1.8 mM CaCl2, 0.6 
mM MgCl2, 0.5 mM KH2PO4, 0.5 mM NaPO4·(H2O)7, insulin, 5.5 mM glucose, and 
supplemented with 1% FCS, 1 mM L-alanyl-L-glutamine (GlutaMAX), 2 mM glutamine, 
1% MEM Vitamins, 1% MEM Amino Acids, 1% MEM Non-Essential Amino Acids, 1% 
Penicillin/Streptomycin. All inorganic salts used were obtained from Sigma-Aldrich (St. 
Louis, MO) and organic supplements obtained from GIBCO/Life Technologies (Grand 
Island, NY) unless otherwise noted. After recording 3 baseline oxygen consumption rate 
(OCR) measurements, the response of cells to 1 μM FCCP (carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone) was measured. This assay (maximal respiratory 
capacity) is frequently used as a mitochondrial stress test [85]. Uncoupled OCR’s for 
each condition were recorded and reported as mean +/- standard error of the mean 




3.4.8 Statistical Analysis 
Unless otherwise specified, graphing and statistical analyses were performed in 
GraphPad Prism 6.02 (GraphPad Software, La Jolla, CA). Tests for significance 
amongst groups were conducted via the non-parametric Kruskal-Wallis test and post-
hoc pairwise tests (Dunn’s correction for multiple tests) based on normality of underlying 
data as determined using D’Agostino-Pearson omnibus normality test. Outlying fields 
(low seeding density, bacterial contamination, poor staining, etc.) were excluded using 
the Rout algorithm (Q = 10%) on every experimental replicate (microscopic field) within 
each treatment group. The mean value for each parameter (without outliers) was then 
calculated per experiment. Data shown are mean ± s.e.m. amongst replicate 
experiments. Multiplicity-adjusted P values were determined; p < 0.05 compared with 
vehicle denoted with an asterisk. Power analysis was not performed to determine 
sample sizes in mitochondrial morphological studies (Figure 3-1 through Figure 3-5) as 
these studies represented the first quantification of mitochondrial subtype areas and the 
authors had no expectations of standard deviation or expected effect size. For the 
membrane potentiometric studies, it was defined that a difference of 20% would be of 
biological interest and the coefficient of variance from all mitochondria area (5.1%) was 
used to calculate power. The result of this analysis was that n=3 experiments should be 
the minimum number of replicates needed to achieve 80% power in a one-way ANOVA 
with three groups and α = 0.05. Russ Lenth’s web-based power analysis software was 





3.5.1 Overview of Results 
The performance of the classifier is presented in Section 3.5.2 followed by 
analysis of the mitochondrial morphological response to known mitochondrial toxicants 
in Section 3.5.3. This is then followed by the analysis of mitochondrial membrane 
potential in Section 0. In the morphological analysis (Section 3.5.3), seven 
measurements are reported: total mitochondrial area (comprised of all phenotypes, 
representative of total mitochondrial mass), puncta area, rod area, networked area, large 
and round area, total mitochondrial count, and the average fiber length (length along all 
branches) of networked mitochondria. To correlate these morphological findings with the 
effects of toxicants on mitochondrial electron transport chain function, respirometry was 
conducted in parallel experiments (Method described in Section 3.4.7). All treatments 
were for 24 h unless otherwise noted. 
3.5.2 Performance of Mitochondrial Subtype Classifier 
In order to enable automated classification of mitochondria, the computational 
technique of machine learning was employed to establish an optimized classification 
scheme. Briefly, 1386 mitochondria were manually classified into the four bins 
(networked, rod-like, punctate, and large & round, followed by separation of these 
mitochondria into a test set of 489 and a training set of 897. The training set was then 
used as input to a published computational toolbox for conditional inference recursive 
partitioning  to train a decision tree [76]. Supplementary Figure 2 describes the 
measures and breakpoints along those measures that the machine learning algorithm 
determined most effective in partitioning categories (details in Section 3.4.5.7). 
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To evaluate the performance of the decision tree, several confusion matrices 
(tables of predicted categories versus manually determined categories) were generated 
as well as κ statistics to evaluate agreement. The predictions within the training set 
(Supplementary Table 1a) were accurate and errors were somewhat predictable – that 
is, confusion was highest amongst similar shapes. Excluding misclassification as junk, 
rods were most often misclassified as networks (23/29 misclassifications) and vice versa 
(5/6 misclassifications), large and round were most often confused with puncta (6/12 
misclassifications) and vice versa (13/14 misclassifications). The accuracies within the 
consensus test set (Supplementary Table 1b) followed the same trends as those in the 
training set with the following exceptions. Excluding misclassification as junk, rods were 
most often misclassified as puncta rather than networks (18/26 misclassifications), and 
large and round mitochondria were tied for confusion with puncta or rods (2/4 
misclassifications each). Taken together, performance degraded marginally as expected 
in moving to a set of mitochondria “never seen” by the classifier (as measured by κ of 
0.710 for training set and 0.644 for test set). The small difference between these κ‘s 
indicates a tolerable degree of optimism regarding the classifier’s generalizability to data 
naïve to the classifier, quantified as decreases in accuracy in test set as compared to 
training set [87, 88].   
Before reaching consensus, the authors were blinded from one another in their 
classification of the same 489 mitochondria in Supplementary Table 1b (test set) to 
further characterize the original classification tree and quantify its optimism, as the 
disagreement between authors can serve as a benchmark for error. Although 
degradation was observed in comparing the classifier (developed using author AL’s 
training data) against author RC’s classifications of the same test data (κ=0.557), 
(Supplementary Table 2b), this amount of decreased agreement was consistent given 
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the level of disagreement of authors AL and RC: κ=0.641 (Supplementary Table 2b). 
To provide insight into the generalizability of this classifier, authors AL and RC together 
decided on a consensus classification for the full test set: κ=0.601, (Supplementary 
Table 1b), which is similar to the levels of agreement between the classifier and the 
blinded author AL’s κ=0.644 (Supplementary Table 2a) and classifier v. blinded author 
RC’s κ=0.577, (Supplementary Table 2c), indicating that the classifier is not 
significantly biased to a single individual.  
To test whether or not the classifier performs better on easy to classify 
(unambiguous) mitochondria, its levels of agreement with two conditions of the test set 
were evaluated: 1) when author AL and RC agreed (likely unambiguous) and 2) when 
author AL and RC disagreed (likely ambiguous). The classifier demonstrated increased 
performance when compared against a subset of the test mitochondria that both authors 
blindly agreed upon (κ=0.731, Supplementary Table 2d), and decreased performance 
when analyzing mitochondria that the authors blindly disagreed upon (κ=0.258, 
Supplementary Table 2e), supporting the hypothesis that the classifier’s accuracy – just 
like that of a human classifier – was better when morphology is unambiguous.  
Using this classifier, 95% of aberrantly detected objects (junk) were excluded. 
Within the four mitochondrial classes (networks, rods, puncta, and large & round), 
accuracies were 95%, 77%, 95%, and 64%, respectively, as judged by agreement with a 
test set of 489 consecutively detected mitochondria classified via consensus between 
authors AL and RC (Supplementary Table 1b). These accuracies correspond with a 
kappa statistic (κ) of 0.601, indicating the algorithm agreed well with two human 




3.5.3 Known Mitochondrial Toxicants Produce Divergent Effects on 
Individual Mitochondrial Morphological Phenotypes 
661w cells were exposed to 1 
mM TBHP (b, d) or vehicle (a, 
c) for 24 h and analyzed using 
the described morphometric 
analysis. Pre-processed images 
of living mitochondria stained 
with MitoTracker Deep Red 
(MTDR) (a, b). Classification 
results overlaid (c, d). Nuclear 
borders were identified from 
Hoechst staining, and cell 
borders were defined via 
“opening” the preprocessed and 
segmented MTDR image. A cell 
is defined as an object 
containing a nucleus and 





3.5.3.1 Oxidative stress – t-butyl hydroperoxide (TBHP) 
The model oxidant tert-butyl hydroperoxide (TBHP) causes oxidative stress and 
mitochondrial damage [89-91]. At 24 h, this functional damage is readily visualized as a 
loss of filamentous networked mitochondria and induction of swelling (Figure 3-2). 
Respirometry demonstrated an 80% decrease in respiratory capacity at TBHP 
concentrations of 500 µM and higher, confirming mitochondrial dysfunction (Figure 
3-3a). At 500 μM, a 25% decrease in total mitochondrial area (Figure 3-3b) and a 25% 
increase in the large & round phenotype were observed (Figure 3-3g). At 1 mM, twice 
as many changes were noted, including a 40% decrease in overall mitochondria counts 
Figure 3-2 Representative 
images of t-butyl 
hydroperoxide (TBHP)-induced 




and rod area (Figure 3-3c, e), a 50% decrease in area of networked mitochondria 
(Figure 3-3f), and a 10% decrease in networked fiber length (Figure 3-3h). Interestingly, 
no changes in puncta area were observed at any concentration (Figure 3-3d). 
 
Figure 3-3. Quantitative assessment of oxidant-induced mitochondrial damage. 
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-uncoupled respiratory capacity, which 
measures mitochondrial electron transport chain function, was measured via Seahorse XF96 respirometry 
following 24 h treatment with t-butyl hydroperoxide (TBHP) at the concentrations indicated (a). Results of the 
corresponding mitochondrial morphological assessment (b-h). n=4-9 experiments (numbers on each bar), 
representing 30k-300k mitochondria per condition, bars s.e.m. Data analyzed by Kruskal-Wallis test followed 
by Dunn’s post test, all groups versus vehicle only. *multiplicity-adjusted p<0.05 versus vehicle. 
 
3.5.3.2 Mitochondrial Electron Transport Chain Inhibition 
Following the studies of general oxidative stress, mitochondrial morphological 
remodeling in response to 24 h incubation with toxicants specific to a single 
35 
 
mitochondrial target was measured. Rotenone and antimycin A inhibit electron transport 
chain complexes (ETC) I and III, respectively [92, 93]. Oligomycin inhibits the Fo subunit 
of ETC complex V, blocking oxygen consumption linked to ATP phosphorylation [94]. 
 
Figure 3-4. Quantitation of changes in morphology elicited by mitochondrial toxicants. 
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-uncoupled respiratory capacity which 
measures mitochondrial electron transport chain function, was measured via Seahorse XF96 respirometry 
following 24 h treatment with toxicant at the concentrations indicated (a-d). Results of the corresponding 
mitochondrial morphological assessment are shown in Panels e-p. n=3-9 experiments (numbers on each 
bar), bars s.e.m. Data analyzed by Kruskal-Wallis followed by Dunn’s post test, all groups versus vehicle 
only. *multiplicity-adjusted p<0.05 versus vehicle. Additional measures for each toxicant are quantified in 
Supplementary Figs. 6-9). 
Rotenone decreased mitochondrial respiratory capacity by 60% at 100 nM 
(Figure 3-4a). While no morphological changes were statistically significant at this low 
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concentration, increasing the dose to 1 μM elicited a 33% decrease in mitochondrial total 
area (Figure 3-4e), count, and areas of rods and networks (Figure 3-4i). Increasing the 
concentration to 10 μM further decreased the aforementioned measures and decreased 
puncta area by 60%. At no concentration of rotenone were changes noted in either the 
large & round subtype (Figure 3-4m) or of the average fiber length of networks 
(Supplementary Figure 6). 
Antimycin A decreased respiratory capacity at 1 μM (80%, Figure 3-4b). 
However, morphological remodeling was observed at lower concentrations. At 1 nM, 
antimycin A caused a 20% decrease in networks (Figure 3-4j), which at higher 
concentrations was accompanied by 20% decreases in total mitochondrial area (Figure 
3-4f). None of the other measures were altered at 1 nM or 10 nM (Supplementary 
Figure 7). 
Oligomycin decreased respiratory capacity by 85% at 10 μM (Figure 3-4c). At 
this concentration, overall mitochondrial area and count decreased 40 and 25%, 
respectively, indicating an overall loss of mitochondrial mass (Figure 3-4g). Oligomycin 
also induced decreases in rods and networked areas (Figure 3-4k), and the length of 
networks (30%, 55%, and 15%, respectively), while the large & round population 
increased 130% (Figure 3-4o). No decreases in puncta area were observed with 
oligomycin treatment (Supplementary Figure 8). 
3.5.3.3 Na+/K+ ATPase Inhibition at the Plasma Membrane 
Ouabain is an inhibitor of the plasma membrane Na+/K+ ATPase, which results in 
the influx of Na+ and water into the cell, leading to cell and  mitochondrial swelling [95]. 
At 500 μM ouabain, mitochondrial respiratory capacity decreased 30% (Figure 3-4d). 
Total mitochondrial area decreased 20%, comprised mainly of decreases in the 
networked population (25%, Figure 3-4h, l). As expected, since ouabain increases 
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water content, a 75% increase was detected in the large & round subtype (Figure 3-4p). 
The fiber length of networks also decreased 10% (Supplementary Figure 9). No 
significant changes were observed in other measures. 
3.5.3.4 Relative Abundance of Mitochondrial Phenotypes 
One motivation for looking at subtypes individually is that there is an unequal 
abundance of mitochondrial phenotypes. Mitochondria in 661w cells treated with vehicle 
are comprised of 61%, 28%, 9%, and 2% of networks, rods, puncta, and large & round, 
respectively (Figure 3-5, Supplementary Table 3, Supplementary Table 4). Treatment 
with oligomycin increased the proportion of large & round mitochondria to 5% (Figure 
3-5c). Treatment with TBHP shifted all proportions, with a 15% loss in networks and 
increases in rod, puncta and large & round mitochondria by 6%, 7%, and 2%, 
respectively (Figure 3-5e). Treatment with antimycin A, ouabain, or rotenone induced no 
significant shifts in proportions (Figure 3-5b, d, and f).  
 
Figure 3-5. Relative abundance of mitochondrial phenotype proportions per cell. 
Vehicle control (a), antimycin A (b) oligomycin (c), ouabain (d), t-butyl hydroperoxide (e), and rotenone (f). 
The size of each shaded area within each panel represents the proportion of each individual phenotype’s 
average area of the total mitochondrial area. Data analyzed by Kruskal-Wallis followed by Dunn’s post test, 
all groups versus vehicle only. *multiplicity-adjusted p<0.05 versus vehicle (proportion of subtype in 
treatment group versus proportion of same subtype in vehicle control). See Supplemental Tables 3 and 4 




3.5.4 Quantification of Mitochondrial Membrane Potential (ΔΨm) 
Many studies have used the positively charged dye TMRM to measure ΔΨm, yet 
none have analyzed its intensity amongst different morphological classes or developed 
an automated process for separating intramitochondrial fluorescence from other cellular 
compartments [75, 96-99]. MTDR, previously used in this study to label all cellular 
mitochondria, is well-retained in depolarized mitochondria (Supplementary Figure 1). 
Thus, this dye was used to reliably locate all mitochondria followed by analysis of TMRM 
intensity within the MTDR-derived mitochondria-specific mask. The colocalization of 
these two dyes was nearly identical in control cells as assessed by values of Pearson’s 
correlation > 0.90 following registration (Section 3.4.5.1). For imaging, cells were loaded 
with TMRM and MTDR for 30 min (followed by a wash step and 3 h of incubation with no 
treatment), incubated for one hour with vehicle, the uncoupler FCCP, or oligomycin, and 
then imaged. Mitochondria were localized and classified using MTDR images only, and 
the mean fluorescence intensity of TMRM within each mitochondrion was calculated and 
averaged per subtype (Figure 3-6). Compared to control conditions (Figure 3-6a), 
uncoupling mitochondria with 1 μM FCCP induced depolarization as evidenced by a 
90% decrease in mitochondrial TMRM fluorescence intensity in each cell (Figure 3-6b, 
d). Oligomycin (10 M) le d to hype rpola riza tion a s  e vi    -fold increase in 
mitochondrial TMRM fluorescence intensity compared to vehicle (Figure 3-6c, d). FCCP 
and oligomycin affected mitochondrial membrane potential in all mitochondrial subtypes, 
although surprisingly, the large and round population was more resistant to FCCP-






Figure 3-6. Quantification of mitochondrial membrane potential (ΔΨm) via mitochondria-specific 
labeling. 
Representative images displaying intensity of tetramethylrhodamine methyl ester (TMRM) staining within 
mitochondria located using MitoTracker Deep Red (a-c). Mean intensity of TMRM located within all 
mitochondria in each cell was calculated and the distribution shown using a density plot (higher TMRM 
intensity to the right) (d). Treatments were as indicated above each panel and were conducted for 1 h for 
n=3 independent experiments. Distributions in (d) were compared using a two-way Kolmogorov-Smirnov test 
and were adjusted for multiple comparisons; all pairwise combinations returned p<0.05, indicating significant 
induction of polarization or depolarization. See Supplementary Fig. 10 for a summary of polarization 
responses of each morphological bin (puncta, rods, networks, large & round) and Supplementary Fig. 1 to 
see individual MitoTracker Deep Red and TMRM staining responses to treatment. 
3.6 Discussion 
This study reports the development of a high-throughput method for the analysis 
of mitochondrial dynamics and function via automated fluorescence microscopy and a 
new software algorithm, and evaluates the response of mitochondrial morphology to 
known chemical inhibitors of mitochondrial function in 661w photoreceptor cells. 
Depending on the target and the concentration of these toxicants, qualitatively and 
quantitatively different effects on mitochondrial morphology were observed, 
demonstrating concentration-dependent mitochondrial morphological changes for the 
first time. Using conditional inference-based machine learning, mitochondria were 
classified into four distinct bins according to their shape (puncta, rod, network, large & 
round). This classification was crucial to enabling the quantification of toxicant-induced 
changes in low abundance subtypes (large & round, 2% of mitochondria by area), and 
also improved the quantification of more common shapes (networks, rods, and puncta 
are 61%, 21% and 9%, of cellular mitochondria by area, respectively). By segregating 
subtypes and thus measurements, this strategy improved sensitivity and statistical 
power to detect toxicant-induced differences. For instance, fiber length of networks had 
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a much lower coefficient of variation (3%) than all the other measures, which ranged 
from 6-20% in control cells (derived from measures presented in Figure 3-3, Figure 3-4, 
and Figure 3-5). Regarding the reproducibility of previous studies, Koopman et al. 
described the utility of measures such as Form Factor, Area, and Perimeter for 
describing interconnectedness [75] and as expected, these measures were utilized in 
the machine learning-derived classifier (Supplementary Figure 2).  
One example of this increased sensitivity is apparent in the quantification of 
concentration-dependent changes in the rare population of large & round mitochondria, 
which may serve as the first useful indicator of mitochondrial swelling in live cells. For 
instance, TBHP, oligomycin, and ouabain increased the prevalence of large & round 
mitochondria by 40-130%, whereas rotenone and antimycin A had no effect. Oxidant 
TBHP is a known activator of permeability transition pore opening and Ca2+-induced 
mitochondrial swelling [90, 91, 98]. Ouabain treatment is expected to induce 
mitochondrial swelling via cellular osmotic dysregulation [100, 101]. These data support 
that swollen mitochondria form a significant portion of the large and round population. 
However, two punctuate mitochondria undergoing fusion may exist in a large & round 
shape temporarily (or vice versa); a rod-puncta intermediate [62]. Since swollen and rod-
puncta intermediate phenotypes have a similar appearance, they are not separable by 
morphological classification alone.  TMRM signal intensity of the large and round 
mitochondrial subpopulation in cells treated with control or other treatments resembles a 
Gaussian distribution (and not bimodal), indicating mitochondrial polarization does not 
dichotomize this population.  In addition to swelling, exposure to TBHP recapitulated 
previously published findings including mitochondrial fragmentation [102] (fewer rods 
and networks, decreased fiber length) and increased mitochondrial turnover/mitophagy 
[103] (indirectly inferred from decreased total area).Additional studies, including 
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simultaneous fluorometric measurement of intramitochondrial calcium [Ca2+]m (expected 
to rise during swelling [96, 104]), might be helpful in defining or subdividing this 
population in the future. Recent studies into mitochondrial superoxide “flashes” have 
highlighted the importance of the mitochondrial permeability transition pore in conducting 
a transient outward (mitochondria to cytoplasm) Ca2+ current through VDAC [105]. In 
conjunction with respirometry, it will be interesting to use this method to understand the 
role of mitochondrial morphology as either a determinant or result of superoxide flash 
frequency. 
It would appear that the networked phenotype was the most sensitive to stress, 
as decreases in both total mitochondrial area and networked area (and in many cases, 
length of networks) were observed with all mitochondrial toxicants tested. Yet, neither 
complex I inhibition by rotenone nor complex III inhibition via antimycin A resulted in 
decreased networked fiber length or increased large & round. These data support the 
idea that mitochondria display a complex response to damage, and fission of networks 
into simpler phenotypes is a common feature.  
Although the conditional inference decision tree classifier used here to bin 
mitochondria was capable of quantifying concentration-responsive changes in 
mitochondrial morphology, a further improvement would be the ability to implement more 
robust machine learning algorithms to improve accuracy. Future efforts to implement this 
analysis in an open source platform that supports three spatial dimensions (requiring 
perhaps 1-2 orders of magnitude more computing power) and advanced machine 
learning implementations to further improve accuracy would be of great benefit to the 
research community. 
Automation facilitated by use of an off-the shelf microscope and analysis tools 
provides the throughput necessary for the technique to be useful as a discovery or 
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diagnostic tool. Compound libraries could be screened for their potential to improve or 
damage mitochondrial function. Many failures of therapeutics have been attributed to 
mitochondrial toxicity; early discovery of such liabilities may improve both patient safety 
and financial success. Through RNAi screening, genetic determinants of MD could be 
identified. Indeed, image-based RNAi screens have proven their utility in determining 
genes involved in induction of autophagy and parkin-directed mitophagy in cells [106, 
107]. By analyzing colocalization of mitochondrial subtypes with 
phagosomes/lysosomes, this method could segregate general autophagy and selective 
mitophagy [108]. Current diagnosis of mitochondrial diseases uses genetic, biochemical 
and functional analyses, yet none of these methods directly test the regulation of MD 
[109, 110]. For example, mutations in outer membrane fusion GTPase mitofusin 2 
(Mfn2) result in the 2A subtype of peripheral neuropathy Charcot-Marie-Tooth Disease 
(CMT2A) [111]. While manual analysis of fibroblast mitochondrial morphology from 
CMT2A patients and controls found no difference between the two [112], computational 
methods were able to detect pro-fission and pro-fusion changes in mouse fibroblasts 
with genetic complex I defects [113]. The binning-based computational morphometric 
method presented here may detect smaller, though very significant to phenotype, 
differences by enabling subtype-specific analysis of mitochondrial morphology in many 
replicates. Finally, the morphological binning classifier scheme presented here may be 
applied to any fluorescently labeled intracellular organelle/target with morphology 
ranging from filamentous to punctate, or to quantify the localization of uncharacterized 





A high-content microscopic method for the automated classification of 
mitochondrial morphology and membrane potential is presented using an automated 
fluorescence microscope platform (GE INCell Analyzer 2000) and new software built on 
the R platform. Classification of mitochondria into four shape bins (punctate, rod, 
networked, and large & round) allowed for the quantification of concentration-responsive 
mitochondrial swelling, dynamics, and membrane potential in response to a number of 
mitochondrial toxicants. To our knowledge, this is the first method to discriminate 
between mitochondrial subtypes and to determine their individual membrane potentials 
with sufficient throughput for pharmacological or toxicological evaluation to further 




4. Chapter 2—IBMX Administration Results in Mitochondrial 
Membrane Hyperpolarization, Increased Network Morphology, 
and Decreased Uncoupled Respiration 
4.1 Abstract 
IBMX is commonly used as a nonselective inhibitor of cyclic nucleotide 
phosphodiesterases and adenosine receptors. Previous results have indicated that 
IBMX administration to retina-derived photoreceptor cell line 661w results in decreased 
mitochondrial respiration at 24 h followed by decreased cellular viability at 48 h. As this 
sequence of mitochondrial dysfunction followed by cytotoxicity is also observed in 
inherited retina degeneration, our lab has used IBMX administration to 661w as a cell-
based model of photoreceptor degeneration. However, the early stage events that lead 
to decreased mitochondrial respiration are not fully understood. Using a novel high 
content microscopic method for determining mitochondrial membrane potential and 
interconnectedness, these studies demonstrate concentration- and time-dependent 
changes in mitochondrial physiology occur following IBMX administration. As early as 1 
h, an increase in interconnected morphology is observed (108-120% of control), followed 
by subsequent increases in mitochondrial membrane potential at 4 h (150-200% of 
control). Both of these changes are sustained for 24 h, at which time decreases in 
uncoupled respiration are observed (70-80% of controls). Pharmacological inhibition of 
GSK-3β reversed IBMX-induced increases in membrane potential and networked 
morphology. Taken together, these results suggest resistance of the mitochondrial inner 
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membrane to proton influx increases following IBMX administration, which may be in 
part due to increased GSK-3β activity and/or decreased opening of the mitochondrial 
permeability transition pore.   
4.2 Introduction 
3-isobutyl 1-methylxanthine (IBMX) is a xanthine derivative structurally similar to 
adenine, caffeine, and theophylline (Figure 4-1). IBMX has been characterized to inhibit 
cyclic nucleotide phosphodiesterases PDE1-PDE7 and adenosine receptors. As many of 
these targets have been reported to couple to downstream regulators of mitochondrial 
morphology and function (e.g. increased cAMP activates PKA, reported to phosphorylate 
Drp1 [60]), it was hypothesized that modulation of one or more of these targets may 
result in altered mitochondrial physiology.  
The following studies will characterize the effects 
of IBMX on mitochondrial morphology and function using 
Seahorse XF96 respirometry in combination with a novel 
high content microscopic method developed in our lab 
[114] and described in detail in Section 3, Chapter 1—
Quantitative Analysis of Mitochondrial Morphology 
and Membrane Potential in Living Cells Using High 
Content Imaging, Machine Learning, and 
Morphological Binning.  
As mutations in PDE6 result in retina degeneration in mice and humans, our lab 
has utilized IBMX treatment of photoreceptor-derived cell line 661w to mimic this loss of 
PDE function [3, 4, 115]. Briefly, in this model, following IBMX administration, 
recapitulation of the phenotype observed in multiple retina degenerative mouse models 
[15] is observed, namely, an induction of mitochondrial dysfunction that precedes cell 






death. For a more extensive review of 661w cells, PDE biology, and adenosine receptor 
signaling, please see Section 2, Review of Literature. 
4.3 Materials and Methods 
4.3.1 High Content Determination of Mitochondrial Morphology and 
Membrane Potential  
To evaluate the concentration- and time-dependency of IBMX-induced 
mitochondrial changes, the method of Leonard et al. [114] was used. Briefly, 661w cells 
were seeded into Nunc Edge 96-well plates (Fisher) at a density of 8900/well and 
incubated in DMEM-HG (Invitrogen) for 24 h. Media was changed to DMEM 
supplemented with 1% fetal calf serum (FCS, Atlanta Biologicals) and incubated 
overnight before staining. 661w cells were loaded with 50 nM MitoTracker Deep Red, 
and 10 µM Hoechst 33342 for 30 min and then washed followed by a 3 h incubation at 
37 °C in DMEM-HG supplemented with 1% FCS. After 3 h, cells were treated with IBMX 
at the indicated concentrations and cells imaged. Imaging was performed on a GE 
INCell Analyzer 2000 automated wide-field fluorescence microscope using a 40x Nikon 
ELWD objective (NA 0.6) matched with the large-format 2048x2048 pixel 12-bit 
Coolsnap K4 camera. Images were saved in the TIFF image file format and subjected to 
the high content mitochondrial morphological analysis as described in Section 3, 
Chapter 1. 
4.3.2 Seahorse XF96 Respirometry 
661w photoreceptor cells were seeded (6,000 cells/well) into XF96 polystyrene 
plates (Seahorse Biosciences, Billerica, MA) and incubated for 48 h in DMEM-HG 
(Sigma-Aldrich) supplemented with 5% FCS. Media was then changed for DMEM 
supplemented with 5.5 mM glucose and 1% FCS and vehicle or toxicant treatments 
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administered for 24 h. Just prior to time of assay, media was switched to bicarbonate-ion 
free RS (reduced serum) buffer at pH 7.4 prepared with 130 mM NaCl, 5.33 mM KCl, 1.8 
mM CaCl2, 0.6 mM MgCl2, 0.5 mM KH2PO4, 0.5 mM NaPO4·(H2O)7, insulin, 5.5 mM 
glucose, and supplemented with 1% FCS, 1 mM L-alanyl-L-glutamine (GlutaMAX), 2 mM 
glutamine, 1% MEM Vitamins, 1% MEM Amino Acids, 1% MEM Non-Essential Amino 
Acids, 1% Penicillin/Streptomycin. All inorganic salts used were obtained from Sigma-
Aldrich (St. Louis, MO) and organic supplements obtained from GIBCO/Life 
Technologies (Grand Island, NY) unless otherwise noted. All oxygen consumption rate 
(OCR) measurements used cycle times of 4 minutes per mix (probes moving) and 3 
minutes per measure (probes down). After recording 3 baseline OCR measurements, 
oligomycin (100 nM) was administered and 3 additional OCR measurements obtained. 
This was followed by administration of FCCP (carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone) (1 μM) and two OCR measurements obtained. Finally, 
a combination of rotenone (5 µM) and antimycin A (100 nM) was administered and two 
final OCR measurements obtained. Uncoupled OCR’s for each condition were recorded 
and reported as mean +/- standard error of the mean (s.e.m.) across experiments. As 
the sequence of mitochondrial perturbing agents above includes non-reversible 
pharmacology, each time point was performed on separate plates. 
4.3.3 Cytotoxicity Determination via Propidium Dye Exclusion 
For cytotoxicity experiments, 661w cells were seeded at a density of 6,000 
cells/well in DMEM-HG supplemented with 5% FCS. 24 h later, this media was 
withdrawn and changed to DMEM-HG supplemented with 1% FCS. 48 h following 
seeding, treatments were administered in DMEM-HG supplemented with 1% FCS (final 
[DMSO] = 0.1%). Cells were incubated with these treatments for 48 h before imaging on 
the GE INCell Analyzer 2000. Prior to imaging, conditioned media contained treatments 
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was withdrawn and set aside. Cells were stained for 30 min with 10 μM Hoechst 33342 
and 1.5 μg/mL propidium iodide (Sigma). Following staining, cells were washed one 
time, and then conditioned media was returned to cells and cells incubated at 37 °C until 
imaged (10-45 minutes). Images were captured using the DAPI filter set for Hoechst and 
the Cy3 filter set for propidium iodide, with a Nikon 10x ELWD objective, and saved in 
the TIFF format. Images were analyzed in Developer Toolbox, with Object segmentation 
used to identify all nuclei in the DAPI-filtered images and a second Object segmentation 
used to identify PI-stained nuclei in the Cy3-filtered images. The measure of % PI-
Positive Cells was obtained by dividing the PI-positive nuclei count by the total nuclei 
count and then multiplying by 100. 
4.3.4 Genome-wide Microarray Expression Profiling 
mRNA was isolated from 661w cells grown to confluence in 10 cm dishes and 
purified using the RNeasy RNA purification kit (Qiagen, Valencia, CA). cDNA was 
synthesized from high-quality RNA (A260/280 ≥ 1.80) and subjected to microarray analysis 
using conditions identical to those described previously [116]. Briefly, GeneChip Mouse 
Genome 430 2.0 oligonucleotide arrays (Affymetrix) were hybridized with equal amounts 
of labeled cRNA (15 µg/array) and readout were performed by the DNA Microarray Core 
Facility at the Medical University of South Carolina using the Affymetrix Fluidics Station. 
4.3.5 Statistical Analysis 
Statistical analysis was conducted using either one-way ANOVA or two-way 
ANVOA, respectively, for single time-point (>2 concentrations/treatments) or multiple 
time-point and multiple concentration experiments. Holm-Sidak multiplicity-adjusted 





As previous results indicated that IBMX induces pathophysiological changes 
(increased ROS, calpain activation) in a timeframe shorter than 24 h [3, 115], the time 
course of mitochondrial physiological changes was first evaluated. Interestingly, it was 
observed that concentrations of IBMX ranging from 10 nM to 1 mM failed to induce 
significant decreases in mitochondrial respiratory capacity at early time points (1, 4, and 
12 h) when compared to vehicle control (data not shown). As previously demonstrated, a 
20-30% decrease in respiratory capacity at 10-500 µM concentrations at 24 h was 
observed, followed by increased cell death (200-400% of control) at 48 h (Figure 4-2).  
 
Figure 4-2. IBMX Induces Decreased Mitochondrial Uncoupled Respiration and Cellular Viability.  
Data are mean ± s.e.m. of n=3-11. Results of XF96 respirometry following 24 h incubation with IBMX at the 
indicated concentrations (A). Rates corrected for non-mitochondrial respiration (following rotenone and 
antimycin A administration). 661w cells were treated for 48 h at the indicated concentrations of IBMX or 
vehicle (0.1 % DMSO), then stained with Hoechst 33342 and propidium iodide (PI), imaged using the INCell 
2000 Analyzer, and PI positive and total nuclei counted with a high content image analysis algorithm (see 
Section 0) (B). Values shown are % of PI-positive cells calculated via (100 * PI-positive nuclei / Hoechst-
positive nuclei). *Multiplicity-adjusted p<0.05 via one-way ANOVA and post-hoc tests with Holm-Sidak 
adjustment for multiple comparisons.  
  
Decreased mitochondrial respiratory capacity may arise from a variety of insults.  
To determine if the decreases in respiratory capacity observed are preceded by changes 
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in mitochondrial morphology or membrane potential, a high content microscopic 
technique developed in our lab was employed to evaluate the interconnectedness of 
mitochondria in living 661w cells in response to IBMX [114]. Briefly, this method detects 
fluorescently labeled mitochondria in micrographs of living or fixed cells using automated 
segmentation and then classifies each mitochondrion found into one of four bins based 
on its shape: punctate, rod-like, networked, or large & round (swollen). The area 
represented by each morphological subtype is then aggregated for each individual cell 
and normalized to the total mitochondrial area within each cell to obtain a proportion for 
each individual subtype. Using this method, an increase in the proportion of 
mitochondria that display networked morphology is observed within the first hour of 
treatment at IBMX concentrations 100 μM and less (Figure 4-3). 
 
Figure 4-3. IBMX Administration Induces Rapid and Sustained Mitochondrial Fusion.  
661w nuclei and mitochondria were stained with Hoechst 33342 (false colored blue) and MitoTracker Deep 
Red (MTDR, false colored green), treated with IBMX or vehicle (0.1% DMSO) for the indicated periods of 
time and imaged using the GE INCell Analyzer 2000 (A, B). Mitochondrial morphology was assessed using 
the method of Leonard et al [114] and proportion of mitochondria with networked morphology displayed in 
(C). Data shown are mean ± s.e.m. of n=6 experiments. Scale bar is 10 μm. Data were analyzed via 2-way 
ANOVA (explanatory variables of time and IBMX concentration) and post-tests comparing each 




Next, the effects of IBMX administration on mitochondrial membrane potential 
(ΔΨm) were determined. Interestingly, 50-100% increases in TMRM fluorescence 
intensity v. vehicle were observed as early as 4 h following administration of IBMX at 10-
500 μM, indicating mitochondrial membrane hyperpolarization (Figure 4-4).  
As electron transport chain complexes (ETC) effectively form an electrical circuit 
(protons pumped from matrix to intermembrane space via ETC I, III, and IV; protons flow 
from intermembrane space to matrix via ETC V ATP synthase), this circuit can be 
described according to Ohm’s law, expressed in general and mitochondrial forms in 
Equation 4-1 and Equation 4-2. 
𝑉𝑉 = 𝐼𝐼 ∗ 𝑅𝑅 
Equation 4-1. Ohm’s Law (general form). 
V is electrical potential in volts, I is current in amps, and R is resistance in ohms. 
∆𝛹𝛹𝑚𝑚 ≈ 𝑄𝑄𝑂𝑂2 ∗ 𝑅𝑅 
Equation 4-2. Ohm’s Law (mitochondrial symbols). 
ΔΨm is the potential difference between mitochondria and a reference point (nucleus in this report), Ψm is 
absolute mitochondrial membrane potential, QO2 is oxygen consumption, a surrogate of mitochondrial 
respiration which approximates to flow of protons across mitochondria inner membrane, and R is resistance. 
“Approximately equal to” symbols are utilized here to recognize the non-mitochondrial sources of oxygen 






Figure 4-4. IBMX Induces Mitochondrial Membrane Hyperpolarization (↑ΔΨm). 
661w cells were stained with MitoTracker Deep Red and tetramethylrhodamine methyl ester (TMRM) and 
subjected to membrane potential analysis as previously described [114]. At 1, 6, 12, and 24 h following 
treatment, cells were visualized and ΔΨm measured by subtracting the nuclear fluorescence intensity from 
the average fluorescence intensity of all mitochondria within each cell. Values are shown as percentage of 
vehicle control at each time point. Data shown are mean ± s.e.m. of n=6 experiments. *multiplicity-adjusted 





Using algebraic interpretation of these equations, it may be interpreted that at 24 
h, the IBMX-induced increase in electrical potential accompanied by a decrease in 
current is likely reflective of an increased resistance of the mitochondrial membrane to 
inward proton flow. Sources of increased resistance along the electron transport chain 
are diverse and include phosphorylation of ETC complexes, tighter coupling of the 
mitochondrial inner membrane via loss of uncoupling protein expression, increased high 
energy electron substrate availability, or decreased availability of ADP and inorganic 
phosphate for ETC Complex V to use as substrate. 
To elucidate a mechanism by which these electrophysiological parameters are 
perturbed by IBMX, studies began with examination of the mitochondrial permeability 
transition pore (PTP). PTP opening has been shown to regulate membrane potential and 
is the only known method by which mitochondria are able to exchange ADP for ATP 
[117, 118]. To ask the question of whether or not PTP opening plays a role in IBMX-
induced membrane potential changes in 661w, the role of PTP stabilizing protein 
cyclophilin D (CyD) via the inhibitor cyclosporin A was evaluated. Cyclosporin A also 
inhibits protein phosphatase calcineurin (Ppp3ca). Calcineurin inhibition by FK506 
(tacrolimus) and its analogs (rapamycin, cyclosporin A, ascomycin) is dependent upon 
binding to ubiquitously expressed protein FK506 binding protein FKBP12. The murine 
ortholog (Fkbp1a) of the human FK506 binding protein (FKBP12) is expressed 
abundantly in the 661w cell line as assessed using genome-wide expression profiling 
(see Section 4.3.4). Using 1 µM cyclosporin A, which inhibits both PTP regulator 
cyclophilin D and phosphatase calcineurin, an increase is observed in mitochondrial 
membrane potential (130-140% of control) but no change in interconnectedness is 
observed. Increasing the concentration to 10 µM cyclosporin A increases mitochondrial 
membrane potential further (to 200-220% of control; beyond the 150-175% of control 
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induced by IBMX), and a small (110% of control) increase in mitochondrial 
interconnectedness at 24 h is observed (Supplementary Figure 12).  
To determine if these cyclosporin A-induced phenomena are a result of inhibition 
of CyD/PTP or calcineurin (Ppp3ca), the calcineurin-selective inhibitor ascomycin was 
next examined. At 10 nM, ascomycin induced an increase in membrane potential at 24 
h, but no change in networked morphology. Increasing the concentration to 100 nM 
resulted in increased membrane potential at 1, 5, and 24 h similar in magnitude to that 
induced by 500 µM IBMX with a 60% decrease in networked morphology at 24 h 
(Supplementary Figure 13). Further increasing the dose of ascomycin to 1 µM resulted 
in a rapid and massive increase in membrane potential (500% of control at 1 h, 300% at 
24 h; versus 150-175% of controls for IBMX), accompanied by an increase in network 
morphology at 24 h (125% of control).  
PTP opening is also regulated by glycogen synthase kinase 3-β (GSK-3β). In 
order to understand its role, the selective GSK-3β inhibitor 3F8 was evaluated (3F8 IC50 
for GSK-3β: 34-304 nM depending on [ATP]). Following administration of 100 nM or 1 
µM 3F8, increased mitochondrial membrane potential was observed (120-140% of 
control values) within 1 h (Supplementary Figure 14). At 24 h, membrane potential at 
either dose was not significant from controls. 3F8 administration induced no significant 
effect on mitochondrial networked proportion. At lower concentrations (1-10 nM), 3F8 
induced no significant effects when administered alone (data not shown). A similar 
concentration response was obtained with LiCl administration at 1 h (also inhibits GSK-
3β; data not shown). To determine if GSK-3β activation plays a role in transducing 
altered mitochondrial physiology following administration of IBMX, GSK-3β inhibitor 3F8 
was administered 1 h prior to administration of IBMX. Interestingly, pretreating 661w 
cells at 1 nM, a concentration of 3F8 lower than that necessary to induce altered 
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physiology when administered 
alone, resulted in significant 
prevention of increases in 
networked morphology and 











Figure 4-5. GSK3-β (Gsk3b) inhibition partially reverses IBMX-induced alterations in mitochondrial 
networked morphology and membrane potential. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Proportion of networked mitochondria following 24 h treatment is 
presented in (A), and mitochondrial membrane potential in (B). Data shown are mean ± s.e.m. of n=4 
experiments. “X”: multiplicity-adjusted p<0.05. Analyzed by one-way (A) or two-way ANOVA (B), post-test 




In this study, IBMX was observed to induce mitochondrial membrane 
hyperpolarization and increased networked morphology at 1 h and 4 h (respectively), 
which were followed by decreased mitochondrial respiratory capacity at 24 h, eventually 
followed by increased cell death at 48 h. To our knowledge, the combination of these 
effects has not been previously described for a single agent, although a recently 
published paper demonstrated 100 µM IBMX pretreatment increased mitochondrial form 
factor (a measure of interconnectedness) in patient-derived olfactory neurons, and 
furthermore prevented mitochondrial fragmentation induced by mutations in a putative 
Zn2+ active transport pump, or by exogenous administration of Zn2+ [119]. Insights into a 
mechanism of action that includes membrane hyperpolarization include inhibition of 
mitochondrial electron transport chain (ETC) Complex V, stimulation of the tricarboxylic 
acid cycle or other pathways that increase high energy electron carriers NADH or 
FADH2, or alteration of mitochondrial membrane permeability transition pore (PTP) 
opening. Previous studies with Complex V inhibitor oligomycin (Figure 3-4 and Figure 
3-6) demonstrated increased membrane potential and decreased respiratory capacity 
were not associated with an increase but instead with loss of networked morphology, 
suggesting loss of Complex V activity alone may not account for the altered 
mitochondrial physiology observed with IBMX administration. Inhibition of ATP 
consumption using ouabain (which should increase high energy electron carrier 
concentrations) similarly resulted in fragmentation: Figure 3-4).  
Although the absolute amounts of cell death observed in Figure 4-2 were lower 
than expected (increasing from only 0.4% in vehicle treated cells to 1.6% in cells treated 
with 500 μM IBMX), this likely is due to the majority of dead (propidium-stained) cells 
lifting off of the plate bottom and not being within the imaging plane at time of assay. 
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Manual inspection of IBMX-treated wells indeed demonstrated fewer total (Hoechst 
33342-stained) cells remaining. Thus, the data are likely more reflective of a death rate 
assay as only recently dead cells remain on the well bottom. 
Taken together, the data in Supplementary Figure 12 and Supplementary 
Figure 13 demonstrated the difficulty in understanding the role PTP opening by 
cyclosporin A-mediated inhibition of cyclophilin-D (CyD), as pure calcineurin inhibition by 
ascomycin appeared to regulate 661w mitochondrial membrane potential and 
morphology independent of CyD. The results highlighted an inability to distinguish 
between calcineurin-mediated effects and mediated effects in these experiments. Thus, 
concomitant administration of cyclosporin A with IBMX was not pursued.  
A second attempt to understand the role of PTP opening in mediating IBMX-
induced alterations in physiology was more fruitful as GSK-3β inhibitor 3F8 (expected to 
lead to increased closure of PTP) induced a transient (1-5 h) increase in mitochondrial 
membrane potential at 100 nM and higher (Supplementary Figure 14). Very 
interestingly, concomitant administration of IBMX and 3F8 at concentrations of 3F8 lower 
than those needed to induce changes by 3F8 alone demonstrated a reversal of IBMX-
induced changes, suggesting that IBMX-induced activation of GSK-3β is at least in part 
responsible for increasing mitochondrial membrane potential and networked morphology 
in 661w (Figure 4-5). Although future studies will be needed to further elucidate the 
signaling pathways involved, these experiments suggest that either excess inhibition of 
GSK-3β or IBMX-induced activation of GSK-3β both result in mitochondrial membrane 
hyperpolarization and dysregulation of mitochondrial morphology prior to loss of 





In this study, the effects of 3-isobutyl 1-methylxanthine (IBMX) on mitochondrial 
physiology are demonstrated – namely, decreased mitochondrial respiration as 
measured by decreases in mitochondrial respiratory capacity, which is preceded by 
increases in networked morphology and increased mitochondrial membrane potential 
(ΔΨm). As IBMX is commonly used as an inhibitor of cyclic nucleotide 
phosphodiesterase enzymes, this work highlights the potential confounding effects of 
IBMX use on cellular bioenergetics and cell signaling in physiological studies. 
Furthermore, IBMX administration to 661w photoreceptor cells recapitulates the 
phenomena of mitochondrial functional loss preceding cellular death in inherited retina 
degeneration, providing additional support to the use of 661w as a cell-based 
photoreceptor model. Data are shown that demonstrate that GSK-3β inhibition alone and 
IBMX administration alone hyperpolarize mitochondria; however, the combination of the 
two leads to mitigation of effects. A plausible explanation for this result is that IBMX 
administration leads to activation of GSK-3β, raising the question of whether decreased 





5. Chapter 3—IBMX Inhibition of Cyclic GMP 
Phosphodiesterases Leads to Mitochondrial Dysfunction  
5.1 Abstract 
3-isobutyl 1-methylxanthine (IBMX) is a commonly used non-selective inhibitor of 
cyclic nucleotide phosphodiesterases (PDEs). This report describes the role of selective 
PDE inhibition in conveying the mitochondrial and cellular toxicities induced by IBMX in 
the photoreceptor-derived cell line 661w. Following administration of IBMX, a 
concentration- and time-dependent increase in networked morphology (102-120% of 
control) was followed by increased membrane potential (tetramethylrhodamine methyl 
ester fluorescence intensity 125-200% of control) and decreased mitochondrial 
respiratory capacity (30% of control at 24 h). These changes were recapitulated entirely 
or partially (respectively) by PDE5-selective inhibitor of sildenafil and PDE3-selective 
inhibitor cilostamide. IBMX induced cell death (400% of control at 48 h), but this toxicity 
was not observed with inhibition of either PDE3, PDE5, or both. IBMX led to increased 
cAMP and cGMP, but PDE3 and PDE5 inhibition selectively increased cGMP. Taken 
together, these results indicate that cGMP is a strong regulator of mitochondrial 
physiology and alterations may occur to a large extent without effects on cellular viability. 
The results also suggest that increased cAMP or another as yet to be determined target 
of IBMX are responsible for 661w photoreceptor cytotoxicity. As mitochondria are central 
to regulating cellular bioenergetics and programmed cellular death, these results have 
implication for researchers in a broad variety of fields ranging from physiology and 




3-isobutyl 1-methylxanthine (IBMX) is a well-known and widely used non-
selective inhibitor of cyclic nucleotide phosphodiesterase (PDE) enzymes. However, the 
role of individual phosphodiesterase enzymes in regulating mitochondrial physiology is 
poorly understood. In Section 4, the effects of IBMX on mitochondrial physiology are 
discussed (Chapter 2—IBMX Administration Results in Mitochondrial Membrane 
Hyperpolarization, Increased Network Morphology, and Decreased Respiratory 
Capacity). The goal of the present work is to characterize the roles of individual PDE 
enzymes in conducting IBMX-induced alterations in mitochondrial physiology. 
As a non-selective inhibitor of PDE enzymes, IBMX has been characterized to 
inhibit PDE isoforms PDE1-PDE8. PDE enzymes catalyze the cleavage of the 
intramolecular 3’-5’ phosphodiester bond in cyclic adenosine monophosphate (cAMP) or 
cyclic guanosine monophosphate (cGMP). Individual PDE isoforms may display 
selectivity towards cAMP or cGMP or cleave both cyclic nucleotides. Table 5-1 
summarizes the cyclic nucleotide selectivity of PDE isoforms and their expression within 
661w as determined by genome-wide expression profiling.  
Cyclic 
Nucleotide 
PDE1 PDE2 PDE3 PDE4 PDE5 PDE6 PDE7 
cAMP X X X X no no X 
cGMP X X X no X X no 
 
Table 5-1. IBMX-sensitive Cyclic Nucleotide Phosphodiesterase Enzymes and Their Selectivity 
LEGEND: ‘X’: PDE isoform cleaves the cyclic nucleotide on the same row; ‘no’: PDE isoform unable to 
cleave the cyclic nucleotide on the same row; White: expressed in 661w; Gray: no expression. Expression 




5.3 Materials and Methods 
5.3.1 Cell Culture 
661w photoreceptor cells were generously provided by Dr. M. Al-Ubaidi 
(University of Oklahoma) [18] and maintained under standard conditions using DMEM-
HG media (Sigma-Aldrich #D-7777) supplemented with 10% fetal calf serum (FCS, 
Atlanta Biologicals #S11550) and 1 mM L-alanyl-L-glutamine (GlutaMAX) (Life 
Technologies #35050-061). For imaging studies, cells of passages 15-25 were cultured 
to 80% confluency before trypsinization and seeded at a cell density of 8,900 cells per 
well in 96 well plates (Nunc Edge Plate, Thermo Scientific #167314) supplemented with 
5% FCS and edge reservoirs filled with 1x phosphate buffered saline, (PBS, Life 
Technologies #14080-055). After allowing cells to reach 80% confluency (24 h), cells 
were washed in PBS, and media was changed to DMEM with 5.5 mM glucose without 
phenol red (Sigma-Aldrich #D-5030) supplemented with 1% FCS to induce cell cycle 
arrest. Cells were used for experiments 24 h after this switch to normal glucose and 1% 
FCS-containing media, with treatments for either 24 h (morphological analysis) or 1 h 
(membrane potential analysis). All compounds used for treatment were from Sigma-
Aldrich (St. Louis, MO) unless otherwise specified, and were prepared at 1000x 
concentration in DMSO before administration to cells (final [DMSO] = 0.1%). 
5.3.2 Genome-wide Microarray Expression Profiling 
mRNA was isolated from 661w cells grown in 10 cm dishes to confluence and 
purified using the RNeasy RNA purification kit (Qiagen, Valencia, CA). cDNA was 
synthesized from high-quality RNA (A260/280 ≥ 1.80) and subjected to microarray analysis 
using conditions identical to those described previously [116]. Briefly, GeneChip Mouse 
Genome 430 2.0 oligonucleotide arrays (Affymetrix) were hybridized with equal amounts 
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of labeled cRNA (15 µg/array) and readout were performed by the DNA Microarray Core 
Facility at the Medical University of South Carolina using the Affymetrix Fluidics Station. 
5.3.3 Determination of Cyclic Nucleotide Concentrations 
661w cells were seeded at 200k in 10 cm dishes and cultured in DMEM-HG 
supplemented with 5% FCS and incubated for 72 h to allow cells to reach 80% 
confluency. Media was then changed to DMEM-HG supplemented with 1% FCS and 
cells incubated an additional 24 h to allow for synchronization of cell cycle. Cells were at 
90-100% confluency at time of treatment. Treatments were made at the indicated 
concentrations in DMEM-HG supplemented with 1% FCS with a final DMSO 
concentration of 0.1% (v/v) and equilibrated in 5% CO2 at 37 °C before being 
administered for 20 min at 37 °C in 5% CO2. Following this incubation, media was 
withdrawn and cells were washed one time with phosphate buffered saline containing no 
Ca2+/Mg2+ (Life Technologies) and 200 μL of 100 mM HCl was immediately added to 
each plate. Plates were scraped at room temperature and samples immediately placed 
on ice. Samples were centrifuged at 14,000 x g and pellets discarded. Supernatants 
were assayed directly for cAMP or cGMP via EIA using manufacturer's protocol (Catalog 
#581001 or #581021, Cayman Chemical, Ann Arbor, MI, USA). Unless otherwise 
specified, all chemicals were from Sigma-Aldrich (St. Louis, MO, USA) and were of 
reagent grade or higher. 
5.3.4 High Content Determination of Mitochondrial Morphology and 
Membrane Potential  
To evaluate the concentration- and time-dependency of IBMX-induced 
mitochondrial changes, we employed the method of Leonard et al. [114]. Briefly, 661w 
cells were seeded into Nunc Edge 96-well plates (Fisher) at a density of 8900/well and 
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incubated in DMEM-HG (Invitrogen) for 24 h. Media was changed to DMEM 
supplemented with 1% FCS and incubated overnight before staining. 661w cells were 
loaded with 50 nM MitoTracker Deep Red, and 10 µM Hoechst 33342 for 30 min and 
then washed followed by a 3 h incubation at 37 °C in DMEM-HG supplemented with 1% 
FCS. After 3 h, cells were treated with IBMX at the indicated concentrations and cells 
imaged. Imaging was performed on a GE INCell Analyzer 2000 automated wide-field 
fluorescence microscope using a 40x Nikon ELWD objective (NA 0.6) matched with the 
large-format 2048x2048 pixel 12-bit Coolsnap K4 camera. Images were saved in the 
TIFF image file format and subjected to the high content mitochondrial morphological 
analysis as described in Section 3, Chapter 1—Quantitative Analysis of 
Mitochondrial Morphology and Membrane Potential in Living Cells Using High 
Content Imaging, Machine Learning, and Morphological Binning. 
5.3.5 Seahorse XF96 Respirometry 
661w photoreceptor cells were seeded (6,000 cells/well) into XF96 polystyrene 
plates (Seahorse Biosciences, Billerica, MA) and incubated for 48 h in DMEM-HG 
(Sigma-Aldrich) supplemented with 5% FCS. Media was then changed for DMEM 
supplemented with 5.5 mM glucose and 1% FCS and vehicle or toxicant treatments 
administered for 24 h. Just prior to time of assay, media was switched to bicarbonate-ion 
free RS (reduced serum) buffer at pH 7.4 prepared with 130 mM NaCl, 5.33 mM KCl, 1.8 
mM CaCl2, 0.6 mM MgCl2, 0.5 mM KH2PO4, 0.5 mM NaPO4·(H2O)7, insulin, 5.5 mM 
glucose, and supplemented with 1% FCS, 1 mM L-alanyl-L-glutamine (GlutaMAX), 2 mM 
glutamine, 1% MEM Vitamins, 1% MEM Amino Acids, 1% MEM Non-Essential Amino 
Acids, 1% Penicillin/Streptomycin. All inorganic salts used were obtained from Sigma-
Aldrich (St. Louis, MO) and organic supplements obtained from GIBCO/Life 
Technologies (Grand Island, NY) unless otherwise noted. All oxygen consumption rate 
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(OCR) measurements used cycle times of 4 minutes per mix (probes moving) and 3 
minutes per measure (probes down). After recording 3 baseline OCR measurements, 
oligomycin (100 nM) was administered and 3 additional OCR measurements obtained. 
This was followed by administration of FCCP (carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone) (1 μM) and two OCR measurements obtained. Finally, 
a combination of rotenone (5 µM) and antimycin A (100 nM) was administered and two 
final OCR measurements obtained. Uncoupled OCR’s for each condition were recorded 
and reported as mean +/- standard error of the mean (s.e.m.) across experiments by 
subtracting the final rate (non-mitochondrial respiration, determined following rotenone 
and antimycin A) from the first rate obtained following FCCP administration. 
5.3.6 Cytotoxicity Determination via Propidium Dye Exclusion 
For cytotoxicity experiments, 661w cells were seeded at a density of 6,000 
cells/well in DMEM-HG supplemented with 5% FCS. 24 h later, this media was 
withdrawn and changed to DMEM-HG supplemented with 1% FCS. 48 h following 
seeding, treatments were administered in DMEM-HG supplemented with 1% FCS (final 
[DMSO] = 0.1%). Cells were incubated with these treatments for 48 h before imaging on 
the GE INCell Analyzer 2000. Prior to imaging, conditioned media containing treatments 
was withdrawn and incubated at 37 °C in 5% CO2 balance air. Cells were stained for 30 
min with 10 μM Hoechst 33342 and 1.5 μg/mL propidium iodide (PI, Sigma) in serum-
free DMEM-HG. Following staining, cells were washed once with PBS containing 
Ca2+/Mg2+ (GIBCO/Life Technologies), and then conditioned media was returned to cells 
and cells incubated at 37 °C until imaged (10-45 minutes). Images were captured using 
the DAPI filter set for Hoechst and the Cy3 filter set for PI, with a Nikon 10x ELWD 
objective, and saved in TIFF format. Images were analyzed in Developer Toolbox, with 
Object segmentation used to identify all nuclei in the DAPI-filtered images (Hoechst 
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stain) and a second Object segmentation used to identify PI-stained nuclei in the Cy3-
filtered images. The measure of % PI-Positive Cells was obtained by dividing the PI-
positive nuclei count by the total (Hoechst-stained) nuclei count and then multiplying by 
100. 
5.3.7 Statistical Analysis 
Statistical analysis was conducted using either one-way ANOVA or two-way 
ANVOA, respectively, for single time-point (>2 concentrations/treatments) or multiple 
time-point and multiple concentration experiments. Holm-Sidak multiplicity-adjusted 
post-hoc analyses were conducted in each analysis to compare across treatment groups 
(not timepoints) and p values < 0.05 were considered significant. 
5.4 Results 
5.4.1 IBMX Administration Leads to Increased Intracellular [cAMP] and 
[cGMP]  
As a first effort to delineate the PDE isoforms responsible for the mitochondrial 
physiological effects observed, the concentration of intracellular cyclic nucleotides cAMP 
and cGMP was measured following administration of IBMX or selective PDE inhibitors. 
The results indicate a 140% increase in intracellular cAMP and a 3,400% increase in 
intracellular cGMP following IBMX treatment. cGMP-specific PDE5 inhibitor sildenafil 
(PDE5 IC50: 4 nM)  and PDE3-selective inhibitor cilostamide (PDE3 IC50: 50 nM) were 
observed to have no effect on cAMP, but induced an increase in [cGMP] 8,000% and 




Figure 5-1. IBMX and Selective PDE Treatments Increase cAMP and cGMP 
661w cells were washed and lysed following 20 min treatment with compounds at the indicated 
concentrations and cAMP or cGMP concentration determined via a commercially available enzyme-linked 
immunosorbance assay (Section 5.3.2). Data shown are mean ± s.e.m of n=3 experiments. *multiplicity-
adjusted p<0.05 by one-way ANOVA; multiple comparisons made v. vehicle and adjusted via Holm-Sidak. 
 
As IBMX induced increases in both cAMP and cGMP, it was next sought to 
determine which cyclic nucleotide phosphodiesterase isoform(s) were able to 
recapitulate the alterations in mitochondrial physiology observed in Section 4, Chapter 
2—IBMX Administration Results in Mitochondrial Membrane Hyperpolarization, 
Increased Network Morphology, and Decreased Respiratory Capacity using a high 




5.4.2 The Role of cAMP-selective Phosphodiesterase Inhibition in 
Regulating Mitochondrial Physiology 
As IBMX administration increased both intracellular cAMP and cGMP, the two 
cAMP-selective phosphodiesterases expressed in 661w were first examined, PDE4 and 
PDE7. Interestingly, rather than inducing a decrease in uncoupled respiration, selective 
inhibitors of these enzymes increased uncoupled respiration. At a concentration of 1 μM, 
the selective inhibitor of PDE4 rolipram (IC50 313 nM [120]), increased uncoupled 
respiration by ~45%. At concentrations of 10 μM and 100 μM, ~60% increases in 
uncoupled respiration were observed with BRL 50481 (IC50 2.4 μM [121]) (Figure 5-2). 
 
Figure 5-2. PDE4 and PDE7 Inhibition Increase, not Decrease Uncoupled Respiration.  
Data are mean ± s.e.m. of n=4 experiments; analyzed by one-way ANOVA with Holm-Sidak correction for 




5.4.3 The Role of PDE5-cGMP in Regulating Mitochondrial Physiology 
 
Figure 5-3. Inhibition of PDE5 recapitulates IBMX-induced alterations in mitochondrial physiology. 
High-content analysis of mitochondrial membrane potential (A, D) and networked morphology (B, D) of 661w 
cells were conducted using the method of Leonard et al. [114]. Seahorse XF96 respirometry was conducted 
at 24 h following treatment with compounds at the indicated concentration (C). Data shown are mean ± 
s.e.m. of n=4 experiments and were analyzed by one-way (C) or two-way (A, B) ANOVA with Holm-Sidak 
correction for multiple comparisons. * or X: p<0.05 v. vehicle. Scale bar 10 μm (D). 
  
At 100 nM, sildenafil administration led to a rapid (at 1 h) and sustained (up to 24 
h) increase in mitochondrial membrane potential (200-220% of control), networked 
morphology (120-140% of control) and decreased uncoupled respiration (70% of control) 
as measured by Seahorse XF96 respirometry (Figure 5-3). At the lower dose of 10 nM, 
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only an increase in networked mitochondria (135% of control) was observed at 24 h. In 
context with the changes induced by IBMX at 500 μM, sildenafil at 100 nM at all times 
exceeded the amount of hyperpolarization achieved (200% v. 160% of control), and at 
later time points partially recapitulated the amount of mitochondrial fusion (135% v. 
180% of control). However, at earlier time points, the magnitude of increase in 
mitochondrial networks induced by sildenafil at 100 nM matched that of IBMX (120% of 
control). 
5.4.4  The Role of PDE2 and PDE3 (cAMP and cGMP) in Mitochondrial 
Physiology 
The third category of phosphodiesterase enzymes according to specificity are the 
non-selective PDEs, which cleave both cAMP and cGMP. In 661w, two such isoforms 
are expressed as determined by genome-wide expression profiling, PDE2 and PDE3 
(Table 5-1). A similar approach was taken in which concentration-response profiles for 
inhibitors selective for PDE2 and PDE3, BAY60-7550 and cilostamide, were determined 
first using respirometry. PDE2 inhibition by BAY60-7550 (IC50: 4.7 nM [122]) failed to 
alter uncoupled respiration (Figure 5-4). 
At 10 and 100 nM, cilostamide (PDE3 IC50 1.3 μM [123]) led to increased 
mitochondrial membrane potential (120-140% of control) and decreased uncoupled 
respiration (80% of control), but failed to recapitulate increased network morphology 
(Figure 5-4). In context with IBMX, the magnitude of these changes was smaller for both 




Figure 5-4. PDE2 Inhibition Does Not Alter Mitochondrial Uncoupled Respiration. 
24 h treatment. Data are mean ± s.e.m. of n=4 experiments; analyzed by one-way ANOVA with Holm-Sidak 





Figure 5-5. PDE3 Inhibition Increases Mitochondrial Membrane Potential and Decreases Uncoupled 
Respiration but Induces No Changes in Mitochondrial Networks. 
High-content analysis of mitochondrial membrane potential (A, D) and networked morphology (B, D) of 661w 
cells were conducted using the method of Leonard et al. [114]. Seahorse XF96 respirometry was conducted 
at 24 h following treatment with compounds at the indicated concentration (C). Data shown are mean ± 
s.e.m. of n=4 experiments and were analyzed by one-way (C) or two-way (A, B) ANOVA with Holm-Sidak 





5.4.5 Inhibition of PDE3/5 Does Not Increase Cell Death 
As IBMX-induced alterations in 
mitochondrial physiology at 1-24 h were 
found to be followed by 661w cell death 
at 48 h, the amount of cell death following 
PDE3 and PDE5 inhibition was next 
examined. Neither sildenafil nor 
cilostamide recapitulated the IBMX-
induced increase in number of nuclei 
staining positive with propidium iodide 
(400% of control). To determine if 
concomitant inhibition of PDE3 and PDE5 
are required for IBMX-induced cell death, 
the combination of sildenafil and 
cilostamide was evaluated. No increase 
in cell death was observed following the 
combination, suggesting that IBMX 
inhibition of PDE3 and PDE5 leads to 
mitochondrial changes but not cell death 
(Figure 5-6).  
5.5 Discussion 
As cGMP-selective phosphodiesterase but not cAMP-selective 
phosphodiesterase inhibition recapitulated IBMX-induced mitochondrial alterations, it 
would appear that IBMX alters mitochondrial physiology by increasing cGMP in 661w. 
 
Figure 5-6. Neither PDE5 nor PDE3 inhibition 
recapitulate IBMX-induced cell death 
Data are mean ± s.e.m. of n=11 exps. 661w cells 
treated for 48 h at the indicated concentrations or 
with vehicle (0.1% DMSO), then stained with 
Hoechst 33342 and propidium iodide (PI), imaged 
using the INCell 2000 Analyzer, and PI positive and 
total nuclei counted with a high content image 
analysis algorithm (see 5.3.4). Values shown are % 
of PI-positive cells calculated via (100 * PI-positive 
nuclei / Hoechst-positive nuclei). *Multiplicity-
adjusted p<0.05 via one-way ANOVA and post-hoc 




As the 661w cells are widely thought to be photoreceptor derived, we were surprised 
that no PDE6 expression was detected. This isn’t the first study showing 661w cells 
have been shown to be missing a component of the visual transduction pathway, as 
Fitzgerald et. al. showed CNGA3 is not expressed [22], Tang et. al. showed the absence 
of RPE65 expression [20], and the original paper from the Al-Ubaidi group characterizing 
the 661w cells show an absence of several cone photoreceptor proteins, including 
phosducin, RPE65, peripherin/rds, and ROM1 [19]. Nonetheless, PDE5 and PDE6 share 
substrate specificity as both cleave only cGMP. Furthermore, following inhibition of 
PDE5, the 661w cells demonstrate mitochondrial dysfunction, which has been observed 
in multiple retina degenerative phenotypes [10, 15, 124-127]. Although IBMX 
recapitulated increased cell death as well, we failed to observe an increase in cell death 
following isolated inhibition of PDE3, PDE5, or both PDE3 and PDE5. These results 
suggest a PDE3/PDE5-independent mechanism of action in inducing cell death. 
Perhaps sustained increased intracellular [cAMP] following IBMX administration is 
responsible for inducing cell death via an independent pathway. In combination with this 
lack of cell death induced by cilostamide, this hypothesis is supported by the unexpected 
result that PDE3 inhibition with cilostamide failed to increase cAMP (Figure 5-1). This 
increase in cAMP may be a result of inhibiting cAMP-specific and cAMP/cGMP PDEs 
like PDE2, PDE4 or PDE7, or may result by inhibiting targets other than PDEs, such as 
the cell surface GPCRs like the P1 class of adenosine receptors [128].  
Functional CNG channels, which mediate influx of Ca2+ into the cytoplasm, are 
not expressed in 661w. Ca2+ influx normally inactivates guanylate cyclase (GC), a 
negative feedback mechanism which offsets the cGMP increase induced by inhibition of 
cGMP-specific PDE’s [23]. Administration of PDE inhibitors to purified rod outer 
segments resulted in only 20-30% increases in intracellular cGMP in the absence of 
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Ca2+ chelator ethylene glycol tetraacetic acid (EGTA) but when EGTA was included, 
400% increases were observed, suggesting compensatory GC inactivation was 
overcome by removing Ca2+ stimulus [24]. Indeed, we observe no increased plasma 
membrane conductance with whole cell electrophysiological recordings obtained 
following exogenous administration of IBMX or 8-Br cGMP (Supplementary Figure 11) 
and no increase in fluorescence intensity of 661w cells loaded with Ca2+ dye Fluo 4-AM 
was observed following IBMX administration (data not shown). Taken together with the 
observation that 1,600-8,000% increases in intracellular [cGMP] occur following 
administration of IBMX, sildenafil, or cilostamide, these observations suggest that IBMX 
does not require and does not induce increased intracellular Ca2+ to alter mitochondrial 
physiology. 
5.6 Conclusion 
IBMX administration to 661w cells recapitulates mitochondrial dysfunction and 
increased cell death observed in several in vivo models of retina degeneration. 
Alterations in mitochondrial physiology (increased mitochondrial membrane potential and 
networked morphology with decreased respiratory capacity) appeared to result from 
increased intracellular [cGMP] following inhibition of PDE3 or PDE5, whereas cell death 
was not explained by loss of function of these phosphodiesterases. Future studies will 





6. Chapter 4—Inverse Agonism of the Adenosine A2B Receptor 
(Adora2b) Alters Mitochondrial Physiology 
6.1 Abstract 
The adenosine A2B receptor (A2B) has been increasingly studied as a regulator of 
mitochondrial susceptibility to ischemia/reperfusion injury, but its role in regulating 
mitochondrial respiration, morphology, and membrane potential has not been studied. 
Furthermore, the action of 3-isobutyl 1-methylxanthine (IBMX, a non-selective inhibitor of 
cyclic nucleotide phosphodiesterase enzymes and adenosine receptors) at A2B has not 
been studied. Using the 661w retina-derived cell line (expressing only the A2B isoform of 
adenosine receptor) A2B’s role in regulating mitochondrial physiology, is examined. A2B-
selective inverse agonist MRS-1706, but not agonist BAY60-6583 or neutral antagonist 
PSB-603, recapitulates IBMX-induced alterations. IBMX-induced alterations are reduced 
by pretreating with BAY60-6583 or PSB-603. Similarly, prior activation of adenylate 
cyclase (AC) with forskolin partially reduced IBMX-induced alterations whereas protein 
kinase C (PKC) activation via phorbol myristate acetate (PMA) fully reduced IBMX-
induced changes. Only small, but early and sustained, increases in membrane potential 
were observed following incubation with cell permeable PKA inhibitor myr-PKI 14-22. 
Taken together, these studies suggest A2B appears to signal through a cAMP-
dependent/PKA-independent, and a PKC-dependent pathway to support mitochondrial 
function in 661w and that IBMX functions as an inverse agonist at the A2B receptor. The 
results have important implications for those interested in photoreceptor 
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neurodegeneration and highlight a previously uncharacterized action of IBMX at A2B 
receptor. 
6.2 Introduction 
Adenosine signaling is an important regulator of myriad physiological functions, 
from wakefulness and metabolic regulation in the central nervous system (CNS) and 
heart, and from photoreceptor coupling (a tradeoff between resolution and sensitivity) in 
the retina to protecting against mitochondrial damage following ischemia/reperfusion 
injury in CNS, liver, kidney and heart [41-44, 129-133]. Adenosine and its biological 
derivatives bind to a number of extracellular G protein-coupled receptors (GPCRs) and 
ligand-gated ion channels split into three broad classes. The first major class of 
adenosine-binding GPCRs are deemed the P2X receptors, and are oligomeric ion 
channels activated by various phosphorylated purines and pyrimidines (e.g. adenosine 
di- and tri-phosphate [ADP, ATP], and uridine diphosphate [UDP] and UDP-glucose). 
P2Y receptors are the second major class of purine phosphate-binding receptors, and 
are GPCRs. The P1, or simply termed adenosine receptor class, is represented currently 
by four GPCRs, the A1, A2A, A2B, and A3 adenosine receptors [134-137]. Each receptor 
has varying specificity as to which G protein subunit(s) it couples to, and are involved in 
diverse intracellular signaling mechanisms within the cell (Table 6-1). As the xanthine 
derivative 3-isobutyl 1-methylxanthine (IBMX) has been previously described to inhibit 
the P1 or adenosine receptor subclass, and this subclass has been linked to the 
regulation of mitochondrial physiology, this report will focus its efforts on understanding 




Receptor Gene Symbol (human, mouse) G Proteins 
A1 ADORA1, Adora1 Gαi 
A2A ADORA2A, Adora2a Gαs 
A2B ADORA2B, Adora2b Gαs, Gαq/11, Gαi 
A3 ADORA3, Adora3 Gαi 
Table 6-1. Adenosine receptor family members and the G proteins to which they couple. 
  
The work of several labs indicates the necessity of adenosine in activating the 
protective pathways involved in the phenomena of ischemic preconditioning and 
postconditioning. Briefly, preconditioning is the cytoprotective phenomenon observed 
following a series of short vascular occlusions made minutes to hours prior to a major 
occlusion of vascular supply. Postconditioning is a similar phenomenon, with the 
exception that the short vascular occlusions are made after reperfusion. Activation of the 
epsilon isoform of protein kinase C (PKCε) and the extracellular release of adenosine, 
bradykinin, and opioids along with an increase in reactive oxygen species (ROS) have 
been observed followed preconditioning [43]. PKC and the adenosine A2B receptor have 
been shown to be necessary in rabbit heart postconditioning as non-selective activation 
of protein kinase C isoforms with phorbol myristate acetate (PMA) was demonstrated to 
be sufficient to recapitulate post-conditioning, which was subsequently lost with 
concomitant inhibition of adenosine receptor A2B [42]. This suggests that the A2B receptor 
is a downstream target of one or more protein kinase C isoforms. However, the coupling 
of adenosine A2B receptor to Gαq (resulting in the receptor functioning upstream of PKC 
isoforms) cannot be excluded, as in the CNS cell line U373 MG (astrocytoma) activation 
of PKCε and δ isoforms was observed following administration of A2B agonist NECA 
[139].  
6.3 Materials and Methods 
6.3.1 Cell Culture 
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661w photoreceptor cells were generously provided by Dr. M. Al-Ubaidi 
(University of Oklahoma) [18] and maintained under standard conditions using DMEM-
HG media (Sigma-Aldrich #D-7777) supplemented with 10% fetal calf serum (FCS, 
Atlanta Biologicals #S11550) and GlutaMAX (Life Technologies #35050-061). For 
imaging studies, cells of passages 15-25 were cultured to 80% confluency before 
trypsinization and seeded at a cell density of 8,900 cells per well in 96 well plates (Nunc 
Edge Plate, Thermo Scientific #167314) supplemented with 5% FCS and edge 
reservoirs filled with 1x phosphate buffered saline, (PBS, Life Technologies #14080-055) 
and grown for 24 h. For studies involving collection of cellular lysates, 661w cells were 
seeded at 200k per dish in 10 cm dishes in DMEM-HG supplemented with 5% FCS, and 
grown for 72 h. 24 h prior to assay, cells were at 80% confluency, and were washed in 
PBS, followed by change of media to DMEM with 5.5 mM glucose without phenol red 
(Sigma-Aldrich #D-5030) supplemented with 1% FCS to induce cell cycle arrest. Cells 
were used for experiments 24 h after this switch to normal glucose and 1% FCS-
containing media, with treatments for either 24 h (morphological analysis) or 1 h 
(membrane potential analysis). All compounds used for treatment were from Sigma-
Aldrich (St. Louis, MO) unless otherwise specified, and were prepared at 1000x 
concentration in DMSO before administration to cells (final [DMSO] = 0.1%). 
6.3.2 Genome-wide Microarray Expression Profiling 
mRNA was isolated from 661w cells grown in 10 cm dishes to confluence and 
purified using the RNeasy RNA purification kit (Qiagen, Valencia, CA). cDNA was 
synthesized from high-quality RNA (A260/280 ≥ 1.80) and subjected to microarray analysis 
using conditions identical to those described previously [116]. Briefly, GeneChip Mouse 
Genome 430 2.0 oligonucleotide arrays (Affymetrix) were hybridized with equal amounts 
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of labeled cRNA (15 µg/array) and readout was performed by the DNA Microarray Core 
Facility at the Medical University of South Carolina using the Affymetrix Fluidics Station. 
6.3.3 Western Blotting 
Antibody for the adenosine A2B receptor was obtained from Fisher Scientific 
(#PIPA518422, goat polyclonal). GAPDH antibody was obtained from Fitzgerald (10R-
G109a, mouse monoclonal). 661w cells grown to confluence on 10 cm dishes were 
lysed in 1% sodium dodecyl sulfate with 6M urea in phosphate buffered saline at pH 7.4. 
The lysates were loaded as typical using Pierce loading buffer at 25% and beta 
mercaptoethanol at 10%, with the exception that these samples were kept at room 
temperature, not boiled, for 30 min. Gels were run at 100V for 25 min, followed by 200V 
for 1 hr. Proteins were transferred to iBlot nitrocellulose membrane using program 3 for 8 
minutes. Membranes were blocked with 2.5% bovine serum albumin (fraction V fatty 
acid free, Fisher Scientific) in tris-buffered saline/tween 1% (TBS-Tween) at room 
temperature for 1 h and antibody stocks made in 0.5% bovine serum albumin in TBS-
Tween at the manufacturer’s suggested concentration of 1000 x. Incubation with primary 
antibody was for 18 h at 4 deg. C and secondary antibody (horseradish peroxidase 
(HRP)-conjugated donkey anti-goat (Fitzgerald #43R-ID040hrp) or HRP-conjugated 
rabbit anti-mouse (Fitzgerald #43R-1418) for 2 h at room temperature with 3x washes in 
TBS-Tween at each change. Membranes were developed using SuperSignal West Dura 
development substrate (Fisher PI-34076) and imaged. 
6.3.4 High Content Determination of Mitochondrial Morphology and 
Membrane Potential  
To evaluate the concentration- and time-dependence of IBMX-induced 
mitochondrial changes, the method of Leonard et al. [114] was used. Briefly, 661w cells 
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were seeded into Nunc Edge 96-well plates (Fisher) at a density of 8900/well and 
incubated in DMEM-HG (Invitrogen) for 24 h. Media was changed to DMEM 
supplemented with 1% FCS and incubated overnight before staining. 661w cells were 
loaded with 50 nM MitoTracker Deep Red, and 10 µM Hoechst 33342 for 30 min and 
then washed followed by a 3 h incubation at 37 °C in DMEM-HG supplemented with 1% 
FCS. After 3 h, cells were treated with IBMX at the indicated concentrations and cells 
imaged. Imaging was performed on a GE INCell Analyzer 2000 automated wide-field 
fluorescence microscope using a 40x Nikon ELWD objective (NA 0.6) matched with the 
large-format 2048x2048 pixel 12-bit Coolsnap K4 camera. Images were saved in the 
TIFF image file format and subjected to the high content mitochondrial morphological 
analysis as described in Section 3. 
6.3.5 Seahorse XF96 Respirometry 
661w photoreceptor cells were seeded (6,000 cells/well) into XF96 polystyrene 
plates (Seahorse Biosciences, Billerica, MA) and incubated for 48 h in DMEM-HG 
(Sigma-Aldrich) supplemented with 5% FCS. Media was then changed for DMEM 
supplemented with 5.5 mM glucose and 1% FCS and vehicle or toxicant treatments 
administered for 24 h. Just prior to time of assay, media was switched to bicarbonate-ion 
free RS (reduced serum) buffer at pH 7.4 prepared with 130 mM NaCl, 5.33 mM KCl, 1.8 
mM CaCl2, 0.6 mM MgCl2, 0.5 mM KH2PO4, 0.5 mM NaPO4·(H2O)7, insulin, 5.5 mM 
glucose, and supplemented with 1% FCS, 1 mM L-alanyl-L-glutamine (GlutaMAX), 2 mM 
glutamine, 1% MEM Vitamins, 1% MEM Amino Acids, 1% MEM Non-Essential Amino 
Acids, 1% Penicillin/Streptomycin. All inorganic salts used were obtained from Sigma-
Aldrich (St. Louis, MO) and organic supplements obtained from GIBCO/Life 
Technologies (Grand Island, NY) unless otherwise noted. All oxygen consumption rate 
(OCR) measurements used cycle times of 4 minutes per mix (probes moving) and 3 
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minutes per measure (probes down). After recording 3 baseline OCR measurements, 
oligomycin (100 nM) was administered and 3 additional OCR measurements obtained. 
This was followed by administration of FCCP (carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone) (1 μM) and two OCR measurements obtained. Finally, 
a combination of rotenone (5 µM) and antimycin A (100 nM) was administered and two 
final OCR measurements obtained. Uncoupled OCR’s for each condition were recorded 
and reported as mean +/- standard error of the mean (s.e.m.) across experiments. As 
the sequence of mitochondrial perturbing agents above includes non-reversible 
pharmacology, each time point was performed on a separate plate. 
6.3.6 Statistical Analysis 
Statistical analysis was conducted using either one-way ANOVA or two-way 
ANVOA, respectively, for single time-point (>2 concentrations/treatments) or multiple 
time-point and multiple concentration experiments. Holm-Sidak multiplicity-adjusted 
post-hoc analyses were conducted in each analysis to compare across treatment groups 
(not timepoints) and p values < 0.05 were considered significant. 
6.4 Results 
6.4.1 Expression of Adenosine Receptor Subtypes in 661w 
As the adenosine receptor subtypes display significant heterogeneity with 
regards to phenotypic regulation and secondary messenger coupling, genome-wide 
expression profiling, Western blotting, and cyclic nucleotide accumulation determination 
by enzyme-linked immunosorbance assay were conducted to determine which subtypes 
are expressed in the 661w photoreceptor cell line. These efforts demonstrated that at 
the mRNA level, only the adenosine receptor A2B subtype was expressed (Figure 6-1A). 
Expression of A2B was then confirmed at the protein level by Western blotting (Figure 
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6-1B). Functional activity of A2B was confirmed by measuring an ~15-fold increase in 
cAMP following 20 min stimulation with A2B-selective agonist BAY60-6583 (Figure 
6-1C). 
 
Figure 6-1. Functional Expression of Adenosine A2B Receptor Expression in 661w. 
RNA isolated from 661w was reverse transcribed to cDNA and subjected to genome-wide expression 
profiling by hybridization to Affymetrix GeneChip mouse microarray (A). Data shown are mean ± s.e.m. of 
n=3 experiments. Expression of A2B receptor by Western blotting (B). cAMP concentrations were determined 
by EIA following 20 min incubation with A2B-selective agonist BAY60-6583 or vehicle (0.1% DMSO). 
  
6.4.2 Adenosine A2B Receptor Agonism Fails to Recapitulate IBMX-
induced Mitochondrial Physiological Changes 
Having demonstrated functional expression of the A2B receptor in the 661w 
retina-derived cell line, mitochondrial physiological response was next examined 
following administration of 3-isobutyl 1-methylxanthine (IBMX) or a selective agonist of 
the adenosine A2B receptor, BAY60-6583 (EC50 for A2B: 2.8 nM). IBMX increased 
mitochondrial membrane potential (ΔΨm) (Figure 6-2A), increased mitochondrial fusion 
as evidenced by significant increases in the proportion of networks (in comparison to the 
less interconnected punctate, rod, and large & round phenotypes) (Figure 6-2B), and 
decreased mitochondrial respiratory capacity (current) as evidenced by a decrease in 
uncoupled respiration (Figure 6-2C). In comparison to IBMX, BAY60-6583 failed to 
recapitulate any of these changes, instead inducing a small magnitude effect in the 
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opposite direction by decreasing mitochondrial networks by up to 12% after 12 - 24 h 
exposure at 10 and 100 nM (Figure 6-2B). 
 
Figure 6-2. A2B-selective Agonist BAY60-6583 Fails to Recapitulate IBMX-induced Mitochondrial 
Physiological Changes. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Mitochondrial membrane potential is presented in (A), proportion of 
networked mitochondria in (B), uncoupled respiration in parallel experiments at 24 h in (C), and 
representative images in (D). Data shown are mean s.e.m. of n=6 experiments. *multiplicity-adjusted 
p<0.05. Analyzed by one-way (C) or two-way ANOVA (A & B), post-test treatment group versus vehicle at 
each time point. Scale bar 10 μm (D).  
 
6.4.3 Adenosine A2B Receptor Antagonism Fails to Recapitulate IBMX-
induced Mitochondrial Physiological Changes 
Following studies with the A2B receptor agonist BAY60-6583, the effect of A2B 
antagonist PSB-603 (Ki for A2B: 0.55 nM) on mitochondrial physiology was next 
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examined. No significant changes in mitochondrial physiology were observed following 
administration of 10-100 nM PSB-603 (Figure 6-3). 
 
Figure 6-3. A2B-selective Antagonist PSB-603 Fails to Recapitulate IBMX-induced Mitochondrial 
Physiological Changes 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Mitochondrial membrane potential is presented in (A), proportion of 
networked mitochondria in (B), uncoupled respiration in parallel experiments at 24 h in (C), and 
representative images in (D). Data shown are mean s.e.m. of n=6 experiments. *multiplicity-adjusted 
p<0.05. Analyzed by one-way (C) or two-way ANOVA (A & B), post-test treatment group versus vehicle at 




6.4.4 Adenosine A2B Receptor Inverse Agonism Induces Increased 
Mitochondrial Membrane Potential and Decreased Respiration 
 
Figure 6-4. A2B-selective Inverse Agonist MRS-1706 Recapitulates IBMX-induced Mitochondrial 
Membrane Hyperpolarization and Decreased Respiration 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Mitochondrial membrane potential is presented in (A), proportion of 
networked mitochondria in (B), uncoupled respiration in parallel experiments at 24 h in (C), and 
representative images in (D). Data shown are mean s.e.m. of n=6 experiments. *multiplicity-adjusted 
p<0.05. Analyzed by one-way (C) or two-way ANOVA (A & B), post-test treatment group versus vehicle at 
each time point. Scale bar 10 μm (D). 
 
Following studies with the A2B receptor agonist BAY60-6583, the effect of A2B 
inverse agonist MRS-1706 (Ki for A2B: 1.39 nM) on mitochondrial physiology was next 
examined. MRS-1706 recapitulated two out of three physiological effects induced by 
IBMX. At 10 nM, MRS-1706 recapitulated IBMX-induced hyperpolarization at 6 h (130% 
v. 140% of control TMRM intensity) but this effect was transient and not observed at 24 
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h (Figure 6-4A). No alterations in morphology or uncoupled respiration were observed at 
any time point. At a 100 nM concentration, no significant changes in morphology were 
observed (Figure 6-4B), but ~50% of the IBMX-induced decrease in respiration was 
recapitulated (85% v. 62% of control values) and a small amount of hyperpolarization 




6.4.5 IBMX Functions as an Inverse Agonist at the Adenosine A2B Receptor 
 
Figure 6-5. A2B agonist BAY60-6583 reduces latent IBMX-induced physiological changes. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Proportion of networked mitochondria at 24 h is presented in (A), 
mitochondrial membrane potential in (B), and representative images in (C). Data shown are mean s.e.m. of 
n=5 experiments. *multiplicity-adjusted p<0.05. Analyzed by one-way (A) or two-way ANOVA (B), post-test 
treatment group versus IBMX at each time point. Scale bar 10 μm (C). 
  
As IBMX’s pharmacology has not been previously characterized at the adenosine 
A2B receptor and the antagonist PSB-603 had no effect, the hypothesis that IBMX may 
be functioning as an inverse agonist was next tested using competition.  In these 
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studies, 1 h incubation with adenosine A2B receptor agonist BAY60-6583 or adenosine 
A2B receptor antagonist PSB-603 was conducted prior to administration with IBMX, and 
the effects measured at 1 h and 24 h following IBMX administration.  
At 1 h, no differences were noted between the IBMX treatment group and the 
cells given PSB-603 or BAY60-6583. However, the long-term effects of IBMX (at 24 h) 
on networked morphology and membrane potential were competed away by A2B agonist 
BAY60-6583 (Figure 6-5). The same phenomenon was observed with PSB-603, 
suggesting that latent, but not immediate changes in mitochondrial physiology may occur 





Figure 6-6. A2B antagonist PSB-603 reduces latent IBMX-induced physiological changes. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Proportion of networked mitochondria at 24 h is presented in (A), 
mitochondrial membrane potential in (B), and representative images in (C). Data shown are mean s.e.m. of 
n=5 experiments. *multiplicity-adjusted p<0.05. Analyzed by one-way (A) or two-way ANOVA (B), post-test 





Figure 6-7. Forskolin abrogates most IBMX-induced mitochondrial physiological changes. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Proportion of networked mitochondria at 24 h is presented in (A), 
mitochondrial membrane potential in (B), uncoupled respiration in parallel experiments at 24 h in (C), and 
representative images in (D). Data shown are mean s.e.m. of n=3-6 experiments. Different letters (A, C) or X 
in (B) denote multiplicity-adjusted p<0.05 v. IBMX. Analyzed by one-way (C) or two-way ANOVA (A & B). 
Scale bar 10 μm (D). 
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6.4.6 Adenosine A2B Receptor Coupling to Gαs–Adenylate Cyclase is 
Responsible for Regulation of Mitochondrial Physiology 
As the adenosine A2B receptor has been reported to couple to multiple G protein 
alpha subunits depending on cell type, the importance of coupling of this receptor to the 
Gαs subunit in 661w was first examined. Forskolin, an activator of adenylate cyclase, 
was preincubated with cells 1 h before administration of IBMX and the response of 
cellular mitochondria recorded. At 1 h, no significant differences between forskolin and 
forskolin + IBMX were observed, but a small trend towards restoration of mitochondrial 
membrane potential was observed. However, it was observed that alterations in 
networked morphology and mitochondrial membrane potential were completely restored 
at 24 h along with a partial (~50%) reversal of decreases in uncoupled respiration. These 
data indicate that latent but not immediate IBMX-induced mitochondrial physiological 
alterations are likely transduced via inactivation of adenylate cyclase.  
To further elucidate the mechanism of altered mitochondrial physiology via Gαs-
adenylate cyclase-coupled signaling, the effects of PKA inactivation via the myristoylated 
PKI amide inhibitory peptide 14-22 (myr-PKI, PKA Ki=36 nM) were next examined. 
These studies demonstrate that loss of PKA signaling in 661w has no effect on 
networked morphology nor uncoupled respiration (Figure 6-8A,C); however, a small but 
rapid and sustained increase in mitochondrial membrane potential is elicited (~120-
125% of control values) (Figure 6-8B) with 10 µM myr-PKI 14-22 administration. 
Compared to IBMX, the magnitude of this change was much smaller, indicating that loss 
of PKA activation by cAMP elicited from adenylate cyclase likely accounts only for a 
small portion of altered signaling induced by IBMX administration, or that IBMX 
inactivation of cAMP selective phosphodiesterases balances the inactivation of A2B-




Figure 6-8. PKA inhibition recapitulates IBMX-induced mitochondrial membrane hyperpolarization. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Proportion of networked mitochondria at 24 h is presented in (A), 
mitochondrial membrane potential in (B), uncoupled respiration in parallel experiments at 24 h in (C), and 
representative images in (D). Data shown are mean s.e.m. of n=5 experiments. *multiplicity-adjusted p<0.05 
v. vehicle. Analyzed by one-way (C) or two-way ANOVA (A & B). Scale bar 10 μm (D). 
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6.4.7 Role of A2B-Gαq/11-PKC Coupling in Regulation of Mitochondrial 
Physiology 
As alterations in A2B-Gαs-coupled signaling explained only a portion of the 
mitochondrial physiological changes observed, it was hypothesized that a significant 
portion of alterations induced by inverse agonism at the receptor may be conducted by 
other G protein coupled pathways. Canonical Gαq and Gα11-coupled signaling occur via 
activation of a plasma-membrane bound phospholipase C beta (PLC-β), which leads to 
cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol triphosphate (IP3) 
and diacylglycerol (DAG) [140]. Soluble IP3 may travel to the endoplasmic reticulum and 
activate store-operated Ca2+ release, increasing cytoplasmic concentrations of Ca2+. 
Together with DAG, Ca2+ leads to the activation of one or more isoforms of protein 
kinase C (PKC). However, intracellular Ca2+ does not change following IBMX 
administration, nor is a plasma membrane current induced by IBMX administration 
(Supplementary Figure 11). Additionally, cyclic nucleotide-gated cation channels 
(CNGs) are not expressed in 661w (genome-wide expression profiling in these studies 
and [22]). Studies have demonstrated that several isoforms of PKC signal in a Ca2+-
independent manner [141, 142], demonstrating that even in the absence of increases in 
the rise of cytoplasmic Ca2+, PKC signaling may be invoked.  
Using genome-wide expression profiling, the presence of Gαq, Gα11, but neither 
Gα14 nor Gα15 transcripts were found to be expressed. Additionally, phospholipase C 
beta (PLC-β) isoforms 1 and 3, but not 2 were expressed (Section 6.3.2). As either 
PLC- β1 or 3 isoforms are capable of coupling to Gαq/Gα11 and cleaving PIP2 into IP3 
and DAG ultimately leading to PKC activation [140], the expression levels of PKC 
isoforms in 661w cell line were next examined (Table 6-2). 
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Isozyme Requires Ca2+ Requires DAG Expression EC50 PMA (nM) 
alpha X X Present 112±18 [142] 
delta  X Present 574±37 [142] 
epsilon  X Present 15-37 [143] 
eta  X Marginal 0.1±.01 [142] 
iota   Present ND 
PKN1   Present ND 
PKN2   Present ND 
PKN3   Present ND 
Table 6-2. Protein Kinase C Isoforms Expressed in 661w. 
Expression as determined by genome-wide profiling. See Section 6.3.2 for experimental details. 
 
Having established the expression of all members of the pathway necessary for 
PKC activation, the role of all PKC isoforms was next examined by incubating 661w cells 
with classical and novel-PKC isoform activator phorbol 12-myristate 13-acetate (PMA) 
prior to IBMX administration (Figure 6-9). Although only a trend for reversal of 
membrane hyperpolarization is displayed with 10 nM PMA pretreatment, followed by 1 h 
incubation with IBMX, at 24 h, complete reversal of IBMX-induced changes in networked 
morphology, respiratory capacity, and membrane potential were observed. 
Unexpectedly, concentrations of PMA greater than 10 nM resulted in a partial loss of this 
effect in respirometric studies (Figure 6-9C). These studies suggest A2B receptor 
coupling to Gαq/11 upstream of PKC is responsible for latent, but not early alterations in 
mitochondrial physiology, or that one or more isoforms of PKC modulate downstream 




Figure 6-9. Activation of PKC reverses latent IBMX-induced mitochondrial physiological changes. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential 
analysis as previously described [114]. Proportion of mitochondria displaying networked morphology is 
presented in (A), mitochondrial membrane potential in (B), uncoupled respiration in parallel experiments at 
24 h in (C), and representative images in (D). Data shown are mean s.e.m. of n=6-9 experiments. Different 
letters (A, C) or X (B) denote p<0.05 v. IBMX. Analyzed by one-way (A, C) or two-way ANOVA (B). Scale 




These studies demonstrate for the first time that IBMX functions as an inverse 
agonist at the adenosine A2B receptor, and that stimulation of both Gαs– and Gαq/11–
mediated pathways in 661w cells reverse IBMX-alterations in mitochondrial physiology. 
As inverse agonism but neither antagonism nor agonism led to these changes, it is likely 
that constitutive activity of the A2B receptor is necessary for maintenance of 
mitochondrial physiology in 661w. Interestingly, in combination studies, IBMX’s effect on 
mitochondrial physiology were abrogated only at 24 h but not at 1 h, suggesting that loss 
of A2B receptor signaling requires a slower mechanism than protein-protein interaction or 
post-translational modifications to induce a hyperpolarized and fused state. Examples of 
such a mechanism include transcriptional regulation, protein turnover, mitochondrial 
turnover, or another pathway with slower kinetics. Previous work in the lab has shown 
that inhibition of cyclic guanosine monophosphate (cGMP)-selective phosphodiesterase 
enzymes play a role in the immediate (1 h) effects (Section 4). Thus, the primary focus 
of the remaining discussion centers on these longer-term effects. 
Loss of PKA signaling appears to play a limited role in this latent regulation of 
mitochondrial physiology, regulating only membrane potential (Figure 6-8B). However, 
A2B coupling to Gαs-adenylate cyclase appears to regulate latent alterations in 
morphology and membrane potential to a larger degree, with a partial (50%) regulation 
of decreases in mitochondrial uncoupled respiration (Figure 6-7). These results suggest 
a cAMP-dependent but PKA-independent pathway of regulation, perhaps through PI3K 
or MAPK and subsequent regulation of transcription [144]. However, these results are 
unexpected given IBMX has also been shown to increase cAMP (Figure 5-1 in Section 
5). This highlights the possibility that although total intracellular cAMP concentrations 
rise due to IBMX’s dual nature as a cyclic nucleotide phosphodiesterase inhibitor 
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(Section 5.4.1), local cAMP concentrations near A2B-Gαs may decrease following 
administration of IBMX, or the initial increase in cAMP is followed by global decreases. 
Further experiments using a FRET-based cAMP biosensor would be informative in 
understanding the role of subcellular cAMP localization in IBMX-induced mitochondrial 
changes [145].  
While other known mechanisms of GPCR signaling remain possible, such as 
internalization, arrestin-dependent signaling, or Gαi and Gβ/γ signaling, any unevaluated 
pathways are likely to converge on PKC to induce effects on mitochondrial physiology as 
restoration of PKC signaling during IBMX treatment completely rescued normal 
mitochondrial physiology at 24 h (Figure 6-9). However, the question remains of which 
PKC isoform is responsible for these altered changes. This Ca2+ independence suggests 
that a “novel” or “atypical”1 isoform of PKC is responsible for the alterations observed in 
mitochondrial physiology, seven of which are expressed in 661w (Table 6-2). By virtue 
of each isoform’s differential affinity for PMA and in the context of no calcium 
mobilization with IBMX administration (Supplementary Figure 11), it is tempting to 
suggest that at higher concentrations of PMA (100 nM to 1 µM), activation of the lower 
affinity delta isoform (PKCδ) is responsible for the abrogation of protective effect on 
respiration modulated by activation of the higher affinity epsilon (PKCε) or eta (PKCη) 
isoforms by PMA (Figure 6-9C). 
Taken together with previous results from this lab demonstrating that inhibition of 
cGMP-specific cyclic nucleotide phosphodiesterases (PDEs) recapitulates some of the 
altered mitochondrial physiological changes, namely increased mitochondrial membrane 
potential and network morphology, with partial decreases in respiratory capacity 
1 “Novel” PKC isoforms require DAG but not Ca2+, whereas “atypical” isoforms require 
neither DAG nor Ca2+ 
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(Section 5), it is reasonable to suggest that cGMP PDE inhibition ultimately results in 
altered PKC/adenosine A2B receptor signaling. One explanation for an interplay between 
PDE and adenosine signaling is activation of cGMP-dependent protein kinases (PKG).  
PKG Type I and PKG Type II are expressed in 661w cells as determined by genome-
wide expression profiling. PKG activation has been reported to be followed by opening of 
the mitochondrial KATP channel, ultimately resulting in the activation of PKC [146, 147]. A 
hypothesis that would explain the necessity for inverse agonism and rescue of 
mitochondrial physiological alterations by restoration of Gαq/11 or Gαs is difficult, 
especially considering that in many non-retina model systems cGMP signaling is 
protective of mitochondria [36, 147]. However, cGMP-mediated switching of a positive 
feedback mechanism between A2B and one or more isoforms of PKC is attractive—as 
the delta and epsilon isoforms of PKC have been shown to have opposing effects on 
mitochondrial physiology, with delta promoting and epsilon inhibiting pyruvate 
dehydrogenase [148]. Evidence in support of PKC signaling upstream of A2B is manifest 
in that the cardioprotection against ischemia observed by mimicking ischemic post-
conditioning with administration of PKC agonist phorbol myristate acetate was abrogated 
upon prior administration of A2B antagonist MRS-1754 [146]. The precise mechanism of 
this sensitization of A2B by PKC, although reproducible, remains unknown.  
An important question remaining is characterization of the remaining members in 
the pathway by which IBMX-induced loss of A2B-PKC or A2B-cAMP mediated signaling 
alters mitochondrial physiology. Previous results indicated that GSK-3β, a constitutively 
active kinase inactivated by phosphorylation, was activated following IBMX 
administration (Section 4.4). As GSK-3β is reported to be downstream of PKA, PKC, 
and PKG, it may serve as the ultimate regulator of mitochondrial physiology following 
IBMX administration. Quite interestingly, A2B has been reported to localize to 
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mitochondria in rat cardiomyocytes [149]. The subcellular localization of A2B would be 
expected to be important for signaling, as recent evidence suggests cytosolic and 
mitochondrial pools of cAMP remain functionally distinct, with mitochondrial cAMP 
generation mediated by soluble adenylate cyclase (sAC) and turnover mediated by a 
mitochondria-targeted splice variant of PDE2, PDE2A2 [150, 151]. As genome-wide 
expression profiling reveals expression of PDE2A in 661w, a plausible hypothesis is that 
PKC-mediated sensitization of A2B results via selective interaction of PKC with A2B 
dependent on A2B location. This is expected as the adenosine-binding N-terminal domain 
(normally located on the extracellular leaf of the plasma membrane) of A2B located on 
mitochondria would be expected to face the cytoplasm. The roles of mitochondria- and 
plasma membrane-bound A2B are just beginning to be defined, and will be important 
future studies to place in context of these results. 
6.6 Conclusion 
These studies demonstrate for the first time that IBMX functions as an inverse 
agonist of the endogenously expressed adenosine A2B receptor in 661w cells, and that 
its action as an inverse agonist is responsible not for immediate, but for sustained 
alterations in mitochondrial physiology. These alterations were comprised of an increase 
in membrane potential, increased fusion as evidenced by increases in mitochondrial 
networks, and decreased respiration. Additional studies highlighted that altered 
mitochondrial physiology induced by inverse agonism of this receptor by IBMX may be 
conducted through loss of A2B receptor signaling via coupling to Gαs and Gαq/11. While 
more work is needed to understand the precise intracellular signaling networks 
perturbed by IBMX and how these alterations lead to changes in mitochondrial 
physiology, the studies outlined demonstrate the importance of adenosine receptor 
signaling in supporting mitochondrial function in 661w photoreceptor cells.  
100 
 
7. General Summary 
7.1 Abbreviated Results and Discussion 
Taken together, this work has shown that mitochondrial physiology in 661w is 
regulated in a time-dependent manner and via multiple mechanisms in the context of 3-
isobutyl 1-methylxanthine (IBMX) administration. Central to the facilitation of this work 
was the development of a high content microscopic method for the high throughput 
measurement of mitochondrial morphology and membrane potential ([114] and Section 
3), which complemented existing methodologies for high throughput measurement of 
mitochondrial respiration (Seahorse Biosciences’ XF96 instrument). A brief written 














Time (h):  1 24 1 24 1 24  
Investigatory (IBMX) Vehicle ↑ ↑ ↑ ↑ NC ↓ ↑ cAMP+cGMP at 20 
min, ↑ cell death at 48 h 
PDE2 (cAMP+cGMP) inhib. (BAY60-7550) Vehicle      NC  
PDE3 (cAMP+cGMP) inhib. (cilostamide) Vehicle NC NC ↑ ↑  ↓ ↑ cGMP 
PDE4 (cAMP) inhib. (rolipram) Vehicle      ↑  
PDE5 (cGMP) inhib. (sildenafil) Vehicle ↑ ↑ ↑ ↑  ↓ ↑ cGMP 
PDE7 (cAMP) inhib. (BRL 50481) Vehicle      ↑  
Adenosine A2B Receptor:         
   A2B Agonist (BAY60-6583) Vehicle NC ↓ NC NC  NC ↑ cAMP 
   A2B Antagonist (PSB-603) Vehicle NC NC NC NC  NC  
   A2B Inverse Agonist (MRS-1706) Vehicle NC NC NC ↑  ↓  
PKA inhibitor (myr PKI 14-22) Vehicle NC NC ↑ ↑  NC  
Calcineurin + mPTP inhib. (cyclosporin A) Vehicle  ↑ ↑ ↑    
Calcineurin inhib. only (ascomycin) Vehicle NC ↑ ↓ ↑ ↑    
GSK-3β inhib. (3F8) Vehicle NC NC ↑ NC    
COMBINATION STUDIES (IBMX + …)         
   Sham (Vehicle only, no IBMX) IBMX ↓ ↓ ↓ ↓ NC ↑  
   + A2B agonist (BAY60-6583) IBMX  ↓ NC ↓    
   + A2B antagonist (PSB-603) IBMX  ↓ NC ↓    
   + AC activator (forskolin) IBMX  ↓ NC ↓  ↑ (50% of respiration) 
   + PKC agonist (PMA) IBMX  ↓ NC ↓  ↑ (100% of respiration) 
   + GSK-3b antagonist (3F8) IBMX ↓ ↓ ↓ NC    
Table 7-1. Summary of Findings.  
Statistically significant findings are listed as compared to the appropriate controls (vehicle for rows above combination studies, and as compared to IBMX for rows 
for combination studies (beneath the double line). Key: Light blue upwards arrow: increase compared to control. Red downwards arrow: decrease compared to 




Figure 7-1. Working Model 
of IBMX-induced Pathways 
That Alter 661w 
Mitochondrial Physiology at 
1 h, Panel A. 
Integration of experimental 
results suggests IBMX 
treatment leads to altered 
mitochondrial physiology by 
multiple mechanisms in a 
temporally compartmentalized 
fashion. First, at 1 h (Panel A, 
this page), IBMX action at 
PDE enzymes predominates. 
This is followed at 24 h 
(Panel B, following page) by 
action as an inverse agonist 
at the adenosine A2B 
receptor. Common pathway 
mediators at both time points 
are likely to exist, and by the 
results these appear to 
include loss of function 
glycogen synthase kinase 3b 
(GSK-3β). Via this 
mechanism, alterations are 
triggered in all three 
parameters of mitochondrial 
physiology measured 
(mitochondrial membrane 
potential, Ψm), mitochondrial 
morphology (fission/fusion), 
and mitochondrial respiration 
(as measured by oxygen 
consumption, QO2). mRNA 
expression of each protein 
member of the pathway 
printed above is confirmed in 
661w by genome-wide 
expression profiling. A key to 
abbreviations is found in Section v.: Key to Symbols, Abbreviations on Page xii. 
LEGEND: Solid lines represent direct evidence from studies in this dissertation. Dashed lines indicate 
expected relationships based on literature. Green lines with an arrowhead denote stimulation (between 
pathway members) or promotion of homeostasis (member to parameter), red lines with a blunt end indicate 
inhibition or inverse agonism (between members) or dysregulation of homeostasis (pathway member to 
parameter). Pathway members (in rectangles) are colored by their canonically-associated secondary 
messenger pathway, i.e. cAMP in orange, cGMP in purple, and PKC in cyan.  
‡For sake of clarity, the results (solid arrows) indicating that selective PDE3/5 inhibition leads to alteration of 
all three mitochondrial physiological parameters are omitted (Section 5.4). Furthermore, PKG has been 






Figure 7-1 (continued). Working Model of IBMX-induced Pathways That Alter 661w Mitochondrial Physiology at 24 h, Panel B.  




The effects of IBMX on mitochondrial function are first characterized in Section 
4, specifically that IBMX administration to 661w leads to both a rapid (at 1 h) and 
sustained (at 24 h) increase in microscopically measured mitochondrial membrane 
potential and interconnectedness (Figure 4-3 and Figure 4-4). At 24 h, decreases in 
mitochondrial respiration, and at 48 h, a decrease in cell viability are observed (Figure 
4-2).  
Next, the role of IBMX’s known function as a cyclic nucleotide phosphodiesterase 
(PDE) inhibitor in effecting these changes was explored in Section 5. Using genome-
wide expression profiling, potential PDE candidate isoforms expressed in 661w were 
identified and selective inhibitors of these isoforms then administered to determine if a 
particular isoform or a particular cyclic nucleotide (cyclic adenosine monophosphate 
[cAMP] or cyclic guanosine monophosphate [cGMP]) were responsible for the effects 
induced by IBMX. IBMX administration was noted to increase both cAMP and cGMP 
following administration (Figure 5-1), but only inhibition of PDE isoforms that cleave 
cGMP (PDE5 and to a lesser degree PDE3) recapitulated the effects of IBMX (Figure 
5-3 and Figure 5-5).  
The authors next sought to characterize IBMX’s role in altering adenosine 
receptor signaling in modulating mitochondrial physiology. In these experiments, it was 
demonstrated that only the A2B isoform was expressed (Figure 6-1), and that selective 
inverse agonist MRS-1706 – but not an agonist or antagonist – of this isoform 
recapitulated IBMX-induced hyperpolarization and decreased respiration at 24 h but not 
at 1 h (Figure 6-2, Figure 6-3, and Figure 6-4). Furthermore, pretreatments with agonist 
BAY60-6583 or antagonist PSB-603 resulted in abrogation of IBMX-induced effects at 
24 h but not 1 h (Figure 6-5 and Figure 6-6), leading to the conclusion that IBMX is an 
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inverse agonist of the A2B receptor and that inverse agonism of the A2B receptor 
facilitates sustained, but not immediate, mitochondrial dysfunction in 661w.  
However, the question remained of which downstream pathways are engaged 
following inactivation of cGMP PDEs or A2B receptor. A2B has been reported to couple to 
(functionally signal through) multiple G protein alpha subunits, including Gαs, Gαq, and 
Gαi/o [152-156]. Hence, the next experiments elucidated the role of members of 
pathways that could be plausibly invoked, including adenylate cyclase, PKA, ion 
channels, and PKC.  
As inhibition of A2B coupled to Gαs would decrease adenylate cyclase (AC) 
activity (generation of secondary messenger cyclic adenosine monophosphate (cAMP) 
from adenosine triphosphate (ATP)), AC activator forskolin was administered prior to 
IBMX and determined to abrogate 100% of morphological and membrane potential 
changes, and approximately 50% of decreases in respiration at 24 h but not at 1 h 
(Figure 6-7). These data indicated that despite the overall increases in intracellular 
cAMP following IBMX exposure, long-term loss of AC activity nonetheless alters 
mitochondrial function.  
Loss of cAMP could lead to alterations in a number of pathways, including 
decreased signaling through protein kinase A (PKA). At the highest concentration tested 
(10 µM, 277-fold above its Ki of 36 nM), PKA inhibition with a small peptide inhibitor 
(PKI14-22) recapitulated increased membrane potential at 1 h and 24 h (Figure 6-8). 
However, no other effects were observed, leading to the conclusion that loss of PKA, if 
involved, is involved only tangentially. Following these results, previously described 
remaining possibilities of Gαs-based signaling include PI3K, and MAPK. Combined with 
recent studies that demonstrate the mitochondrial localization of A2B in some cell types, 
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there is additionally the possibility that an as yet undescribed intramitochondrial GPCR 
signaling cascade regulates mitochondrial physiology. 
Next, the role of PKC was examined. Loss of A2B signaling would be expected to 
decrease Gαq-mediated signaling, in turn decreasing the activity of one or more isoforms 
of PKC. Table 6-2 shows the isoforms of PKC expressed in 661w as determined using 
genome-wide expression profiling. By pretreating with PKC activator phorbol myristate 
acetate (PMA), losses in PKC signaling could be mitigated. Interestingly, 100% of 
changes in all three mitochondrial physiological parameters were reversed with PMA 
pretreatment at 24 h, but not 1 h, suggesting an active role for PKC in the maintenance 
of mitochondrial homeostasis (Figure 6-9). To determine which of the PKA subtypes 
were involved, single cell electrophysiological recordings were obtained following 
administration of IBMX, and showed no current, effectively ruling out the role of Ca2+-
dependent PKC isoform alpha (Supplementary Figure 11). Taken together, these data 
suggest that loss of signaling in “novel” or “atypical” isoforms of PKC, such as PKC delta 
or PKC epsilon may follow decreased A2B signaling.  
As the results thus far demonstrated a diversity of mechanisms by which 
mitochondrial function may be regulated, two questions were next raised: first, whether 
or not a common downstream mediator is involved in coordinating these messages and 
second, whether feedback/crosstalk occurs between these pathways. 
A potential common downstream signal coordinator is glycogen synthase kinase 
3 beta (GSK-3β). As it functions to regulate multiple cellular functions, including opening 
of the voltage-dependent anion channel (VDAC) found on mitochondria, is described as 
a substrate of PKA, PKC, and PKG (all three of which have been implicated in these 
results), GSK-3β was next examined. Inhibition of GSK-3β with selective small molecule 
inhibitor 3F8 (IC50 34-304 nM) at 100 nM or 1 µM led to hyperpolarization at 1 h, but not 
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24 h (Supplementary Figure 14). Interestingly, preincubation with even lower 
concentrations of 3F8 (1-10 nM) abrogated hyperpolarization induced by IBMX (Figure 
4-5). Together, these data suggest that either inhibition or activation of GSK-3β results in 
mitochondrial hyperpolarization, perhaps by regulation of VDAC.  
As VDAC is a constitutive member of the mitochondrial membrane permeability 
transition pore (mPTP), integral for ADP/ATP exchange (bioenergetics) as well as 
release of cytochrome c (effector of apoptosis), efforts were undertaken to understand 
its role. Unfortunately, these efforts were unsuccessful owing to the presence of 
functional calcineurin in 661w. Cyclosporin A is a well-characterized inhibitor of 
cyclophilin D but also is a potent calcineurin inhibitor. Experiments using a pure 
calcineurin inhibitor (ascomycin) demonstrated alterations in mitochondrial membrane 
potential and morphology similar to cyclosporin A, making the interpretation of mPTP’s 
role in early v. latent mitochondrial physiological changes induced by IBMX difficult 
(Supplementary Figure 12 and Supplementary Figure 13)2.  
The second question, of whether cross talk occurs between the pathways 
discussed, has already been partially discussed. The most obvious level of crosstalk is 
at the level of cAMP. cAMP would be expected to decrease following inverse agonism at 
the A2B receptor, whereas it is expected to increase following inhibition of cyclic 
nucleotide phosphodiesterase enzymes. At 20 min, cAMP was found to be significantly 
elevated following administration of IBMX (Figure 5-1). At 1 h, IBMX-induced 
morphological and membrane potential effects can be observed (Figure 4-3 and Figure 
4-4). However, these effects were recapitulated with cGMP- but not cAMP-selective PDE 
2 NIM-811 is a direct, selective small molecule inhibitor of CyD/mPTP. However, it is no 
longer commercially available (personal communication, John Lemasters 2014). Genetic 
manipulation has its strengths, but a major weakness in these studies is the lack of kinetic control 
regarding timing of knockdown (as these methods rely on protein turnover). 
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inhibitors (Figure 5-3 and Figure 5-5), implicating cGMP as important for the immediate 
changes. Further arguments that implicate cGMP over cAMP in the changes observed at 
1 h include the results that cAMP-selective inhibitors appeared to increase mitochondrial 
respiration at 24 h as compared to IBMX’s decrease in respiration (Figure 4-2 and 
Figure 5-2). Without further studies, one might be tempted to conclude that increased 
[cGMP] is permissive for increased [cAMP] to mediate the effects. However, activation of 
adenylate cyclase prior to IBMX administration resulted in no changes at 1 h, but at 24 h 
complete abrogation of mitochondrial hyperpolarization and networked morphological 
increases with partial abrogation of decreases in mitochondrial respiration was observed 
(Figure 6-7). As mentioned before, this abrogating effect was mimicked by other 
constituents of adenosine A2B receptor signaling, including A2B agonist BAY60-6583, A2B 
antagonist PSB-603, PKC activation with PMA, (Figure 6-5, Figure 6-6, and Figure 
6-9), while inverse agonism of the A2B receptor alone recapitulated physiological 
changes only at 6-24 h (Figure 6-4). 
This leads to two possible explanations for rapid yet sustained IBMX-induced 
alterations without taking A2B-PKC signaling into context. First, an initial increase in 
intracellular [cAMP] is exhausted at some time between 1 h and 24 h, followed by 
continued inverse agonism at A2B, decreasing [cAMP] at some time. Second, 
microdomains of [cAMP] drive A2B-dependent effects on signaling. While the first option 
is an attractive explanation, it is not plausible to explain the effects that an inverse 
agonist in and of itself can cause changes as observed in Figure 6-4. Literature from 
multiple laboratories is emerging that describes the mitochondrial localization of the 
adenosine A2B receptor and the necessary components for GPCR signaling, including an 
isoform of the PDE2 cAMP phosphodiesterase and localization of soluble adenylate 
cyclase (sAC)[149, 151, 157]. Therefore, at this time, the data best fit a mitochondrial 
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localization hypothesis in that some or all of A2B is located on the mitochondrial 
membrane of 661w cells and drives latent changes in mitochondrial physiology in 
response to inverse agonism by IBMX. Further experiments to evaluate this hypothesis 
are outlined in Section 7.2. 
7.2 Future Directions 
This work highlights several avenues for future research. First, further elucidating 
the participation of kinases would be informative. Considering the potential for >5 
downstream pathways to be involved, a medium-throughput, parallelized “kinase screen” 
approach measuring phosphorylation levels of downstream substrates following IBMX, 
MRS-1706, or sildenafil administration would be most straightforward. This approach 
has the added benefit of being confirmatory in cases where the downstream substrates 
are relatively specific. Of particular note, this experiment would be of great utility in 
confirming results with GSK-3β inhibitor 3F8 and PKA inhibitor myr-PKI 14-22. These 
results should be followed by immunoprecipitation to confirm binding of putative 
interacting partners. At this point, elucidation of any transcriptional activating or 
repressing members of the pathway should be conducted as appropriate. Chromatin 
immunoprecipitation for <5 targets is recommended, whereas genome-wide expression 
microarray followed by bioinformatic determination may be required if transcription 
factors remain elusive or too many targets are identified in the kinase screen. 
In coordination with examining alterations in kinase activity, further exploring the 
role of downstream mediators to be common between the two pathways would be 
straightforward. Teasing apart whether GSK-3β activation follows PDE inhibition, A2B 
inverse agonism, or both could be examined by pretreating with 3F8 prior to sildenafil 
administration (and repeated with cilostamide and MRS-1706) and following the same 
mitochondrial physiological parameters as before. 
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Establishing the physiological relevance of these studies is of paramount 
importance. The most straightforward approach to establish relevancy of PDE5 inhibition 
(and subsequent cGMP increase) in the retina was recently conducted by Nivison-Smith 
et al. ([33] and reviewed in Section 2.4). In short, sildenafil demonstrated limited retinal 
toxicity (2 days) when administered to wild-type mice but even greater and prolonged 
toxicity (2 weeks) to otherwise phenotypically normal PDE6Bwt/rd1 rodents as measured 
by electroretinogram (ERG). To further implicate PDE5 in retinal mitochondrial function, 
retinas from wild-type and mice homozygous or heterozygous for the rd1 mice could be 
isolated and measured with respirometry before and after administration of sildenafil. To 
measure mitochondrial membrane potential in situ, tail vein injections of TMRM prior to 
sildenafil or vehicle treatment could be followed by live retinal imaging to measure 
mitochondrial polarization prior to excision for use in respirometry or other imaging 
studies.  
Determination of whole cell cAMP levels at 1-24 h (beyond the 20 min time 
period currently evaluated) would aid in determining whether inverse agonism results in 
global cAMP decreases outlined in the discussion above (Section 7.1). 
Immunocytochemical determination of A2B’s subcellular location with concomitant 
labeling of mitochondria with MitoTracker Deep Red and fluorescence microscopy could 
determine whether or not A2B is expressed on mitochondria. In conjunction with 
potentiometric dyes such as TMRM, the role of membrane potential in driving this 
localization could be subsequently determined. As previously mentioned, fluorescent 
cAMP biosensors would provide the ability to evaluate a mitochondrial localization 
hypothesis [145]. Alternative approaches include subcellular fractionation of 
mitochondria and Western blotting, but these approaches would result in the complete 
loss of spatial resolution and limit close examination of temporal information. However, 
111 
 
even if initial imaging studies were promising, subcellular fractionation of mitochondria in 
conjunction with radiolabeled ligand studies would be necessary to quantify the affinity of 
IBMX and adenosine for A2B localized to mitochondria, as well as immunoprecipitation to 
determine interactions between the proposed intramitochondrial GPCR signaling 
complex (A2B/Gαs, Gαs/sAC). Perturbation of G protein alpha subunit signaling via 
agents such as cholera toxin, pertussis toxin, melittin, and suramin could provide 
additional support regarding the coupling of A2B to Gαs or another. The aforementioned 
agents would be expected to mitigate, mitigate, intensify, and mitigate (respectively) the 
long-term effects of IBMX if inverse agonism at A2B results in decreased Gαs signaling, 
and would effectively rule out the role of Gαi coupling. Gαq could be further implicated via 
usage of newly reported Gαq inhibitor BIM-46187, which would be expected to 
recapitulate the effects of A2B inverse agonist MRS-1706 [158]. 
7.3 Conclusion 
These results have several implications for retinal and mitochondrial research, as 
well as for researchers outside of these fields. Firstly, the generation of a high 
throughput high content image analysis tool to simultaneously quantify mitochondrial 
interconnectedness and polarization should boost efforts of the mitochondrial research 
community to identify small molecules, proteins, and genes that influence mitochondrial 
physiology, from bioenergetics to biogenesis and mitochondrial turnover. Secondly, the 
result that retina-derived 661w mitochondrial respiration is responsive to alterations in 
phosphodiesterase function provides evidence of a complex bioenergetic regulatory 
system that may serve to limit mitochondrial function in sustained photoreceptor neuron 
stimulation, while providing a mechanism by which sildenafil side effects and toxicity 
may manifest. Furthermore, this research describes IBMX’s activity as an inverse 
agonism at the adenosine A2B receptor for the first time, and elucidates the intracellular 
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pathways engaged both by A2B and known targets of IBMX, the cyclic nucleotide PDE’s. 
Researchers using IBMX as a tool are cautioned that its effects on mitochondrial 






• Agonist – a small molecule or protein that upon binding to a receptor, stimulates 
one or more downstream signaling pathways (positive efficacy). Agonists 
stimulate signaling beyond constitutive activity levels. 
• Antagonist – a small molecule or protein that upon binding to a receptor, 
competitively (same site) or noncompetitively (alternate site) inhibits agonist 
binding or agonist-induced conformational changes and thus reduces agonist-
stimulated signaling (zero efficacy, equivalent to unstimulated receptor). 
Antagonists do not reduce constitutive activity of receptor signaling (that level of 
signaling achieved in absence of agonist). 
• Chelator – chemical substance that binds another to reduce the free 
concentration of the latter, typically, metal ions such as Ca2+, Mg2+, or Fe2+. May 
also be referred to as a “buffer”. 
• Ionophore – substance which increases membrane permeability to an ion, e.g. 
FCCP increases membrane permeability to H+, uncoupling respiration from ATP 
production. 
• Inverse agonist – a small molecule or protein that upon binding to a receptor, 
induces decreased signaling beyond that observed with unstimulated receptor 
(negative efficacy, termination of constitutive activity). Inverse agonists do reduce 
constitutive activity of receptor signaling.  
• Kappa statistic (κ) – a measure of interobserver agreement. Values range from 
0 (complete disagreement) to 1 (perfect agreement).  
• Ligand – a small molecule or protein capable of binding to a receptor (may be an 
agonist, antagonist, or inverse agonist; typical usage is to describe the 
endogenous or natural agonist). 
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• Machine Learning – Statistical method for establishing/optimizing a 
classification paradigm using known measurements. 
• Matthew’s Correlation Coefficient (Φ, or Phi Coefficient) – Measure of quality 
of a machine learning binary classification. Values range from -1 (total 
disagreement) to 0 (no better than random agreement) to +1 (perfect 
agreement). 
• Registration – Alignment of multidimensional data (spatial and or 
spatiotemporal). In this manuscript, alignment of two dimensional microscopic 
images. Algorithms define “source” image as misaligned image; “target” image is 
image to which alignment is made. 






9. Appendix A—Supplementary Figures and Images 
 
Supplementary Figure 1. MitoTracker Deep Red (MTDR) is retained in depolarized mitochondria.  
Cells were dually stained with MTDR and tetramethylrhodamine methyl ester (TMRM). A representative field 
was chosen by selecting a cell with TMRM fluorescence intensity near the median of each condition – and 
the raw, unprocessed image containing that cell displayed (MTDR in a-c, TMRM in d-f). Vehicle (a, d), FCCP 
(b, e), oligomycin (c, f). Brightness and contrast settings were set to be equal for all panels within each row 
to facilitate comparison. Colocalization of the two dyes was calculated using Pearson’s correlation in 




Supplementary Figure 2. Conditional Inference Recursive Partitioning Decision Tree (Mitochondrial Classification Scheme).  
In a separate protocol, Developer Toolbox analysis was configured to output all calculable morphological measures on the total (unclassified) mitochondrial 
population. 897 mitochondria (training set) spanning four different experimental conditions and multiple microscopic fields were manually classified into one of five 
categories (Networks (N), Rods (R), Puncta (P), Large and Round (LR – “S” in the diagram above), or Junk (J). This training set was then used as input to the 
conditional inference algorithm found in the ctree method within R package “party”. See Supplementary File 2 for a copy of the R code used to generate the above 
tree. The final branches of this tree were assigned to a single category (as shown by unique colors in the legend) based on accuracy, converted into logic 
statements, input into Developer Toolbox’s inclusion criteria for each mitochondrial target (subtype), and then used to classify mitochondria into the four 
morphological bins.  The fifth class was included in the classifier to remove aberrantly detected objects, characteristic of background noise, Junk (J). As expected, 
similar morphologies clustered near each other with regards to morphological parameters. One example of this clustering can be observed as the cyan networks 
are found exclusively on the right branch of the first node, sharing a length greater than 3.525 μm. The importance of any individual measure in segregation can be 
measured by the number of the nodes/branches preceding it (e.g. Length is most important as it is the first node) and the number of times it appears (e.g. Area 









Supplementary Figure 3. Developer Toolbox screenshot 1 – Program Control.  
Tracking and blocking definition settings necessary for 2D deconvolution preprocessing shown in the two popup windows. These settings are 1) use extended 




Supplementary Figure 4. Image Analysis Screenshot. Overlay colors correspond to those in Figure 2 of main paper. Channel definitions from top left:  
Ch 1: Hoechst 33342-stained nuclei (with morphological results overlaid) 
Chs 2-8: z stack of MitoTracker Deep Red (Ch 5 is in-focus channel) 
Ch 9: unused, reserved for future use 
Ch 10: preprocessed nuclei 
Ch 11: preprocessed MitoTracker Deep Red (2D deconvolution/nearest 
neighbor deblur, followed by histogram equalization) 
Ch 12: binary/segmented image of Ch 11 (all mitochondria) 
Ch 13: binary image of Swollen mitochondria (Large & Round) 
Ch 14: binary image of Punctate mitochondria 
Ch 15: binary image of Rod mitochondria 




Supplementary Figure 5. Target Linking Summary.  
Programmatic diagram summarizing the overall relationship of segmented (identified) objects to one 
another. One-to-one and one-to-many linkages were made to assign child object(s) to a single parent (left 
column, thin color border). Then, these linkages were linked to one another in composed one-to-one 
linkages (level 1, center column, dashed borders). Finally, these composed linkages were linked to Cells to 
tie every mitochondrion of each subtype to a Cell in the center column (right column, bold borders). The 
overall goal of this hierarchical relationship was multifold: 1. To ensure all measures arising from multiple 
object types could be correlated to one another in the final analysis on a cell-by-cell basis (e.g. size of a cell 
with size/shape of a nucleus can be examined simultaneously with abundance of punctate mitochondria). 2. 
To remove from the analysis aberrantly detected objects too distant from a cell (any objects not assigned to 
a cell were not quantified). 3. By correlating multiple measures, quality control on a per-cell basis can be 
achieved (e.g. out of focus or dead). Nota bene: programmatically, large and round mitochondria are 
referred to as “swollen” or “swo” in code and in the chart above. However, “large & round” is used to 




Predicted    
 
a -Training Set 









L Junk (J)     229 4 10 8 0 251 0.706  
Networks (N) 9 96 1 5 0 111 0.787  
Puncta (P) 55 0 180 10 13 258 0.698  
Rods (R) 25 23 12 138 1 199 0.702  
Large & Round (LR) 11 2 6 4 55 78 0.728  
TOTAL 329 125 209 165 69 897  κ=0.710 
  
Predicted    
 
b - Test Set 



















 Junk (J)     154 0 2 9 0 165 0.608  
Networks (N) 9 39 0 2 0 50 0.793  
Puncta (P) 57 0 61 0 3 121 0.511  
Rods (R) 28 7 18 88 1 142 0.653  
Large & Round (LR) 0 0 2 2 7 11 0.628  
TOTAL 248 46 83 101 11 489  κ=0.601 
 
Supplementary Table 1. Confusion matrices to evaluate decision tree performance.  
Contingency tables for each category (true positive, true negative, false positive, false negative) were 
assembled from the confusion matrix, and Φ (Matthew’s Correlation) calculated to evaluate the classifier’s 
performance for each category.  The κ-statistic was used to assess agreement across all categories as well. 
Performance of classifier against data used to train (generated by author AL) (a) and versus the consensus 





Predicted    
 
a - Test Set 









L Junk (J)     183 0 8 10 0 201 0.674  
Networks (N) 7 33 0 1 0 41 0.737  
Puncta (P) 35 0 57 0 3 95 0.563  
Rods (R) 23 13 17 89 1 143 0.660  
Large & Round (R) 0 0 1 1 7 9 0.697  
TOTAL 248 46 83 101 11 489  κ=0.644 
  
Author RC    
 
b - Test Set 









L Junk (J)     132 1 56 12 0 201 0.649  
Networks (N) 0 37 0 4 0 41 0.781  
Puncta (P) 6 0 83 6 0 95 0.588  
Rods (R) 9 14 12 105 3 143 0.691  
Large & Round (LR) 0 0 4 1 4 9 0.496  
TOTAL 147 52 155 128 7 489  κ=0.641  
  
Predicted    
 
 c - Test Set 










 Junk (J)     136 0 1 10 0 147 0.548  
Networks (N) 10 37 0 5 0 52 0.730  
Puncta (P) 74 0 72 2 7 155 0.535  
Rods (R) 28 9 9 82 0 128 0.638  
Large & Round (LR) 0 0 1 2 4 7 0.446  
TOTAL 248 46 83 101 11 489  κ=0.557  
  
Predicted    
 
d - Test Set (subset) 




















Junk (J)     125 0 0 7 0 132 0.724  
Networks (N) 6 31 0 0 0 37 0.807  
Puncta (P) 25 0 55 0 3 83 0.711  
Rods (R) 14 7 7 77 0 105 0.759  
Large & Round (LR) 0 0 0 0 4 4 0.753  
TOTAL 170 38 62 84 7 361  κ=0.731 
  
Predicted    
 
e - Test Set (subset) 




















Junk (J)     29 0 2 2 0 33 0.325  
Networks (N) 3 8 0 2 0 13 0.726  
Puncta (P) 32 0 6 0 0 38 -0.011  
Rods (R) 14 0 11 11 1 37 0.309  
Large & Round (LR) 0 0 2 2 3 7 0.549  
TOTAL 78 8 21 17 4 128  κ=0.258 
 
Supplementary Table 2. Confusion matrices to evaluate decision tree performance (Part 2). 
Additional confusion matrices were generated: first, against the same test set of data used in 
Supplementary Table 1Supplementary Table 1. Confusion matrices to evaluate decision tree 
performance.  
Contingency tables for each category (true positive, true negative, false positive, false negative) were 
assembled from the confusion matrix, and Φ (Matthew’s Correlation) calculated to evaluate the classifier’s 
performance for each category.  The κ-statistic was used to assess agreement across all categories as well. 
Performance of classifier against data used to train (generated by author AL) (a) and versus the consensus 
decision of authors AL & RC on the full test set (b).b using author AL’s blinded classifications (a), amongst 
authors AL and RC (b), and amongst author RC (blinded) and the classifier (c). The classifier is also 
compared to the subset of 361 mitochondria in the test set upon which both authors agreed (d), and the 
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subset of 128 mitochondria the authors disagreed (e). In all panels of this table, the authors were blinded 




Supplementary Figure 6. Quantitative assessment of mitochondrial morphology after mitochondrial 
electron transport chain Complex I inhibition via rotenone.  
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-uncoupled respiratory capacity (mitochondrial 
respiration) was measured via Seahorse XF96 respirometry following 24 h treatment with rotenone at the 
concentrations indicated (a). Results of the corresponding mitochondrial morphological assessment (b-h). 
n=4-9 experiments (numbers on each bar), bars s.e.m. Data analyzed by Kruskal-Wallis followed by Dunn’s 




Supplementary Figure 7. Quantitative assessment of mitochondrial morphology after mitochondrial 
electron transport chain Complex III inhibition via antimycin A.  
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-uncoupled respiratory capacity (mitochondrial 
respiration) was measured via Seahorse XF96 respirometry following 24 h treatment with antimycin A at the 
concentrations indicated (a). Results of the corresponding mitochondrial morphological assessment (b-h). 
n=4-9 experiments (numbers on each bar), bars s.e.m. Data analyzed by Kruskal-Wallis followed by Dunn’s 




Supplementary Figure 8. Quantitative assessment of mitochondrial morphology after mitochondrial 
electron transport chain complex V inhibition via oligomycin.  
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-uncoupled respiratory capacity (mitochondrial 
respiration) was measured via Seahorse XF96 respirometry following 24 h treatment with oligomycin at the 
concentrations indicated (a). Results of the corresponding mitochondrial morphological assessment (b-h). 
n=4-9 experiments (numbers on each bar), bars s.e.m. Data analyzed by Kruskal-Wallis followed by Dunn’s 




Supplementary Figure 9. Quantitative assessment of mitochondrial morphology after Na/K ATPase 
inhibition.  
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-uncoupled respiratory capacity (mitochondrial 
respiration) was measured via Seahorse XF96 respirometry following 24 h treatment with oligomycin at the 
concentrations indicated (a). Results of the corresponding mitochondrial morphological assessment (b-h). 
n=4-9 experiments (numbers on each bar), bars s.e.m. Data analyzed by Kruskal-Wallis followed by Dunn’s 
post test, all groups versus vehicle only.  *p<0.05 v. vehicle. 
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Treatment Network Rod Puncta Large & Round 
Vehicle Control 60.9 ± 1.84% 28.4 ± 1.32% 9.0 ± 0.55% 1.7 ± 0.09% 
TBHP 1 mM 45.4 ± 2.14% 34.3 ± 1.15% 16.2 ± 1.11% 4.0 ± 0.16% 
Antimycin A 1 μM 56.8 ± 1.02% 30.0 ± 0.82% 10.7 ± 0.41% 2.5 ± 0.28% 
Oligomycin 10 μM 45.5 ± 8.72% 33.0 ± 3.78% 16.8 ± 3.96% 4.7 ± 1.05% 
Rotenone 10 μM 63.7 ± 2.32% 24.8 ± 1.22% 8.7 ± 0.60% 2.9 ± 0.58% 
Ouabain 500 μM 52.5 ± 3.29% 31.9 ± 1.72% 12.4 ± 1.83% 3.2 ± 0.49% 
 
Supplementary Table 3. Relative abundance of mitochondrial morphological subtypes.  





Treatment Network Rod Puncta Large & Round Total 
Vehicle  74.8 ± 7.32 μm² 38.9 ± 3.23 μm² 11.1 ± 0.73 μm² 2.2 ± 0.13 μm² 130.1 ± 11.1 μm² 
TBHP     1 mM 60.8 ± 6.97 μm² 38.1 ± 4.27 μm² 16.4 ± 0.92 μm² 4.7 ± 0.15 μm² 123.3 ± 11.21 μm² 
Antimycin A 1 μM 66.1 ± 20.42 μm² 36.5 ± 11.13 μm² 12.2 ± 3.89 μm² 2.82 ± 0.86 μm² 120.2 ± 37.31 μm² 
Oligomycin 10 μM 30.5 ± 7.68 μm² 27.7 ± 8.66 μm² 16.2 ± 4.55 μm² 4.5 ± 1.29 μm² 78.6 ± 24.01 μm² 
Rotenone  1 μM 86.0 ± 8.14 μm² 39.6 ± 3.30 μm² 13.1 ± 0.77 μm² 2.8 ± 0.18 μm² 144.4 ± 11.50 μm² 
Ouabain 500 μM 66.5 ± 8.96 μm² 38.67 ± 0.77 μm² 16.4 ± 1.42 μm² 4.4 ± 0.53 μm² 172.5 ± 43.98 μm² 
 
Supplementary Table 4. Absolute abundance of mitochondrial morphological subtypes.  
Mean area of mitochondrial area of each subtype per cell per treatment group are shown ± s.e.m. among n=4-9 




Supplementary Figure 10. Morphological subtypes are equally susceptible to depolarization.  
Mean background-subtracted fluorescence intensity of tetramethylrhodamine methyl ester (TMRM) fluorescence was 
determined within each subtype of mitochondria or all subtypes in aggregate (All) for cells treated with 1 μM carbonyl 
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (a) or 10 μM oligomycin (b) for 1 h. This value was then 
normalized by dividing the average background-corrected fluorescence intensity of the corresponding mitochondrial 
phenotype in cells treated with vehicle for each experimental n. Data shown in each column are each experimental 
mean (dots), mean of experiments (center long bar), and s.e.m. (shorter bars above and below mean). Comparisons 
were made amongst all subtype polarization ratios (excluding vehicle) using one-way ANOVA followed by pairwise 
comparisons with Holm-Sidak’s correction to determine significant differences between groups. No multiplicity-





Supplementary Figure 11. IBMX Administration Fails to Induce Plasma Membrane Current in 661w 
Vehicle (A) or IBMX (B) were administered to 661w cells by superfusion after collecting 2 min of baseline recording. 
After 5 min, the superfusate was changed to recording buffer and an additional 3 min of recording obtained. Data 
shown are baseline averages of n=3 cells in each group. The failure to observe deflections greater than 20 pA in 
magnitude and the absence of sustained deflections are interpreted as no IBMX-induced currents. Administration of 





Supplementary Figure 12. Cyclosporin A Increases Membrane Potential and Mitochondrial 
Interconnectedness. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential analysis as 
previously described [114]. Proportion of networked mitochondria following 24 h treatment is presented in (A), and 
mitochondrial membrane potential in (B). Data shown are mean ± s.e.m. of n=5 experiments. * or “X”: multiplicity-






Supplementary Figure 13. Calcineurin (Ppp3ca) inhibition alters networked morphology and increases 
mitochondrial membrane potential. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential analysis as 
previously described [114]. Proportion of networked mitochondria following 24 h treatment is presented in (A), and 
mitochondrial membrane potential in (B). Data shown are mean ± s.e.m. of n=4 experiments. “X”: multiplicity-adjusted 






Supplementary Figure 14. GSK3-β (Gsk3b) inhibition transiently increases mitochondrial membrane 
potential. 
661w photoreceptor cell line mitochondria were subjected to morphological and membrane potential analysis as 
previously described [114]. Proportion of networked mitochondria following 24 h treatment is presented in (A), and 
mitochondrial membrane potential in (B). Data shown are mean ± s.e.m. of n=4 experiments. “X”: multiplicity-adjusted 







10. Appendix B—Computer Programs 
10.1 dPsi.R: Example usage of data analysis functions 
######### 
#Mitochondrial Membrane Potential (dPsi) Analysis 
#High Content Microscopic Analysis of Mitochondrial Morphology and  
#Membrane Potential Using Morphological Binning 
#2014, Anthony Leonard et. al. <leonara@musc.edu>, <apleonard@gmail.com> 
######### 
 
#change these to match the location of saved files from Supplementary File 3.zip 
source('.\\annotateData.R') 
source(".\\plotDensity.R") 
library(XLConnect) #available in CRAN 
 
#first load and annotate data 
 
#load the platemap 
yfile<-".\\platemaps.xlsx" 
yfile<-file.choose() #use if not saved in same directory as this file 
 
y=readWorksheet(loadWorkbook(yfile), sheet="8-2 dPsi") 
 
#paste in locations of the datafile(s) extracted (Default C:/R/) 
 
files<-c( 
  "C:\\R\\n1 1h.csv", 
  "C:\\R\\n2 1h.csv", 
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  "C:\\R\\n3 1h.csv", 
  "C:\\R\\n4 1h.csv" 
) 
 
#using annotateData.R, includes analysis group info 
#setting platenames=0 automatically assigns experimental n and time point to each plate 









#reload results from csv table (if already annotated, see data export at end of file) 
# alldata <- read.csv(file=file.choose(),header=TRUE,sep=",") 
 
#verify import integrity 
str(alldata) 
 
# make sure that group is treated as a number 
alldata$group<-as.numeric(alldata$group) 
 
#Generating Figure 6d (Oligomycin v. vehicle v. FCCP) 
 
# calculate background-corrected intensity values 
# by subtracting nuclear intensity 
alldata$AllMitoBGCy3<-mapply(FUN=function(x,y) ifelse(is.na(x) | is.na(y),NA,max(x-y,0)),  
                           x=alldata$AllMitoCy3Intensity, y=alldata$NucCy3Intensity) 
alldata$NetBGCy3<-mapply(FUN=function(x,y) ifelse(is.na(x) | is.na(y),NA,max(x-y,0)),  
                       x=alldata$NetCy3Intensity, y=alldata$NucCy3Intensity) 
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alldata$RodBGCy3<-mapply(FUN=function(x,y) ifelse(is.na(x) | is.na(y),NA,max(x-y,0)),  
                       x=alldata$RodCy3Intensity, y=alldata$NucCy3Intensity) 
alldata$PunBGCy3<-mapply(FUN=function(x,y) ifelse(is.na(x) | is.na(y),NA,max(x-y,0)),  
                       x=alldata$PunCy3Intensity, y=alldata$NucCy3Intensity) 
alldata$SwoBGCy3<-mapply(FUN=function(x,y) ifelse(is.na(x) | is.na(y),NA,max(x-y,0)),  
                       x=alldata$SwoCy3Intensity, y=alldata$NucCy3Intensity) 
 
#calculate proportional data 







#then calculate proportion of subtype area (divide by total area in each cell) 
alldata$NetMitoP<-mapply(FUN=function(x,y) x/y, alldata$NetTotalArea, alldata$AllMitoArea) 
alldata$RodMitoP<-mapply(FUN=function(x,y) x/y, alldata$RodTotalArea, alldata$AllMitoArea) 
alldata$PunMitoP<-mapply(FUN=function(x,y) x/y, alldata$PunTotalArea, alldata$AllMitoArea) 
alldata$SwoMitoP<-mapply(FUN=function(x,y) x/y, alldata$SwoTotalArea, alldata$AllMitoArea) 
 
#set the groups used for plotting (defined in platemaps.xlsx) 
groups<-c(1,18,5) 
summary(alldata$AllMitoBGCy3[which(alldata$group %in% groups)]) 





#columns 3 and 4 are X and y location of cells, respectively 
summary(alldata[,3:4]) 
#subset out the extreme edge cells (registration adds a bright white border, values invalid) 
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#removes the strange spikes in mitochondrial membrane potential (AllMitoBGCy3) 
subset<-alldata[which(alldata[,3]>20 & alldata[,3]<360 & alldata[,4]>20 & alldata[,4]<360),] 
 
#Plot for Figure 6d: 
plotDensity(dataset=subset[which(subset$plate!=1),],plotvar="AllMitoBGCy3",groups=groups,yli
m=c(0,0.3),xlim=c(0,150),addpvalues=FALSE,xlab="Background-Corrected 
TMRM Intensity (AU)",title="") 
 
#Calculation of Kolmogorov-Smirnov statistics for comparisons in Figure 6d 
#Vehicle v. FCCP 1 uM 
ks.test(alldata$AllMitoBGCy3[which(alldata$treatment=="Vehicle")], 
        alldata$AllMitoBGCy3[which(alldata$group==18)]) 
 
#vehicle versus oligomycin 10 uM 
ks.test(alldata$AllMitoBGCy3[which(alldata$treatment=="Vehicle")], 
        alldata$AllMitoBGCy3[which(alldata$group==5)]) 
 
#vehicle versus FCCP 1 uM 
ks.test(alldata$AllMitoBGCy3[which(alldata$group==18)], 
        alldata$AllMitoBGCy3[which(alldata$group==5)]) 
 
#Help to pick out representative cells for Figure 6 panels a-c: 
#Control representative 
summary(alldata$AllMitoBGCy3[which(alldata$treatment=="Vehicle")],na.rm=TRUE) 
vcpick<-alldata[which(alldata$treatment=="Vehicle" &  
                        alldata$AllMitoBGCy3<30 & alldata$AllMitoBGCy3>29 &  




fccppick<-alldata[which(alldata$group==18 &  
                          alldata$AllMitoBGCy3<2.7 & alldata$AllMitoBGCy3>2.2 &  
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oligopick<-alldata[which(alldata$group==5 &  
                           alldata$AllMitoBGCy3<78 & alldata$AllMitoBGCy3>73 &  
                           alldata$AllMitoArea<72 & alldata$AllMitoArea>69),] 
#end representative cell picking 
 
#Other example plots (not in publication): 
plotDensity(dataset=subset[which(subset$plate!=1),],plotvar="NetBGCy3",groups=groups,ylim=
c(0,0.25),xlim=c(0,150),addpvalues=FALSE,xlab="Background-Corrected 
Networked TMRM Intensity (AU)",title="Networks") 
plotDensity(dataset=subset[which(subset$plate!=1),],plotvar="RodBGCy3",groups=groups,ylim=
c(0,0.3),xlim=c(0,150),addpvalues=FALSE,xlab="Background-Corrected Rod 
TMRM Intensity (AU)",title="Rods") 
plotDensity(dataset=subset[which(subset$plate!=1),],plotvar="PunBGCy3",groups=groups,ylim=
c(0,0.3),xlim=c(0,150),addpvalues=FALSE,xlab="Background-Corrected Puncta 
TMRM Intensity (AU)",title="Puncta") 
plotDensity(dataset=subset[which(subset$plate!=1),],plotvar="SwoBGCy3",groups=groups,ylim
=c(0,0.1),xlim=c(0,150),addpvalues=FALSE,xlab="Background-Corrected Large 
& Round TMRM Intensity (AU)",title="Large & Round") 
 
#test for normality 
summary(subset$SwoBGCy3[which(subset$group==1)]) 











text(labels="Kolmogorov-Smirnov test p value: 0.8992",x=1.0,y=2.7) 
 
#k-s test returns p value of 0.8992, suggesting the data are normally distributed 
#thus, we have no evidence to suggest that there is a bimodal distrubtion of TMRM intensity 
within swollen subpopulation 
 
#examples of data export: 
#save all data 
write.csv(alldata,file="C:/r/dPsi mitoproportion analysis.csv") 
 
#automated collation of data (by mean or median, see line 170) for graphing software, e.g. 
GraphPad Prism 6.0 
 
#first set: (membrane potential studies) 
grep("BGCy3",colnames(alldata)) 
#columns 106-110 are the variables of interest 
vars<-106:110 
 
#second set: (morphometric studies) 
grep("MitoP",colnames(alldata)) 
#columns 111-114 are the variables of interest 
vars<-111:114 
 
#to export all variables 
vars<-106:114 
 
#export in tab-delimited text (use Microsoft Excel to open files (wizard guides import), then copy 
and paste to GraphPad) 
for (i in vars) 
{ 
  x=tapply(subset[,i][which(subset$group %in% groups)], 
           INDEX=list(subset$plate[which(subset$group %in% groups)], 
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                      subset$treatment[which(subset$group %in% groups)], 
                      subset$time[which(subset$group %in% groups)]), 






#example file structure: 
# ""  "Vehicle"                                 (TREATMENT)                       
#,             "1"      "2"      "3"      "4"   (EXPERIMENTAL REPLICATE) 
# "1"       30.5900  31.4980  28.6390  28.5355 
# "2"       27.7100  33.8690  32.0895  29.7730 
# "3"       29.2220  35.0730  32.0790  30.3250 
# "4"       31.3430  37.1510  34.4820  31.5570 
# "5"       33.4670  36.7395  34.7665  32.4240 
 
#time points (in hours on the y axis) 
#experimental replicates are split across the x, first by treatment group, and then by plate # (true 




10.2 plotDensity.R: a function for density plotting and hypothesis testing 
####################### 
# Conditional inference machine-learning based method for mitochondrial 
# classification.  Leonard et. al. 2014 "Automated High Content Analysis 
# of Mitochondrial Morphology and Membrane Potential Using  
# Morphological Binning" 
 
# plotDensity - a function for density plotting and hypothesis testing 
# Plots a univariate data distribution from one or more groups 
# Calculates the median for each group (by subgroups, such as an experiment) 
# and performs multiple t-tests with Holm-Sidak's correction for  
# multiple comparisons, reporting p values 
 





                      
colors=c("black","darkred","blue","darkgreen","slategray1","tomato","yellowgreen"
,"orange"), 
                      
addpvalues=TRUE,trimdata=TRUE,pairFUN="median",legendloc=0.5,title="defa
ult",xlab=plotvar,...) { 
  if(title=="default") { 
    title=unique(dataset$treatment[which(dataset$group==groups[2])]) 
    title=substr(title,1,regexpr(" [0-9]{1,4} ",title)-1) 
    title=paste(title,"-",plotvar) 
    title=paste(title,"-",unique(dataset$time),"h") 
  } 
  groupnames=as.character(dataset$treatment[match(groups,dataset$group)]) 
  nplates=1:length(groups) 
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  ncells=1:length(groups) 
  #plot the first instance of the variable found in the dataset matching 
  var<-grep(plotvar,colnames(dataset))[[1]] 
   
  if(trimdata) 
    dataset<-dataset[which(dataset[,var]<xlim[2] & dataset[,var]>xlim[1]),] 
   
  for (i in 1:length(groups)) { 
    if (!i==1) { 
      lines(density(dataset[,var][which(dataset$group==groups[i])]),col=colors[i],lwd=2) 
       
    } 
    else ( 
      plot(kern<-
density(dataset[,var][which(dataset$group==groups[i])]),xlim=xlim,ylim=ylim,main
=title,lwd=2,xlab=xlab,ylab="Kernel Density Estimate") 
    ) 
    nplates[i] = length(unique(dataset$plate[which(dataset$group==groups[i])])) 
    ncells[i] = length(dataset$plate[which(dataset$group==groups[i])]) 
    groupnames[i] <- paste("G",groups[i],": ",groupnames[i]," | N=",nplates[i]," exps., n=",ncells[i]," 
cells",sep="") 
  } 
   
  legend(x=xlim[1]+((legendloc-0.15)*(xlim[2]-xlim[1])),y=ylim[2]-(0.0*ylim[2]-
ylim[1]),legend=groupnames,bty="n", 
         fill=colors#, border=c("black","dark red","blue") 
         ,bg="light gray",box.lwd=2) 
   
  if(pairFUN=="median") { 
    x=tapply(X=dataset[,var][which(dataset$group %in% groups)], 
         INDEX=list(dataset$group[which(dataset$group %in% groups)], 
                      dataset$plate[which(dataset$group %in% groups)]), 
         FUN=median,na.rm=TRUE) 
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    #make the array pretty 
    attr(x,"dimnames")[[1]]<-paste("G",groups,sep="") 
     
    #names take up too much space, use group # instead 
    #uncomment the line below if your dataset has a 'treatment' variable that you'd prefer versus 
a group number 
    
#factor(x=attr(x,"dimnames")[[1]],levels=groups,labels=as.character(dataset$treat
ment[match(sort(groups),dataset$group)])) 
     
    x2<-stack(data.frame(t(x))) 
     
    #now perform pairwise t tests by row (or transpose and go by column...) 
    test<-pairwise.t.test(x=x2$values,g=x2$ind,p.adjust.method="holm") 
     
  } 
  else if (pairFUN=="mean") { 
    x=tapply(dataset[,var][which(dataset$group %in% groups)], 
             INDEX=list(dataset$group[which(dataset$group %in% groups)], 
                        dataset$plate[which(dataset$group %in% groups)]), 
             FUN=mean,na.rm=TRUE) 
     
    #names take up too much space, use group # instead 
    #uncomment the line below if your dataset has a 'treatment' variable that you'd prefer versus 
a group number 
    
#factor(x=attr(x,"dimnames")[[1]],levels=groups,labels=as.character(dataset$treat
ment[match(sort(groups),dataset$group)])) 
     
    x2<-stack(data.frame(t(x))) 
     
    #now perform pairwise t tests by row (or transpose and go by column...) 
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    test<-pairwise.t.test(x=x2$values,g=x2$ind,p.adjust.method="holm") 
     
  } 
  else { 
    print("pairwise stats function not understood, all data points treated as individual 
experiments") 
    print("use 'mean' or 'median' for meaningful stats") 
    test<-pairwise.t.test(x=x,  
                          g=dataset$group[which(dataset$group %in% groups)], p.adj = "holm") 
  } 
   
if(addpvalues) { 
    stats=round(test$p.value,digits=5) 
    addtable2plot(x=xlim[1]+(legendloc*(xlim[2]-xlim[1])),y=ylim[2]-(0.5*(ylim[2]-
ylim[1])),xjust=0,yjust=0, 
                  display.colnames=TRUE,display.rownames=TRUE, hlines=TRUE,vlines=TRUE, 
                  table=stats,title="Pairwise t-tests w/ Holm-Sidak Correction") 
  } 






10.3 annotateData.R: a function for annotation of GE INCell Analyzer 
Developer Toolbox high content analysis data output (v. 1.9.1) 
################# 
# Conditional inference machine-learning based method for mitochondrial 
# classification.  Leonard et. al. 2013 "Automated High Content Analysis 
# of Mitochondrial Morphology and Membrane Potential Using  
# Morphological Binning" 
 
# annotateData - a function for annotating high content imaging data 
# obtained from the GE INCell Analyzer 2000 automated epifluorescence 
# microscope and INCell Developer Toolbox. Accepts two inputs:  
# a platemap spreadsheet and the unannotated cytometric data output  
# from Developer Toolbox (one row of data per cell) 
 
# Author contact information: Anthony Leonard: apleonard@gmail.com 
################# 
 




#x<-annotateData(platedata=readWorksheet(loadWorkbook(choose.files(caption = "Select Data 
Sheet",multi=FALSE)),sheet="Cytoplasm"),  
#                platemap=readWorksheet(loadWorkbook(choose.files(caption = "Select 
PlateMap")),sheet=1), 
#                fixNAAreas=TRUE, fixText=TRUE, platename=1, time=1); 
 
annotateData <- function (x=dataframe,y=platemap, fixNAAreas=TRUE, fixtext=TRUE, 
platename=NULL,time=0) {  
  #annotate all cells with well, column, row, field, and time 
  #assign group numbers to treatments, and label these numbers using factor() 
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  #first, set up a few vars 
  x$well = as.character("A - 0"); 
  x$row = as.character("A"); 
  x$col = as.numeric(0) 
  x$rownum = as.numeric(0) 
  x$wellnum = as.numeric(0) 
  x$time = as.numeric(time) 
  x$group = as.numeric(0) 
  x$rep = as.numeric(0) 
  x$field =as.numeric(1); 
   
  x$treatment = "A" 
   
  if(is.null(platename)) { 
    #do nothing 
  } 
  else if(is.numeric(platename)) { 
    x$plate <- as.numeric(platename) 
  } 
  else { 
    x$plate = as.factor(platename) 
  } 
     
  if(!is.na(y[23,3])) # initialize analysis group only if there is data to use 
  { 
    x$anzgroup = as.numeric(0) 
  } 
     
  #next, define the regions from platemap for replicate and grouping data 
  txlist <- y[33:128,2] 
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  group <- y[12:19,2:13] 
  rep <- y[34:41,6:17] 
  anzgroup <- y[22:29,2:13] 
   
  #shorten txlist to only have valid (nonzero) groups 
  txlabels = which(!is.na(txlist)) 
 
  #Now assign the metadata to each row 
  x$well=sapply(x[,1],FUN=substr,start=1,stop=6); 
  x$row=sapply(x[,1],FUN=substr,start=1,stop=1); 
  x$col=sapply(x$well,FUN=getCol); 
  x$rownum = sapply(x$row,FUN=getRowNum); 
  x$field = sapply(x[,1],FUN=fieldFind); 
  x$wellnum = mapply(FUN=getWellNum,x$rownum,x$col); 
  x$group <- mapply(function(row,column) as.numeric(group[row, column]), x$rownum, x$col); 
  x$rep <- mapply(function(row,column) rep[row, column], x$rownum, x$col) 
  x$treatment <- factor(x$group,levels=1:length(txlabels), 
labels=txlist[1:length(txlabels)],exclude=0) 
  x$anzgroup <- mapply(function(row,column) anzgroup[row,column], x$rownum, x$col) 
   
  #use this function to get rid of the " um2" that gets added to all of the measures  
  if(fixNAAreas) { 
    cols2Replace= c(grep("Area",colnames(x), ignore.case= 
TRUE),grep("InThisCell",colnames(x), ignore.case= 
TRUE),grep("tPerim",colnames(x), ignore.case= TRUE)) 
    xsub<-x[,cols2Replace] 
    xsub[is.na(xsub)] <- 0 
    x[,cols2Replace] <- xsub 
  } 
   
  cols2Fix = grep("Pos",colnames(x), ignore.case= TRUE) 
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  #only run this function if the user wants it run and it is needed (a number input into trimChars() 
returns an NA) 
  if(fixtext && !is.numeric(x[1,cols2Fix[1]])) { 
    xsub<-x[,cols2Fix]; 
    x[,cols2Fix] <- apply(xsub,MARGIN=2,FUN=trimChars) 
  } 
   
  #ensure that measures that can be read as numeric are forced to be numeric 
  for (i in 1:length(x[1,])) { 
    if (is.numeric(x[,i])) 
      x[,i]<-as.numeric(x[,i]) 
  } 
   
  return (as.data.frame(x)) 
} 
 
getRowNum <- function(row="A") { 
  result=0; 
  for (i in 1:26) { 
    if (LETTERS[i]==row) 
      result=i; 
  } 
  return (result) 
} 
 
getCol <- function(well="A - 1") { 
  result=0; 
  result=as.numeric(substr(well,5,6)); 
  return(result) 
} 
 
getWellNum <- function(rownum,colnum) { 
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  return((rownum-1)*12 + colnum); 
} 
 
fieldFind <- function(str="A - 1 (fld 1)") { 
  field = substr(str,start=regexpr("fld",str)+4,stop=regexpr(")",str)-1) 
   
  if (field=="") { 
    return (1) 
  } 
  else return(as.numeric(field)) 
} 
 
trimLoc <- function(input="4.01 µm") { # function returns the location of the first non-digit for 
substringing and converting values to numeric 
  return(regexpr(pattern="[^0-9.]",text=input)); 
  #above function necessary since some data columns from InCellAnalyzer Dev Toolbox 
obligatorily add "um" to label values 
} 
 
trimChars <- function(inputstring = "14.107 pixel") { 
  if (is.numeric(inputstring)) 
    result=inputstring 
  else { 
    result=as.numeric(substr(x=inputstring, start=1, stop=trimLoc(inputstring))) 
  } 
  return(result) 
} 
 
# a wrapper function that reads in plate number and time information from the directory in which 
files are stored 







  original<-data.frame(); 
  excluded<-data.frame(); 
  result<-data.frame(); 
  x<-data.frame() 
  
   
  for (i in 1:length(filelist)) { 
    rowtitle <-paste("plate",i) 
    nowdir<-dirname(filelist[i]) 
    nowname<-basename(filelist[i]) 
    if(regexpr("[n][0-9]{1,2}[ ][0-9]{1,2}[h]",nowdir,ignore.case=TRUE)==-1) 
    {#if the n1 1h format isn't found in the directory path, then use the filename to find it 
      nowdir<-nowname 
    } 
    infoloc<-regexpr("[n][0-9]{1,2}[ ][0-9]{1,2}[h]",nowdir,ignore.case=TRUE) 
    metadata<-substr(nowdir,start=infoloc,stop=infoloc + attr(infoloc,"match.length")-1) 
    timeloc<-regexpr("[0-9]{1,2}[h]",metadata,ignore.case=TRUE) 
    time<-as.numeric(substr(metadata,start=timeloc,stop=timeloc+attr(timeloc,"match.length")-2)) 
    if(platenames[1]==0) 
    { 
      plate<-as.numeric(substr(metadata,start=2,stop=attr(regexpr("[n][0-
9]{1,2}",metadata,ignore.case=TRUE),"match.length"))) 
    } 
    else 
    { 
      plate<-platenames[i] 
    } 
     
    if(xlsfiles) { 
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    #read in the cytometric data from Dev toolbox 
    platedata<-
readWorksheet(loadWorkbook(filename=filelist[i]),sheet=sheet,startRow=startRo
w) 
    } 
    else { 
      platedata<-read.csv(file=filelist[i],header=TRUE,sep=",",dec=".",skip=1) 
    } 
    #annotate using annotateData function 
     
#     x<-annotateData(...,platedata, platemap, fixNAAreas,  
#                     fixText,  
#                     platename=plate, time=time) 
    tryCatch(x<-annotateData(...,platedata, platemap, fixNAAreas,  
                             fixText,  
                             platename=plate, time=time),error = function(e) { 
                               print(paste("Error Annotating",filelist[i])) #for debugging 
                               e}) 
    if (i==1) { 
      original<-x[which(!is.na(x[,2])),] 
    } 
    else { 
      cols <- intersect(colnames(original), colnames(x)) 
      original<-rbind(original[,cols], x[which(!is.na(x[,2])),cols])       
    } 
    x$metadata<-metadata 
  } 
   
  # at the very end, make sure (one last time!) that all variables that can be treated as numeric 
are. 
  for (i in 1:length(original[1,])) { 
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    if (is.numeric(original[,i])) 
      original[,i]<-as.numeric(original[,i]) 
  } 
  #and finally drop the mysterious "X" column if it still exists, without removing Pos..X 
  cols2 <- setdiff(grep("X",colnames(original)),grep(".X",colnames(original))) 
  if(length(cols2)==1) 
     original<-original[,c(1:(cols2-1),(cols2+1):ncol(original))] 





10.4 parallelImageReg.R: a function to parallelize image registration 
############### 
# wrapper function to parallelize image registration 
# Anthony Leonard, <leonara@musc.edu> 
# default behavior is to split the task up according to number of processor cores 










affinelist <- c(1.00198,-1.37093e-05,0,0,7.60416e-07,1.00205,0,0,0,0,1,0,3.55669,-2.04304,0,1) 
affine <- matrix(affinelist, 4, 4); 
 
#Function usage: 
#suggested usage at end of file (just "source" this file to run interactively) 
#source is image that is out of alignment (e.g. Cy3 filter imaged TMRM stained mitochondria) 
#target is image that contains the true location of source image  
#(in focus slice of MitoTracker Deep Red stained mitochondria) 
#ncores=0 (default) uses all available cores 
#suppresswarning is recommended to be set as TRUE unless a job is stopped prior to 
completion 
#optimize is a switch that when TRUE adapts the initial affine to match each image (slower, 
more accurate) 








  if(file.exists(file.path(dirname(source[1]),"unregistered"))) { 
    if(!suppresswarning){ 
      r<-readline(prompt="/unregistered subdirectory exists, registration may have already been 
performed - do you wish to continue? (y/n)") 
      if(r=="n" | r=="N") { 
        stop("execution stopped, images/directory not modified") 
      } 
      r<-readline(prompt="Do you wish to register only the unregistered images?") 
      if(r=="y" | r=="Y") { 
        print("eliminating registered images from list") 
        print(paste("original image count:",length(source))) 
        list<-!file.exists(file.path(dirname(source),"unregistered",basename(source))) 
        source<-source[which(list)] 
        target<-target[which(list)] 
        print(paste("unregistered images found:",length(source))) 
        if(length(source)==0 | is.null(source)){ 
          stop("No images to register!") 
        } 
      } 
    } 
    else{ 
      print("eliminating registered images from list") 
      print(paste("original image count:",length(source))) 
      list<-!file.exists(file.path(dirname(source),"unregistered",basename(source))) 
      source<-source[which(list)] 
      target<-target[which(list)] 
      print(paste("unregistered images found:",length(source))) 
      if(length(source)==0 | is.null(source)){ 
        stop("No images to register!") 
      } 
    } 
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  } 
  else { 
    print("Setting read/write permissions") 
    Sys.chmod(list.dirs(file.path(dirname(source[1]))),"777") 
    f <- list.files(list.dirs(file.path(dirname(source[1]))), all.files = TRUE, full.names = TRUE, 
recursive = TRUE); 
    Sys.chmod(f, (file.info(f)$mode | "664")) 
    print("Creating 'unregistered' subdirectory for original files") 
    dir.create(file.path(dirname(source[1]),"unregistered")) 
  } 
   
  #initialize the cluster 
  #default to use all cores available 
  if(ncores==0) { 
    cl<-makePSOCKcluster(names<-detectCores()) 
    print(paste(names, "processors detected,", names, "processors will be used")) 
  } 
  else  { 
    cl<-makePSOCKcluster(names<-min(ncores,detectCores())) 
    print(paste(detectCores(), "processors detected,", names, "processors will be used")) 
  }    
 
  imagelist<-cbind(source,target) 
  #definitely want to have the algorithm save images as it goes along 
  print("Beginning image registration") 
  clusterMap(cl, fun=function(x,y,z=optimize){ 
    library(oro.nifti) 
    library(tiff) 
    library(parallel) 
    library(RNiftyReg) 




    affine <- matrix(affinelist, 4, 4); 
    print("copying file to unregistered") 
    file.copy(x,file.path(dirname(x),"unregistered",basename(x))) 
    print(paste("analyzing:",x)) 
    if(optimize) 
    { 
      writeTIFF(what=niftyreg.linear(as.nifti(readTIFF(x)), as.nifti(readTIFF(y)), 
                                     scope="affine", initAffine=affine, verbose=FALSE, nLevels=2)[1], 
                where=x, bits.per.sample=16, reduce=TRUE) 
    } 
#     else { #nonfunctional 
#       writeTIFF(what=applyAffine(affine=affine,as.nifti(readTIFF(x)), as.nifti(readTIFF(y)))[1], 
#                 where=x, bits.per.sample=16, reduce=TRUE)     
#     } 
    else { 
      writeTIFF(what=niftyreg.linear(as.nifti(readTIFF(x)), as.nifti(readTIFF(y)), 
                                     scope="affine", initAffine=affine, verbose=FALSE, nLevels=0)[1], 
                where=x, bits.per.sample=16, reduce=TRUE) 
    } 
  }, x=imagelist[,1], y=imagelist[,2]) 
   
  print("Killing Cluster") 
  stopCluster(cl) 
  print("Cluster killed, waiting 5 seconds") 
  Sys.sleep(time=5) 
  print("Image Stack Completed, Please Kill R process to free memory") 
 






#   library(oro.nifti) 
#   library(tiff) 
#   library(parallel) 
#   library(RNiftyReg) 
#   affinelist <- c(.002061,-3.436325e-05,0,0,7.618232e-05,1.002105,0,0,0,0,1,0,2.209438,-
2.706979,0,1); 
#   affine <- matrix(affinelist, 4, 4); 
#   writeTIFF(what=niftyreg.linear(as.nifti(readTIFF(source)), as.nifti(readTIFF(target)), 
#                             scope="affine", initAffine=affine, verbose=FALSE, nLevels=2)[1], 
#             where=source, bits.per.sample=16, reduce=TRUE) 
# } 
 
getImageList<-function(source="Cy3 - Cy3",source2=NULL) { 
  print("Please select the first in focus MTDR Image") 
  file<-file.choose() 
  zloc<-regexpr(pattern=" z [0-9]{1,3}",basename(file)) 
  z<-as.numeric(substr(basename(file),zloc+3,zloc-1+attr(zloc,"match.length"))) 
  zsearch<-paste(" z ",z,sep="") 
  dirloc<-dirname(file) 
  filelist<-dir(dirname(file)) 
  targetlist<-filelist[which(grepl(zsearch,filelist)&!grepl("poly",filelist))] 
  sourcelist<-filelist[which(grepl(source,filelist)&!grepl("poly",filelist))] 
  if(!is.null(source2)) { 
    sourcelist2<-filelist[which(grepl(source2,filelist)&!grepl("poly",filelist))] 
    imagelist<-cbind(file.path(dirloc,sourcelist),file.path(dirloc,targetlist), 
file.path(dirloc,sourcelist2)) 
  } 
  else { 
    imagelist<-cbind(file.path(dirloc,sourcelist),file.path(dirloc,targetlist)) 
  } 
  print(paste(nrow(imagelist),"images (sets) to analyze")) 





#general usage for aligning two images to another image that is very simliar  
#(e.g. TMRM in Cy3 to MitoTracker Deep Red in Cy5 and NAO in FITC to MitoTracker Deep 
Red in Cy5) 
# imagepaths<-getImageList("Cy3 - Cy3","Cy3 - Cy5") 
#  print(imagepaths[1,1]) 
# parImageReg(imagepaths[,1],imagepaths[,2],affine,ncores=8) 
# parImageReg(imagepaths[,3],imagepaths[,2],affine,ncores=8) 
# #  
# print(imagepaths[1,1]) 
 
#for Brett's Imaging 3/13/14 
imagepaths<-getImageList("Cy3 - Cy3","FITC - FITC") 
#print out the first Cy3 image so we can keep track of which image the algorithm is working on 
print(imagepaths[1,3]) 
#register Cy3 images 
parImageReg(imagepaths[,1],imagepaths[,2],affine,ncores=8,optimize=TRUE) #set 
optimize=TRUE only if Cy3 images are TMRM or some other mitochondrial stain 
#register FITC images 
print("First set of images done, registering second set") 
parImageReg(imagepaths[,3],imagepaths[,2],affine,ncores=8,optimize=TRUE) #in this case, we 
know CellROX Green  
#(in the FITC channel, column 3 of imagepaths) does not line up with mitochondria,  
#so we set optimize=FALSE to use stored affine transformation 
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